# EDGAR Filing Document

**Accession Number:** 0000916789
**File Stem:** 0000916789-26-000048
**Filing Date:** 2026-4
**Character Count:** 516874
**Document Hash:** ce8e7d97beb485cebfa56488f6a7ac44
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000916789-26-000048.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0000916789-26-000048

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 125

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HELEN OF TROY LTD
- **CENTRAL INDEX KEY:** 0000916789
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRIC HOUSEWARES & FANS [3634]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 742692550
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14669
- **FILM NUMBER:** 26885470

**BUSINESS ADDRESS:**
- **STREET 1:** CLARENDON HOUSE
- **STREET 2:** 2 CHURCH STREET
- **CITY:** HAMILTON
- **STATE:** D0
- **ZIP:** HM 11
- **BUSINESS PHONE:** 915-225-8000

**MAIL ADDRESS:**
- **STREET 1:** 201 EAST MAIN STREET
- **STREET 2:** SUITE 300
- **CITY:** EL PASO
- **STATE:** TX
- **ZIP:** 79901

?xml version='1.0' encoding='ASCII'? hele-20260228

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-K** 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended February 28, 2026

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-14669

![helenoftroylogoa02.jpg](hele-20260228_g1.jpg)

**HELEN OF TROY LIMITED** 

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Bermuda** | **74-2692550** |
| (State or other jurisdiction | (I.R.S. Employer |
| of incorporation or organization) | Identification No.) |

---

**Clarendon House** 

**2 Church Street** 

**Hamilton HM 11, Bermuda** 

(Address of principal executive offices)

**201 E. Main Street, Suite 300**

**El Paso, Texas 79901**

(Registrant's United States Mailing Address)

**(915) 225-8000** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Shares, $0.10 par value per share** | **HELE** | **The NASDAQ Stock Market LLC** |

---

Securities registered pursuant to Section 12(g) of the Act: **NONE**

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Large accelerated filer  | ☒ | &nbsp;&nbsp;Accelerated filer | &nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-accelerated filer  | ☐ | &nbsp;&nbsp;Smaller reporting company  | &nbsp;&nbsp;☐ |
| | | &nbsp;&nbsp;Emerging growth company  | &nbsp;&nbsp;☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common shares held by non-affiliates of the registrant as of August 31, 2025, based upon the closing price of the common shares as reported by The NASDAQ Global Select Market on such date, was approximately $560.5 million.

As of April 16, 2026, there were 23,257,705 common shares, $0.10 par value per share, outstanding.

**DOCUMENTS INCORPORATED BY REFERENCE**

Portions of the Proxy Statement for the 2026 Annual General Meeting of Shareholders to be filed within one hundred and twenty days of the fiscal year ended February 28, 2026 (2026 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**TABLE OF CONTENTS**

---

| | | | |
|:---|:---|:---|:---|
| | | | **PAGE** |
| <u>[PART I](#i936101cd7c9141b1bfa0ebe7f99e49a9_13)</u> | <u>[Item 1.](#i936101cd7c9141b1bfa0ebe7f99e49a9_16)</u> | <u>[Business](#i936101cd7c9141b1bfa0ebe7f99e49a9_16)</u> | <u>[3](#i936101cd7c9141b1bfa0ebe7f99e49a9_16)</u> |
|  | <u>[Item 1A.](#i936101cd7c9141b1bfa0ebe7f99e49a9_19)</u> | <u>[Risk Factors](#i936101cd7c9141b1bfa0ebe7f99e49a9_19)</u> | <u>[11](#i936101cd7c9141b1bfa0ebe7f99e49a9_19)</u> |
|  | <u>[Item 1B.](#i936101cd7c9141b1bfa0ebe7f99e49a9_22)</u> | <u>[Unresolved Staff Comments](#i936101cd7c9141b1bfa0ebe7f99e49a9_22)</u> | <u>[30](#i936101cd7c9141b1bfa0ebe7f99e49a9_22)</u> |
|  | <u>[Item 1C.](#i936101cd7c9141b1bfa0ebe7f99e49a9_25)</u> | <u>[Cybersecurity](#i936101cd7c9141b1bfa0ebe7f99e49a9_25)</u> | <u>[30](#i936101cd7c9141b1bfa0ebe7f99e49a9_25)</u> |
|  | <u>[Item 2.](#i936101cd7c9141b1bfa0ebe7f99e49a9_28)</u> | <u>[Properties](#i936101cd7c9141b1bfa0ebe7f99e49a9_28)</u> | <u>[32](#i936101cd7c9141b1bfa0ebe7f99e49a9_28)</u> |
|  | <u>[Item 3.](#i936101cd7c9141b1bfa0ebe7f99e49a9_31)</u> | <u>[Legal Proceedings](#i936101cd7c9141b1bfa0ebe7f99e49a9_31)</u> | <u>[32](#i936101cd7c9141b1bfa0ebe7f99e49a9_31)</u> |
|  | <u>[Item 4.](#i936101cd7c9141b1bfa0ebe7f99e49a9_34)</u> | <u>[Mine Safety Disclosures](#i936101cd7c9141b1bfa0ebe7f99e49a9_34)</u> | <u>[33](#i936101cd7c9141b1bfa0ebe7f99e49a9_34)</u> |
| <u>[PART II](#i936101cd7c9141b1bfa0ebe7f99e49a9_37)</u>  | <u>[Item 5.](#i936101cd7c9141b1bfa0ebe7f99e49a9_40)</u> | <u>[Market for Registrant](#i936101cd7c9141b1bfa0ebe7f99e49a9_40)['](#i936101cd7c9141b1bfa0ebe7f99e49a9_40)[s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#i936101cd7c9141b1bfa0ebe7f99e49a9_40)</u> | <u>[33](#i936101cd7c9141b1bfa0ebe7f99e49a9_40)</u> |
|  | <u>[Item 6.](#i936101cd7c9141b1bfa0ebe7f99e49a9_43)</u> | <u>[\[Reserved\]](#i936101cd7c9141b1bfa0ebe7f99e49a9_43)</u> | <u>[35](#i936101cd7c9141b1bfa0ebe7f99e49a9_43)</u> |
|  | <u>[Item 7.](#i936101cd7c9141b1bfa0ebe7f99e49a9_46)</u> | <u>[Management](#i936101cd7c9141b1bfa0ebe7f99e49a9_46)['](#i936101cd7c9141b1bfa0ebe7f99e49a9_46)[s Discussion and Analysis of Financial Condition and Results of Operations](#i936101cd7c9141b1bfa0ebe7f99e49a9_46)</u> | <u>[36](#i936101cd7c9141b1bfa0ebe7f99e49a9_46)</u> |
|  | <u>[Item 7A.](#i936101cd7c9141b1bfa0ebe7f99e49a9_127)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i936101cd7c9141b1bfa0ebe7f99e49a9_127)</u> | <u>[69](#i936101cd7c9141b1bfa0ebe7f99e49a9_127)</u> |
|  | <u>[Item 8.](#i936101cd7c9141b1bfa0ebe7f99e49a9_130)</u> | <u>[Financial Statements and Supplementary Data](#i936101cd7c9141b1bfa0ebe7f99e49a9_130)</u> | <u>[71](#i936101cd7c9141b1bfa0ebe7f99e49a9_130)</u> |
|  | <u>[Item 9.](#i936101cd7c9141b1bfa0ebe7f99e49a9_217)</u> | <u>[Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#i936101cd7c9141b1bfa0ebe7f99e49a9_217)</u> | <u>[124](#i936101cd7c9141b1bfa0ebe7f99e49a9_217)</u> |
|  | <u>[Item 9A.](#i936101cd7c9141b1bfa0ebe7f99e49a9_220)</u> | <u>[Controls and Procedures](#i936101cd7c9141b1bfa0ebe7f99e49a9_220)</u> | <u>[124](#i936101cd7c9141b1bfa0ebe7f99e49a9_220)</u> |
|  | <u>[Item 9B.](#i936101cd7c9141b1bfa0ebe7f99e49a9_223)</u> | <u>[Other Information](#i936101cd7c9141b1bfa0ebe7f99e49a9_223)</u> | <u>[124](#i936101cd7c9141b1bfa0ebe7f99e49a9_223)</u> |
|  | <u>[Item 9C.](#i936101cd7c9141b1bfa0ebe7f99e49a9_226)</u> | <u>[Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#i936101cd7c9141b1bfa0ebe7f99e49a9_226)</u> | <u>[124](#i936101cd7c9141b1bfa0ebe7f99e49a9_226)</u> |
| <u>[PART III](#i936101cd7c9141b1bfa0ebe7f99e49a9_229)</u> | <u>[Item 10.](#i936101cd7c9141b1bfa0ebe7f99e49a9_232)</u> | <u>[Directors, Executive Officers and Corporate Governance](#i936101cd7c9141b1bfa0ebe7f99e49a9_232)</u> | <u>[125](#i936101cd7c9141b1bfa0ebe7f99e49a9_232)</u> |
|  | <u>[Item 11.](#i936101cd7c9141b1bfa0ebe7f99e49a9_235)</u> | <u>[Executive Compensation](#i936101cd7c9141b1bfa0ebe7f99e49a9_235)</u> | <u>[125](#i936101cd7c9141b1bfa0ebe7f99e49a9_235)</u> |
|  | <u>[Item 12.](#i936101cd7c9141b1bfa0ebe7f99e49a9_238)</u> | <u>[Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#i936101cd7c9141b1bfa0ebe7f99e49a9_238)</u> | <u>[125](#i936101cd7c9141b1bfa0ebe7f99e49a9_238)</u> |
|  | <u>[Item 13.](#i936101cd7c9141b1bfa0ebe7f99e49a9_241)</u> | <u>[Certain Relationships and Related Transactions, and Director Independence](#i936101cd7c9141b1bfa0ebe7f99e49a9_241)</u> | <u>[125](#i936101cd7c9141b1bfa0ebe7f99e49a9_241)</u> |
|  | <u>[Item 14.](#i936101cd7c9141b1bfa0ebe7f99e49a9_244)</u> | <u>[Principal Accountant Fees and Services](#i936101cd7c9141b1bfa0ebe7f99e49a9_244)</u> | <u>[125](#i936101cd7c9141b1bfa0ebe7f99e49a9_244)</u> |
| <u>[PART IV](#i936101cd7c9141b1bfa0ebe7f99e49a9_247)</u>  | <u>[Item 15.](#i936101cd7c9141b1bfa0ebe7f99e49a9_250)</u> | <u>[Exhibits and Financial Statement Schedules](#i936101cd7c9141b1bfa0ebe7f99e49a9_250)</u> | <u>[126](#i936101cd7c9141b1bfa0ebe7f99e49a9_250)</u> |
|  | <u>[Item 16.](#i936101cd7c9141b1bfa0ebe7f99e49a9_253)</u> | <u>[Form 10-K Summary](#i936101cd7c9141b1bfa0ebe7f99e49a9_253)</u> | <u>[127](#i936101cd7c9141b1bfa0ebe7f99e49a9_253)</u> |
|  |  | <u>[Signatures](#i936101cd7c9141b1bfa0ebe7f99e49a9_256)</u> | <u>[128](#i936101cd7c9141b1bfa0ebe7f99e49a9_256)</u> |

---

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**EXPLANATORY NOTE**

***In this Annual Report on Form 10-K (the "Annual Report"), which includes the accompanying consolidated financial statements and notes, unless otherwise indicated or the context suggests otherwise, references to "the Company", "our Company", "Helen of Troy", "we", "us", or "our" refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as "common stock." References to "EMEA" refer to the combined geographic markets of Europe, the Middle East and Africa. We use product and service names in this Annual Report for identification purposes only and they may be protected in the United States and other jurisdictions by trademarks, trade names, service marks, and other intellectual property rights of ours and other parties. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their respective owners. References to "fiscal" in connection with a numeric year number denotes our fiscal year ending on the last day of February, during the year number listed. References to "the FASB" refer to the Financial Accounting Standards Board. References to "GAAP" refer to accounting principles generally accepted in the United States of America (the "U.S."). References to "ASU" refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.***

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**PART I**

**Item 1. Business**

**Our Company**

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. We have built leading market positions through new product innovation, product quality and competitive pricing. We go to market under a number of brands, some of which are licensed. Our portfolio of brands includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June, among others.

**Segment Information**

We currently operate in two reportable business segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Home & Outdoor:** Offers a broad range of outstanding world-class brands that help consumers enjoy everyday living inside their homes and outdoors. Our innovative products for home activities include food preparation and storage, cooking, cleaning, organization and beverage service. Our outdoor performance range, on-the-go food storage and beverageware includes lifestyle hydration products, coolers and food storage solutions, backpacks and travel gear. Sales for this global segment are primarily to online and brick & mortar retailers and through our direct-to-consumer channel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Beauty & Wellness:** Provides consumers with a broad range of outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, liquid and aerosol personal care products and nail care solutions that help consumers look and feel more beautiful. In Wellness, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters and fans. Sales for this global segment are primarily to online and brick & mortar retailers, distributors and through our direct-to-consumer channel.

For more segment and geographic information concerning our net sales revenue, long-lived assets and operating income, refer to Note 17 to the accompanying consolidated financial statements.

**Our Strategy**

During fiscal 2026, we made significant organizational and operational changes designed to stabilize our business. The Board of Directors appointed a new Chief Executive Officer with transformation experience needed to help drive our next phase of value creation. Under this new leadership, we are currently engaged in a comprehensive review of our strategic priorities as we re-position our Company to deliver sustained revenue and profit growth, increase market share and create superior long-term value for all stakeholders.

We are taking steps to modernize our business model designed to move at the speed of the consumer and excel in a rapidly evolving environment with fragmented consumer attention and shifting value perceptions. Our strategy includes the following priorities: reenergize our brands and our people, adapt our organizational structure to put the consumer at the center of everything we do, strengthen our brand portfolio for predictable long-term growth, and improve asset efficiency. As part of our strategy, we plan to sharpen our focus on fewer, more impactful initiatives, which include investing more in product innovation, strengthening brand loyalty, and advancing commercial excellence. We intend to energize our brands through a disciplined investment approach focusing on impactful opportunities that generate competitive advantages and deliver product solutions and world-class innovation to our consumers. In

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

addition, we believe our consumer-centric approach will enable us to better understand our consumers, allocate resources more efficiently, and accelerate the time to market for new products and brands with the best opportunities for long-term sustainable growth. We expect this will strengthen our portfolio of brands to provide a pathway for strong cash flow generation to further invest back into our business. We remain focused on improving balance sheet health and productivity, by prioritizing our capital expenditures, optimizing our working capital, and monetizing less productive assets. While we are finalizing this strategy reset, we have already implemented many of the foundational changes intended to drive long-term performance, and we have taken immediate actions we believe will accelerate our product innovation, sharpen our go-to-market execution, strengthen our cash flow, and pay down our debt.

**Our Products**

The following table summarizes the types of products we sell by business segment:

---

| | | |
|:---|:---|:---|
| **Segment** | **Product Category** | **Primary Products** |
| Home & Outdoor | Home Solutions | Food storage containers, kitchen utensils for cooking and preparing salads, fruits, vegetables and meats, graters, slicers and choppers, baking essentials, kitchen organization, bath, cleaning, infant and toddler products and coffee preparation tools and electronics |
| | Insulated Beverageware, Coolers and Food Storage Solutions | Insulated beverageware including bottles, travel tumblers, drinkware and mugs, food and lunch containers, insulated totes, soft coolers, outdoor kitchenware and accessories |
| | Technical, Outdoor, Travel, and Lifestyle Packs and Accessories | Technical and outdoor sports packs, bike packs and bags, hydration and travel packs, duffel bags and luggage, lifestyle and everyday packs, kid carrier packs and accessories |
| Beauty & Wellness | Hair Tools and Accessories | Mass, professional and prestige hair appliances, brushes, grooming tools and accessories |
| | Hair Liquids | Prestige shampoos, liquid hair styling products, treatments and conditioners |
| | Nail Consumables and Grooming Tools | Nail polish, press-on nails, manicure and pedicure systems, grooming tools and nail care essentials |
| | Wellness Devices and Consumables | Thermometers, blood pressure monitors, pulse oximeters, nasal aspirators, humidifiers, faucet mount and pitcher water filtration systems, air purifiers, heaters, fans and humidification, thermometry, water filtration and air purification consumables |

---

**Our Trademarks**

We market and sell certain of our products under our own trademarks and trademarks licensed from third parties. We believe our principal trademarks, both owned and licensed, have high levels of brand name recognition among retailers and consumers throughout the world. Through our favorable partnerships with our licensors, we believe we have developed stable, enduring relationships that provide access to unique brands that complement our owned and internally developed trademarks.

The Beauty & Wellness segment relies on the continued use of trademarks licensed under various agreements for a significant portion of its net sales revenue. New product introductions under licensed trademarks require approval from the respective licensors. The licensors must also approve the product packaging. Some of our license agreements require us to pay minimum royalties. Our licensors and licensees also generally have the ability to terminate or non-renew their license agreements with us at their option subject to each parties' right to continue the license for a period of time following notice of termination or non-renewal.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following table lists our key trademarks by business segment:

---

| | | |
|:---|:---|:---|
| **Segment** | **Owned** | **Licensed** |
| Home & Outdoor | OXO, Good Grips, Soft Works, OXO tot, OXO Brew, OXO Strive, OXO Outdoor, Hydro Flask, Osprey | |
| Beauty & Wellness | Drybar, Hot Tools, Curlsmith, Olive & June, PUR | Revlon, Honeywell, Braun, Vicks |

---

**Patents and Other Intellectual Property**

We maintain utility and design patents in the U.S. and several foreign countries. We also protect certain details about our processes, products and strategies as trade secrets, keeping confidential the information that we believe provides us with a competitive advantage.

**Sales and Marketing**

We currently market our products in approximately 100 countries throughout the world. Sales within the U.S. comprised approximately 72%, 71% and 74% of total net sales revenue in fiscal 2026, 2025 and 2024, respectively. Our segments primarily sell their products through mass merchandisers, sporting goods retailers, department stores, drugstore chains, home improvement stores, grocery stores, specialty stores, prestige beauty chains, beauty supply retailers, e-commerce retailers, wholesalers, warehouse clubs and various types of distributors, as well as directly to consumers. We take a consumer-centric approach to assortment planning by fostering close collaborations with our retail customers. In many instances, we produce specific versions of our product lines with exclusive designs and packaging for our retail customers, which are appropriately priced for their respective customer bases. During fiscal 2026, we realigned our commercial triangle of product, sales and marketing to enhance our go-to-market effectiveness by having our brand marketing teams and North America sales teams report directly into our business segment Presidents. As a result, we also transitioned our business intelligence, insights and analytics, agency management and digital strategy teams to report to our Chief Strategy Officer. We sell products principally through the use of outside sales representatives and our own internal sales associates, supported by our brand marketing teams, category management, engineering, creative services and customer and consumer service associates. These groups work closely together, leveraging marketing data and analytics, to develop pricing and distribution strategies, to design packaging and to help develop product line extensions and new products.

**Research and Development**

Our research and development activities focus on new, differentiated and innovative products designed to drive sustained organic growth. We continually invest to strengthen our product design and research and development capabilities, including extensive studies to gain consumer insights. Research and development expenses consist primarily of salaries and employee benefits, contracted development and testing efforts and third-party design agencies associated with the development of products.

**Manufacturing and Distribution**

We contract with unaffiliated manufacturers, primarily in China, Vietnam and Mexico, to manufacture a significant portion of our finished goods for the Home & Outdoor segment and our Beauty & Wellness segment's hair tools and accessories and nail consumables and grooming tools, as well as certain wellness product categories. The hair liquids category of the Beauty & Wellness segment sources most of its products from U.S. manufacturers. Finished goods manufactured by vendors in Asia comprised approximately 83% of finished goods purchased in fiscal 2026 and approximately 79% of finished goods purchased in both fiscal 2025 and 2024. Finished goods manufactured by vendors in China comprised approximately 57%, 63% and 62% of finished goods purchased in fiscal 2026, 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We occupy owned and leased office and distribution space in various locations to support our operations. These facilities include our U.S. headquarters in El Paso, Texas, and distribution centers in Southaven and Olive Branch, Mississippi, and Gallaway, Tennessee, which are used to support a significant portion of our domestic distribution. See Note 4 to the accompanying consolidated financial statements for additional information.

**Customers**

Sales to our largest customer, Amazon.com Inc., accounted for approximately 20%, 22% and 21% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively. Sales to our second largest customer, Walmart, Inc., including its worldwide affiliates, accounted for approximately 13%, 11% and 9% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively. Sales to our third largest customer, Target Corporation, accounted for approximately 12%, 11% and 10% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively. No other customers accounted for 10% or more of consolidated net sales revenue during these fiscal years. Sales to our top five customers accounted for approximately 50%, 49% and 47% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively.

**Order Backlog**

When placing orders, our individual consumer, retail and wholesale customers usually request that we ship the related products within a short time frame. As such, there usually is no significant backlog of orders in any of our distribution channels.

**Seasonality**

The following table illustrates the seasonality of our net sales revenue by fiscal quarter as a percentage of annual net sales revenue for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Quarters Ended Last Day of Month** | **Fiscal Quarters Ended Last Day of Month** | **Fiscal Quarters Ended Last Day of Month** |
| | **2026** | **2025** | **2024** |
| May | 20.8% | 21.8% | 23.7% |
| August | 24.2% | 24.9% | 24.5% |
| November | 28.7% | 27.8% | 27.4% |
| February | 26.3% | 25.5% | 24.4% |

---

Our sales are seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Historically, the third fiscal quarter produces the highest net sales revenue during the fiscal year.

**Competitive Conditions**

We generally sell our products in markets that are very competitive and mature. Our products compete against similar products of many large and small companies, including well-known global competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. We believe that we have certain key competitive advantages, such as well recognized brands, engineering expertise and innovation, sourcing and supply chain know-how and productive co-development relationships with our manufacturers. We support our products with advertising, promotions, strategic partnerships with ambassadors and influencers and other marketing activities, as well as an extensive sales force in order to build awareness and to encourage new consumers to try our brands and products. We are well positioned in the industry segments and markets in which we operate, often holding leading market share positions. We believe these advantages allow us to bring our retailers a differentiated value proposition.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following table summarizes our primary competitors by business segment:

---

| | |
|:---|:---|
| **Segment** | **Competitor** |
| Home & Outdoor | Lifetime Brands, Inc. (KitchenAid), Breville Group, Corning Incorporated (Pyrex), Progressive International (SnapLock), Meyer Corporation (Farberware), Newell Brands Inc., Simple Human LLC, Yeti Holdings, Inc., Bradshaw International (GoodCook), PMI Worldwide (Stanley), Patagonia, Gregory Mountain Products, CamelBak, The North Face, Deuter, Cotopaxi, Thule Group, Trove Brands, LLC (Owala) |
| Beauty & Wellness | Conair, Spectrum Brands Holdings Inc. (Remington), Coty Inc., Dyson Ltd, L'Oréal S.A., DevaCurl, SharkNinja, Inc., Exergen Corporation, Omron Healthcare, Inc., Crane Engineering, Newell Brands, Inc., Lasko Products, LLC, Vesync Co., Ltd (Levoit), The Clorox Company (Brita), Zero Technologies, LLC, Vornado Air Circulation Systems, Unilever (Blueair), Wella Operations US LLC, KISS USA, Guardian Technologies LLC. |

---

**Environmental and Health and Safety Matters**

Our operations are subject to national, state, local and provincial jurisdictions' environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements and set product identification, labeling and claim requirements. For example, thermometers distributed by our Beauty & Wellness segment must comply with various regulations governing the production and distribution of medical devices. Similarly, some of our Beauty & Wellness segment's customers also require that our hair appliances comply with various safety certifications, including UL certifications. Additionally, some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the "EPA"), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission and the European Union ("EU").

During fiscal 2022 and 2023, we were in discussions with the EPA regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. We continue to have ongoing settlement discussions with the EPA related to this matter. As of February 28, 2026, we accrued an estimated liability of $4.4 million, which represents our best estimate of probable settlement costs related to this matter.

An emerging trend with governmental and non-governmental organizations, consumers, shareholders, retail customers, communities, and other stakeholders is increased focus and expectations on sustainability matters. These trends have led to, among other things, increased public and private social accountability reporting requirements relating to labor practices, climate change, human trafficking and other sustainability matters and greater demands on our packaging and products. In our product space, some requirements have already been mandated, and we believe others may become required in the future. Examples of current requirements include conflict minerals content reporting, customer reporting of foreign fair labor practices in connection with our supply chain vendors and evaluating the risks of human trafficking and slavery.

We believe that we are in material compliance with these laws, regulations and other reporting requirements. Due to our operations and the frequently changing and increasingly burdensome nature of compliance and social reporting standards and technology, we cannot predict with any certainty what future material capital or operating expenditures, if any, will be required in order to comply with applicable laws, regulations and other reporting mandates. Further, any failure to achieve our sustainability goals or a perception of our failure to act responsibly or to effectively respond to new, or changes in, legal or

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

regulatory requirements relating to sustainability concerns could adversely affect our business, financial condition, results of operations and reputation.

**Sustainability Initiatives** 

We uphold rigorous corporate governance standards that support transparency, ethical business practices and long-term value creation for our stakeholders, including associates, consumers, customers, shareholders and communities. As we execute our strategic initiatives, we seek to drive organic sales growth, expand margins and deploy capital strategically, with sustainability initiatives supporting these objectives critical to our operations and market success. This focus enhances our ability to adapt to evolving consumer expectations, mitigate risks and position us as a responsible global market participant.

Our Board of Directors, through the Corporate Governance Committee, oversees sustainability-related matters and their implementation (including environmental, climate change and human rights). Our Vice President of Regulatory, Sustainability and Governance leads these initiatives to implement a strategic plan aligned with globally recognized frameworks, such as the Task Force on Climate-related Financial Disclosures ("TCFD").

Our approach to product design and development prioritizes meeting growing consumer demand for products that are safe, durable and responsibly made. We focus on innovation that incorporates principles of environmental stewardship, such as circularity, recyclability, and reducing packaging waste, ensuring alignment with consumer values and building trust in our brands. Additionally, we conduct comprehensive supply chain audits to ensure compliance with ethical labor practices and responsible sourcing, reinforcing our reputation for quality and integrity.

As part of our sustainability strategy, we report climate-related data to the Carbon Disclosure Project in alignment with TCFD guidelines, implement responsible climate policies and advance science-based emissions reduction targets. These actions position us to address regulatory requirements and investor expectations while mitigating climate-related risks and ensuring long-term business viability.

In June 2025, we published our fifth Sustainability Report, summarizing our strategy and highlighting progress in environmental stewardship and human capital development. These disclosures align with our commitment to transparency and responsible business practices. Information in our Sustainability Report is not part of this Annual Report or any other report we file with, or furnish to, the Securities and Exchange Commission ("SEC"), except as expressly set forth by specific reference in such a filing.

**Human Capital**

*Overview*

We are committed to fostering a positive and engaging culture of inclusion, care, belonging, and support where all members of our global workforce can thrive. To enhance associates' "total well-being," we offer a range of resources, including learning and development opportunities, volunteer time off, financial and retirement planning advice, employee stock purchase programs, health and wellness initiatives and product discounts. Perks and benefits vary by region and office. Additionally, we monitor our culture and associate engagement through various methods, including periodic culture surveys.

Attracting, developing and retaining top talent is critical to our continued success as a business. We have a performance evaluation and feedback process for all associates. We encourage career planning at all levels of the Company. We have a formal system in place to identify and develop talent, along with mechanisms to create development and succession plans for key positions within the organization. Our senior leadership team develops and recommends to the Board of Directors succession plans for all of our senior management.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Our compensation program is designed to offer a competitive package that attracts, retains, motivates and rewards exceptional associates. We adhere to a 'pay for performance' philosophy, linking annual compensation adjustments to overall Company performance and individual contributions. Our compensation processes also ensure fair and equitable pay for all associates.

We believe that our culture, fair pay, benefits, rewards and recognition, healthy-living initiatives, collaborative projects and open communication between management and staff enables us to attract and retain talented associates.

*Our Associates*

As of February 28, 2026, we employed 1,854 full-time associates worldwide. We also use temporary, part-time and seasonal associates as needed.

None of our U.S. associates are covered by a collective bargaining agreement. Certain of our associates in Europe and Vietnam are covered by collective arrangements or works counsel in accordance with local practices. We have never experienced a work stoppage, and we believe that we have satisfactory working relations with our associates.

We believe that an inclusive workforce is essential to fostering innovation, driving growth and meeting the evolving needs of global consumers. By valuing and celebrating the unique perspectives of our associates, we strengthen our ability to develop products that resonate with diverse markets, enhance our global competitiveness and align with consumer demand. This gives us a competitive edge in attracting and retaining top talent, fostering an environment where associates feel empowered to contribute their best.

We are advancing initiatives to foster inclusion and engagement which include: culture building and re-recruiting within our organization, leadership coaching and training to build awareness and sponsorship, recruitment actions, associate learning programs to develop skills, associate resource groups, ongoing dialogue sessions with our associates and charitable donations to non-profit organizations whose missions and values align with our culture.

*Communities*

We have a 50-plus-year tradition of supporting the communities where we live and work through charitable donations from both the Company and its associates. In addition, we provide our associates two paid community service days to donate their time to organizations that matter most to them. We believe our community engagement and good corporate citizenship will lead to stronger communities and shared success for our Company.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Available Information**

We maintain our main Internet site at: http://www.helenoftroy.com. The information contained on this website is not included as a part of, or incorporated by reference into, this Annual Report. We make available on or through our main website's Investor Relations page under the heading "Financials - SEC Filings" certain reports and amendments to those reports that we file with, or furnish to, the SEC in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These include our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K, our proxy statements on Schedule 14A, amendments to these reports and the reports required under Section 16 of the Exchange Act of transactions in our common stock by directors and officers. We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC. The SEC maintains a website at https://www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. Also, on the Investor Relations page, under the heading "Governance," are our Code of Ethics, Code of Conduct, Corporate Governance Guidelines and the Charters of the Committees of the Board of Directors.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Item 1A. Risk Factors**

Carefully consider the risks described below and all of the other information included in our Annual Report when deciding whether to invest in our securities or otherwise evaluating our business. If any of the risks or other events or circumstances described elsewhere in this Annual Report materialize, our business, operating results or financial condition may suffer. As a result, the trading price of our common stock and the value of your investment might significantly decline. The risks listed below are not the only risks that we face. Additional risks unknown to us or that we currently believe are insignificant may also affect our business.

You should also refer to the explanation of the qualifications and limitations on forward-looking statements under "Information Regarding Forward-Looking Statements," at the end of Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations." All forward-looking statements made by us are qualified by the risk factors described below.

The following is a summary of some of the principal risk factors which are more fully described below.

***Business, Operational and Strategic Risks***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The geographic concentration of certain of our U.S. distribution facilities increases our risk to disruptions that could affect our ability to deliver products in a timely manner.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The occurrence of cyber incidents, or failure by us or our third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data, could have a material adverse effect on our operations and profitability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A cybersecurity breach, obsolescence or interruptions in the operation of our central global Enterprise Resource Planning systems and other peripheral information systems could have a material adverse effect on our operations and profitability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks associated with the use of licensed trademarks from or to third parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To compete successfully, we must develop and introduce a continuing stream of innovative new products to meet changing consumer preferences.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our operating results are dependent on sales to several large customers; furthermore, our large customers may take actions that adversely affect our gross profit and operating results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are dependent on third-party manufacturers, most of which are located in Asia, and any inability to obtain products from such manufacturers could have a material adverse effect on our business, operating results and financial condition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to deliver products to our customers in a timely manner and to satisfy our customers' fulfillment standards are subject to several factors, some of which are beyond our control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our operating results may be adversely affected by trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations including uncertainty and business interruptions resulting from political changes and events in the U.S. and abroad, and volatility in the global credit and financial markets and economy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks related to our dependence on the strength of retail economies and may be vulnerable in the event of a prolonged economic downturn, including a downturn from the effects of macroeconomic conditions, geopolitical conditions including global conflicts or wars, any public health crises or similar conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our business is subject to weather conditions, the duration and severity of the cold and flu season and other related factors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on our CEO and a limited number of other key senior officers to operate our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unsuccessful in executing and realizing expected synergies from strategic business initiatives such as acquisitions, divestitures and global restructuring plans, including Project Pegasus.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Legal, Regulatory and Tax Risks***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•*** All of our products are manufactured by unaffiliated manufacturers, most of which are located in China, Vietnam and Mexico; therefore, we face risks of significant tariffs or other restrictions continuing to be placed on imports from China, Vietnam or Mexico and any retaliatory measures taken by these countries against the U.S adversely impacting our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in laws and regulations, including environmental, employment and health and safety and tax laws, and the costs and complexities of compliance with such laws could have a material adverse impact on our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We face risks associated with the increased focus and expectations on climate change and other sustainability matters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant changes in or our compliance with regulations, interpretations or product certification requirements could adversely impact our operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We face risks associated with global legal developments regarding privacy and data security that could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We face risks associated with product recalls, product liability and other claims against us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under current U.S. federal income tax law, tax treatment of our non-U.S. income is dependent on whether we are classified as a "controlled foreign corporation" for U.S. federal income tax purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Regulatory changes in Bermuda, including economic substance and tax governance requirements, could adversely affect our operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our judgments regarding the accounting for tax positions and the resolution of tax disputes may impact our net earnings and cash flow.

***Financial Risks***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our business, liquidity or cost of capital may be materially adversely affected by constraints or changes in the capital and credit markets, interest rates and limitations under and compliance with our credit facility, including our debt covenants.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our goodwill, indefinite-lived and definite-lived intangible assets, and other long-lived assets have recently been impaired, and we could be required to record additional impairment charges, which may be significant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our projections of product demand, sales and net income are highly subjective in nature and our future sales and net income could vary by a material amount from our projections.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increased costs of raw materials, energy and transportation may adversely affect our operating results and cash flow.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We face risks associated with foreign currency exchange rate fluctuations.

You should carefully consider this summary with the more detailed descriptions of risks described below and all of the other information included in our Annual Report when deciding whether to invest in our securities or otherwise evaluating our business.

**Business, Operational and Strategic Risks**

***Certain of our U.S. distribution facilities are geographically concentrated. This factor increases our risk that disruptions could occur and significantly affect our ability to deliver products to our customers in a timely manner. Such disruptions could have a material adverse effect on our business.***

During fiscal 2026, most of our U.S. distribution, receiving and storage functions were concentrated in two distribution facilities in northern Mississippi and our distribution facility in Gallaway, Tennessee, which are in close proximity to each other. Approximately 60% of our consolidated gross sales volume shipped

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

from facilities in this region in fiscal 2026. Due to this geographical concentration, a disruption at any of these facilities, including severe weather events, or government mandated or suggested isolation protocols relating to a pandemic or other public health crisis, even for a few days, could limit or disrupt our distribution process, or potentially lead to the temporary closure of a facility. Any resulting delays in the delivery of our products could have a material and adverse effect on our business, operating results and financial condition.

***The occurrence of cyber incidents, or failure by us or our third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data, could have a material adverse effect on our operations and profitability. Such incidents may also result in faulty business decisions, operational inefficiencies, damage to our reputation or our associate and business relationships, and/or subject us to costs, fines, or lawsuits.***

Information systems require constant updates to their security policies, networks, software, and hardware systems to reduce the risk of unauthorized access, malicious destruction of data or information theft. In addition, attacks upon information technology systems are increasing in their frequency, level of sophistication, persistence and intensity and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. We rely on commercially available systems, software, tools, third-party service providers and monitoring to provide security for processing, transmission and storage of confidential information and data. While we have security measures in place, our systems, networks, and third-party service providers have been and will continue to be subject to ongoing threats. We and our third-party service providers have experienced, and expect to continue to experience, actual or attempted cyber-attacks of our information systems or networks. We do not believe we have experienced any material system security breach that to date has had a material impact on our operations or financial condition. However, if any such event, whether actual or perceived, were to occur, it could have a material adverse effect on our business, operating results and financial condition. Our security measures may also be breached in the future as a result of associate error, failure to implement appropriate processes and procedures, advances in computer and software capabilities and encryption technology, new tools and discoveries, malfeasance, third-party action, including cyber-attacks, hacking, phishing attacks, malware (e.g., ransomware) or other misconduct by computer hackers or otherwise. Additionally, we may have heightened cybersecurity, information security and operational risks as a result of work-from-home arrangements. Our workforce operates with a combination of remote work and flexible work schedules opening us up for cybersecurity threats and potential breaches as a result of increased associate usage of networks other than company-managed networks. Furthermore, due to geopolitical tensions around the world, the risk of cyber-attacks may be elevated. This could result in one or more third-parties obtaining unauthorized access to our customer or supplier data or our internal data, including personally identifiable information, intellectual property and other confidential business information. Third-parties may also attempt through phishing attacks or other forms of social engineering schemes or deceptive practices to fraudulently induce associates into disclosing sensitive information such as usernames, passwords or other information in order to gain access to customer or supplier data or our internal data, including intellectual property, financial, and other confidential business information.

Furthermore, although we govern the use of generative artificial intelligence (including machine learning) (AI) technologies by our associates, our third-party manufacturers, vendors and service providers may use generative AI technologies or systems. The development, adoption and use of AI technologies are still in their early stages and are complex. The algorithms and models utilized in generative AI technologies and systems may have limitations, including biases, errors, or inability to handle certain data types or scenarios. There are also risks of system failures, disruptions or vulnerabilities that could compromise the integrity, security or privacy of the AI generated content, including the use of cyberattacks against such emerging technologies. The ineffective or inadequate AI development or deployment practices by any of our third-party manufacturers, vendors or service providers could result in unintended consequences and may intensify our cybersecurity risks.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We believe our mitigation measures reduce but cannot eliminate the risk of a cyber incident; however, there can be no assurance that our existing and planned precautions of backup systems, regular data backups, security protocols and other procedures will be adequate to prevent significant damage, system failure or data loss and the same is true for our partners, vendors and other third parties on which we rely. Because techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative or mitigating measures. Though it is difficult to determine what harm may directly result from any specific interruption or breach, any failure to maintain performance, reliability, security and availability of our network infrastructure or otherwise maintain the confidentiality, security, and integrity of data that we store or otherwise maintain on behalf of third-parties may harm our reputation and our associate, customer and consumer relationships.

If such unauthorized disclosure or access does occur, we may be required to notify our customers, consumers, associates or those persons whose information was improperly used, disclosed or accessed. We may also be subject to claims of breach of contract for such use or disclosure, investigation and penalties by regulatory authorities and potential claims by persons whose information was improperly used or disclosed. We could also become the subject of regulatory action or litigation from our consumers, customers, associates, suppliers, service providers, and shareholders, which could damage our reputation, require significant expenditures of capital and other resources, and cause us to lose business and revenue. Additionally, an unauthorized disclosure or use of information could cause interruptions in our operations and might require us to spend significant management time and other resources investigating the event and coordinating with local and federal law enforcement. Regardless of the merits and ultimate outcome of these matters, we may be required to devote time and expense to their resolution.

In addition, the increase in the number and the scope of data security incidents has increased regulatory and industry focus on security requirements and heightened data security industry practices. The rapid evolution and increased adoption of complex AI technologies has amplified this focus and continues to influence and impact data security industry requirements and practices. New regulation, evolving industry standards, and the interpretation of both, may cause us to incur additional expense in complying with any new data security requirements. As a result, the failure to maintain the integrity of and protect customer or supplier data or our confidential internal data could result in unintended consequences such as reputational damage, legal liabilities or loss of business, which could have a material adverse effect on our business, operating results and financial condition.

***We rely on central global Enterprise Resource Planning ("ERP") systems and other peripheral information systems. A cybersecurity breach, obsolescence or interruptions in the operation of our computerized systems or other information technologies could have a material adverse effect on our operations and profitability.***

Our operations are largely dependent on our ERP system. We continuously make adjustments to improve the effectiveness of the ERP and other peripheral information systems, including the installation of significant new subsystems. In fiscal 2026, we replaced our financial consolidation, planning and reporting system. In fiscal 2027, we are planning to replace our supply chain planning system. Our ERP system is subject to continually evolving cybersecurity and technological risks, including risks associated with cloud data storage. Any failures or disruptions in the ERP and other information systems, including a cybersecurity breach, or any complications resulting from ongoing adjustments to our systems could cause interruption or loss of data in our information or logistical systems that could materially impact our ability to procure products from our manufacturers, transport them to our distribution facilities, and store and deliver them to our customers on time and in the correct amounts. In addition, natural disasters or other extraordinary events may disrupt our information systems and other infrastructure, and our data recovery processes may not be sufficient to protect against loss.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

In fiscal 2026, we replaced our financial consolidation, planning and reporting system, and we are planning to replace our supply chain planning system to leverage best in class ways of working and modernized technologies that enhance efficiency, effectiveness and experience. In the future, we could identify and embark upon additional projects to upgrade or replace our information systems. These projects will require the investment of significant personnel and financial resources and the re-engineering of business processes. System implementations subject us to substantial costs and inherent risks associated with migrating from our legacy systems and processes. These costs and risks include, but are not limited to: significant capital and operating expenditures; diversion of associates' and management's attention from day-to-day business operations; disruptions to our supply chain; inability to deliver products to our customers in a timely manner; inability to process payments to manufacturers, vendors and associates accurately and in a timely manner; and possible weakened effectiveness of our internal controls over financial reporting. If we are not able to successfully design and implement new systems as planned and in a timely manner, we could incur increased costs, disruptions to our operations or other difficulties, each of which could have a material adverse effect on our business, operating results and financial condition.

***We rely on licensed trademarks from third parties and license certain trademarks to third parties in exchange for royalty income, the loss of which could have a material adverse effect on our revenues and profitability.***

A significant portion of our sales revenue comes from selling products under licensed trademarks, particularly in the Beauty & Wellness segment. As a result, we are dependent upon the continued use of these trademarks. Additionally, we license certain owned trademarks to third parties in exchange for royalty income. It is possible that certain actions taken by us, our licensors, licensees, or other third parties might greatly diminish the value of any of our licensed trademarks. Our licensors and licensees also generally have the ability to terminate or non-renew their license agreements with us at their option subject to each parties' right to continue the license for a period of time following notice of termination or non-renewal. If we, or our licensees, were unable to sell products under these licensed trademarks, or one or more of our license agreements were terminated or the value of the trademarks were diminished, the effect on our business, operating results and financial condition could be both negative and material.

***To compete successfully, we must develop and introduce a continuing stream of innovative new products to meet changing consumer preferences.***

Our long-term success in the competitive retail environment depends on our ability to develop and commercialize a continuing stream of innovative new products that meet changing consumer preferences and take advantage of opportunities sooner than our competition. We face the risk that our competitors will introduce and successfully market innovative new products that compete with our products, which could result in redeployment of shelf space to our competitors or lost distribution. We also face the risk that our competitors will adapt to changing consumer preferences more quickly, which could lead to a decline in our market share. There are numerous uncertainties inherent in successfully developing and commercializing new products on a continuing basis and new product launches may not deliver expected growth in sales or operating income. If we are unable to develop and introduce a continuing stream of competitive new products, it may have an adverse effect on our business, operating results and financial condition.

***Large customers may take actions that adversely affect our gross profit and operating results*.**

With the continuing trend towards retail trade consolidation, we are increasingly dependent upon key customers whose bargaining strength is substantial and growing. We may be negatively affected by changes in the policies of our customers, such as on-hand inventory reductions, limitations on access to shelf space, use of private label brands, price and term demands, actions to respond to public health

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

crises, and other conditions, which could negatively impact our business, operating results and financial condition.

Certain of our customers source and sell products under their own private label brands that compete with our products. Additionally, as large traditional retail and online customers grow even larger and become more sophisticated, they may continue to demand lower pricing, special packaging, shorter lead times for the delivery of products, smaller more frequent shipments, or impose other requirements on product suppliers. These business demands may relate to inventory practices, logistics or other aspects of the customer-supplier relationship. If we do not effectively respond to these demands, these customers could decrease their purchases from us. A reduction in the demand for our products by these customers and the costs of complying with their business demands could have a material adverse effect on our business, operating results and financial condition.

***Our operating results are dependent on sales to several large customers and the loss of, or substantial decline in, sales to a top customer could have a material adverse effect on our revenues and profitability.***

A few customers account for a substantial percentage of our net sales revenue. Our financial condition and operating results could suffer if we lost all or a portion of the sales to any one of these customers. In particular, sales to our two largest customers accounted for approximately 33% of our consolidated net sales revenue in fiscal 2026. While only three customers individually accounted for 10% or more of our consolidated net sales revenue in fiscal 2026, sales to our top five customers in aggregate accounted for approximately 50% of fiscal 2026 consolidated net sales revenue. We expect that a small group of customers will continue to account for a significant portion of our net sales revenue. Although we have long-standing relationships with our major customers, we generally do not have written agreements that require these customers to buy from us or to purchase a minimum amount of our products. A substantial decrease in sales to any of our major customers could have a material adverse effect on our financial condition and operating results. Some of our customers' creditworthiness may be vulnerable to the impact of a prolonged economic downturn or a public health crisis. We regularly monitor and evaluate the credit status of our customers and attempt to adjust sales terms as appropriate. Despite these efforts, a deterioration in the credit worthiness or bankruptcy filing of a key customer could have a material adverse effect on our business, operating results and financial condition.

***We are dependent on third-party manufacturers, most of which are located in Asia, and any inability to obtain products from such manufacturers could have a material adverse effect on our business, operating results and financial condition.***

All of our products are manufactured by unaffiliated companies, most of which are in Asia. For fiscal 2026, finished goods manufactured in Asia comprised approximately 83% of total finished goods purchased, of which 57% was manufactured in China. This concentration exposes us to risks associated with doing business globally, including among others: global public health crises (such as pandemics and epidemics); changing international political relations and conflicts; labor availability and cost; changes in laws, including tax laws, regulations and treaties; changes in labor laws, regulations and policies; changes in customs duties, additional tariffs and other trade barriers; changes in shipping costs; currency exchange fluctuations; local political unrest; an extended and complex transportation cycle; the impact of changing economic conditions; and the availability and cost of raw materials and merchandise. In recent years, increasing labor costs, import tariffs, regional labor dislocations driven by new government policies, local inflation, changes in ocean cargo carrier capacity and costs, the impact of energy prices on transportation, and fluctuations in the Chinese Renminbi against the U.S. Dollar have resulted in variability in our cost of goods sold. In the past, certain Chinese suppliers have closed operations due to economic conditions that pressured their profitability. Although we have multiple sourcing partners for certain products, occasionally we may be unable to source certain items on a timely basis due to changes occurring with our suppliers. We continue to make progress in sourcing certain similar products

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

outside of China and have initiated significant efforts to diversify our supplier base outside of China through continuously exploring the expansion of sourcing alternatives in other countries where we expect tariffs, overall costs or sourcing risks to be lower. However, the relocation of any production capacity will continue to require more time, could require substantial costs and may not be successful. The political, legal, trade and cultural environment in Asia is rapidly evolving, and any change that impairs our ability to obtain products from manufacturers in that region, or to obtain products at marketable rates, could have a material adverse effect on our business, operating results and financial condition. Recently imposed tariffs resulted in the pause or cancellation of direct import orders from China by certain of our key retailers, which adversely impacted our net sales revenue during fiscal 2026. Our sales were also negatively impacted by evolving dynamics in the China market, including a shift toward localized fulfillment models and heightened competition from domestic sellers benefiting from government subsidies. Any further trade-related developments between China and the U.S. could have a material adverse effect on our business, operating results and financial condition.

Any disruption to our supply chain, even for a relatively short period of time, could cause a loss of revenue, which could adversely affect our operating results. Additionally, surges in demand and shifts in shopping patterns, as well as other factors, can strain the global supply chain network resulting in higher inbound freight costs and surges in prices for raw materials, components and semiconductor chips, which could adversely impact our operating costs. Recently imposed tariffs have increased our cost of goods sold in fiscal 2026 and may continue to unfavorably impact our costs. If global supply chain disruptions or further trade-related policies or import restrictions emerge, we may experience further cost increases which could have a material adverse effect on our business, operating results and financial condition.

With most of our manufacturers located in Asia, our production lead times are relatively long. Therefore, we must commit to production in advance of customer orders. If we fail to forecast customer or consumer demand accurately, we may encounter difficulties in filling customer orders on a timely basis or in liquidating excess inventories. We may also find that customers are canceling orders or returning products. Any of these results could have a material adverse effect on our business, operating results and financial condition.

***Our ability to deliver products to our customers in a timely manner and to satisfy our customers' fulfillment standards are subject to several factors, some of which are beyond our control*.**

Retailers place great emphasis on timely delivery of our products for specific selling seasons, especially during our third fiscal quarter, and on the fulfillment of consumer demand throughout the year. We cannot control all of the various factors that might affect product delivery to retailers. Vendor production delays, difficulties encountered in shipping from overseas, customs clearance delays, and operational issues with any of the third-party logistics providers we use in certain countries are on-going risks of our business. We also rely upon third-party carriers for our product shipments from our distribution facilities to customers. In certain circumstances, we rely on the shipping arrangements our suppliers have made in the case of products shipped directly to retailers from the suppliers. Accordingly, we are subject to risks, including labor disputes, inclement weather, public health crises (such as pandemics and epidemics), natural disasters, possible acts of terrorism, port and canal backlogs and blockages, availability of shipping containers, carrier-imposed capacity restrictions, carrier delays, shortages of qualified drivers, tariffs and other trade restrictions and increased security restrictions associated with the carriers' ability to provide delivery services to meet our shipping needs. Our third-party manufacturing partners are not equipped to hold meaningful amounts of inventory and if shipping container capacity is limited or unavailable, they could pause manufacturing, which could ultimately impact our ability to meet consumer demand on a timely basis. Further, our delivery process must often accommodate special vendor requirements to use specific carriers and delivery schedules. During the first quarter of fiscal 2025, we experienced automation system startup issues at our new distribution facility in Gallaway, Tennessee which impacted some of our Home & Outdoor segment's small retail customer and direct-to-consumer orders. As a result, our sales during the first quarter of fiscal 2025 were adversely impacted due to

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

shipping disruptions, and we incurred additional costs and lost efficiency during both the first and second quarters of fiscal 2025 as we worked to remediate the issues. As a result of the remediation efforts performed, the automation system began to operate as designed during the third quarter of fiscal 2025, and we achieved targeted efficiency levels by the end of fiscal 2025. Any future similar incidents could cause us to fail to deliver products to our retailers in a timely and effective manner which could damage our reputation and brands and result in the loss of customers or reduced orders, which could have a material adverse effect on our business, operating results and financial condition.

***Our operating results may be adversely affected by trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations, including uncertainty and business interruptions resulting from political changes and events in the U.S. and abroad and volatility in the global credit and financial markets and economy.***

The economies of foreign countries important to our operations, including countries in Asia, EMEA and Latin America, could suffer slower economic growth or economic, social and/or political instability or hyperinflation in the future. Our international operations in countries in Asia, EMEA and Latin America, including manufacturing and sourcing operations (and the international operations of our customers), are subject to inherent risks which could adversely affect us. Additionally, there may be uncertainty and business interruptions resulting from political changes and events in the U.S. and abroad, ongoing terrorist activity, and other global events. The global credit and financial markets continue to experience volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, and uncertainty about economic stability. The financial markets and the global economy may also be adversely affected by the current or anticipated impact of military conflict or other geopolitical events. Sanctions imposed by the U.S. and other countries in response to such conflicts may also adversely impact the financial markets and the global economy, and any economic countermeasures by affected countries and others could exacerbate market and economic instability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur.

The domestic and foreign risks of these changes include, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• protectionist policies restricting or impairing the manufacturing, sales or import and export of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• new restrictions on access to markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• lack of required infrastructure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inflation (including hyperinflation) or recession;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in, and the burdens and costs of compliance with, a variety of U.S. and foreign laws and regulations, including environmental laws, occupational health and safety laws, tax laws, and accounting standards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• social, political or economic instability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• acts of war and terrorism;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• natural disasters and public health crises, such as pandemics and epidemics;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• reduced protection of intellectual property rights in some countries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increases in duties, tariffs and taxation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• restrictions on transfer of funds or exchange of currencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• currency devaluations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expropriation of assets; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other adverse changes in policies, including monetary, tax or lending policies, encouraging foreign investment or foreign trade by our host countries.

Some of these events have occurred, such as increases in tariffs, which adversely impacted our cost of goods sold and had cascading adverse impacts on our net sales revenue, business, results of operations and cash flows. Should any of these events reoccur or occur in the future, our ability to sell or export our products or repatriate profits could be impaired, we could experience a loss of sales and profitability from

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

our domestic or international operations, and/or we could experience a substantial impairment or loss of assets, any of which could materially and adversely affect our business, operating results and financial condition.

***We are subject to risks related to our dependence on the strength of retail economies and may be vulnerable in the event of a prolonged economic downturn, including a downturn from the effects of macroeconomic conditions, geopolitical conditions including global conflicts or wars, any public health crises or similar conditions.***

Our business depends on the strength of the retail economies in various parts of the world, primarily in North America and to a lesser extent EMEA, Asia and Latin America. These retail economies are affected for the most part by factors such as consumer demand and the condition of the retail industry, which, in turn, are affected by general economic conditions and specific events such as natural disasters, public health crises (such as pandemics and epidemics), global trade and tariff policy disputes, terrorist attacks and political unrest. Consumer spending in any geographic region is generally affected by a number of factors, including among others, local economic conditions, government actions, including trade and tariff policies, inflation, interest rates and credit availability, energy costs, commodity prices, unemployment rates, higher consumer debt levels, reductions in net worth, home foreclosures and reductions in home values, gasoline prices, and consumer confidence, all of which are beyond our control. Consumer purchases of discretionary items tend to decline during recessionary periods, when disposable income is lower, and may impact sales of our products. Measures imposed, or that may be imposed, by national, state and local authorities in response to any public health crises or global trade and tariff policies may have impacts of uncertain severity and duration on domestic and foreign economies. The effectiveness of economic stabilization efforts, including government payments and loans to affected citizens and industries, is uncertain. Any sustained economic downturn in the U.S. or any of the other countries in which we conduct significant business, may cause significant readjustments in both the volume and mix of our product sales, which could materially and adversely affect our business, operating results and financial condition. We cannot reasonably estimate the duration and severity of existing macroeconomic conditions, which have had and may continue to have a material impact on our business. Additionally, global issues may affect our business and the global economy, including the geopolitical impact of military conflict (such as the Israel-United States and Iran conflict) and any related economic or other sanctions, including trade and tariff policies. While we have not experienced any direct impact from the conflicts including the Middle East and elsewhere, the extent and duration of the military action, sanctions and resulting disruptions to supply chains and the global economy are impossible to predict but could be substantial and could adversely affect our operating results as they continue to impact the global economy in the future. As a result, current financial information may not necessarily be indicative of future operating results, and our plans to address the impact of macroeconomic trends and global issues may change.

***Our business is subject to weather conditions, the duration and severity of the cold and flu season and other related factors, which can cause our operating results to vary from quarter to quarter and year to year.***

Sales in our Beauty & Wellness segment are influenced by weather conditions. Sales volumes for thermometers and humidifiers and heating appliances are higher during, and subject to the severity of, the cold weather months, while sales of fans are higher during, and subject to weather conditions in, spring and summer months. Weather conditions can also more broadly impact sales across the organization. Additionally, natural disasters (such as wildfires, hurricanes and ice storms), public health crises (such as pandemics and epidemics), or unusually severe winter weather may result in temporary unanticipated fluctuations in retail traffic and consumer demand, may impact our ability to staff our distribution facilities or could otherwise impede timely transport and delivery of products to and from our distribution facilities. Sales in our Beauty & Wellness segment are also impacted by cough, cold and flu seasonal trends, including the duration and severity of the cold and flu season. In fiscal 2026 and 2025,

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

our Beauty & Wellness segment's net sales revenue was adversely impacted by an illness season below historical averages globally. These factors could have a material effect on our business, operating results and financial condition.

***We rely on our CEO and a limited number of other key senior officers to operate our business. The loss of any of these individuals could have a material adverse effect on our business.***

During fiscal 2026, we had a transition in our CEO. The loss of our current CEO or any of our key senior officers could have a material adverse effect on our business, operating results and financial condition, particularly if we are unable to hire and integrate suitable replacements on a timely basis. Further, as we continue to grow our business, we will continue to adjust our senior management team. If we are unable to attract or retain the right individuals for the team, it could hinder our ability to efficiently execute our business, and could disrupt our operations or otherwise have a material adverse effect on our business.

***We may be unsuccessful in executing and realizing expected synergies from strategic business initiatives such as acquisitions, divestitures, and global restructuring plans (including Project Pegasus), which may adversely affect the price of our common stock.***

We continue to look for strategic business opportunities to drive long-term growth and operating efficiencies, which may include acquisitions, divestitures and/or global restructuring plans. We frequently evaluate our brand portfolio and product portfolio and may consider acquisitions that complement our business or divestitures, or exits of businesses, that we no longer believe to be an appropriate strategic fit. We initiated, and may initiate in the future, global restructuring plans, such as Project Pegasus, to achieve strategic objectives and improve financial results. Any acquisition, divestiture or global restructuring plan, if not favorably received by consumers, shareholders, analysts, and others in the investment community, could have a material adverse effect on the price of our common stock.

In addition, any acquisition, divestiture or global restructuring plan, including Project Pegasus, involves numerous risks, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully complete the initiative in a timely manner, or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the initiative may not advance our business strategy as expected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges realizing anticipated cost savings, efficiencies, synergies, financial targets and other benefits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in accurately predicting costs and future savings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• costs incurred in completing the initiative may be greater than anticipated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the initiative may lead to increases in costs in other aspects of our business such as increased conversion, outsourcing or distribution costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• diversion of management's attention from other business concerns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges in integrating or separating personnel and financial or other systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• potential loss of key employees and/or reduced employee morale and productivity; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in transitioning and preserving customer, contractor, supplier, and other important third-party relationships.

Acquisitions pose additional risks, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in the assimilation of the operations, technologies, and products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges in integrating distribution channels;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in cash flows or other market-based assumptions or conditions that cause the value of acquired assets to fall below book value;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with subsequent losses or operating asset write-offs, contingent liabilities and impairment of related acquired intangible assets including goodwill; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks of entering markets in which we have no or limited experience.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Divestitures pose additional risks, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to find appropriate buyers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties executing transactions on favorable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• separating divested business operations with minimal impact to our remaining operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with operating asset write-offs and impairment charges; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges effectively managing any transition service arrangements.

**Legal, Regulatory and Tax Risks**

***If significant tariffs or other restrictions continue to be placed on imports from China, Vietnam or Mexico, or any retaliatory trade measures are taken by China, Vietnam or Mexico, our business and results of operations could be materially and adversely affected.***

All of our products are manufactured by unaffiliated manufacturers, most of which are located in China, Vietnam, Mexico and the U.S. This concentration exposes us to risks associated with doing business globally, including changes in tariffs. The U.S. government has implemented trade policies intended to restrict imports, including raising tariffs on certain goods. During calendar year 2025, the U.S. government announced and implemented a series of new and revised tariffs on imports from multiple countries, including China, Vietnam and Mexico, and has indicated the potential for additional changes to existing trade agreements. Some tariffs have been temporarily paused or adjusted, but the scope, magnitude and timing of future policies remain uncertain. In response to U.S. actions, other countries have imposed retaliatory tariffs on a broad range of goods, and further tariffs could be enacted by the U.S. or in response to international trade measures.

During fiscal 2026, the impact of the tariffs adversely impacted our cost of goods sold and had cascading adverse impacts on our net sales revenue, interest expense, business, results of operations and cash flows. Our cost of goods sold during fiscal 2026 included $50.7 million of additional pre-tax costs related to the changes in tariffs enacted. Our net sales revenue during fiscal 2026 was also negatively impacted by a combination of factors including the pause or cancellation of direct import orders from China by key retailers in response to increased tariff rates, a slowdown in retailer orders following pull forward activity in the fourth quarter of fiscal 2025 due to tariff uncertainty, and lower consumer confidence and demand. Sales were also negatively impacted by evolving dynamics in the China market, including a shift toward localized fulfillment models and heightened competition from domestic sellers benefiting from government subsidies. Net sales revenue during the second half of fiscal 2026 was unfavorably impacted by stop shipment actions in support of consistent adoption of tariff related price increases by our retail partners, which primarily impacted our Beauty & Wellness segment. We also incurred higher interest expense during fiscal 2026 due to the impact of tariffs resulting in higher inventory carrying costs and higher capital expenditures to diversify our production outside of China. In addition to the uncertainty from evolving global tariff policies, we experienced and expect continued unfavorable cascading impacts on inflation, consumer confidence, employment and overall macroeconomic conditions, all of which may continue to adversely impact our sales, results of operations and cash flows. For additional information regarding tariffs, refer to "Significant Trends Impacting the Business" in Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations".

Any further alteration of trade agreements and terms between China, Vietnam, Mexico and the U.S., including limiting trade with China, Vietnam and Mexico, imposing additional tariffs on imports from China, Vietnam or Mexico and potentially imposing other restrictions on imports from China, Vietnam or Mexico to the U.S. may result in further or higher tariffs, or further retaliatory trade measures by China, Vietnam or Mexico, all of which could have a material adverse effect on our business and operating results.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Changes in laws and regulations, including environmental, employment and health and safety and tax laws, and the costs and complexities of compliance with such laws could have a material adverse impact on our business.***

The impact of future legislation in the U.S. or abroad, including such things as employment and health insurance laws, environmental and climate change related legislation, tax legislation, regulations or treaties is always uncertain. Global, federal and local legislative agendas from time to time contain numerous proposals dealing with environmental policy, energy policy, taxes, financial regulation, transportation policy and infrastructure policy, among others that, if enacted into law, could increase our costs of doing business. Changes in government administrations in the U.S. or abroad increase the uncertainty of future changes in legislation, enhanced regulations, and greater oversight, or more stringent interpretations, of existing policies by regulatory agencies. Changes in such laws, regulations or oversight could cause us to incur material capital or operating expenditures in the future to comply with applicable laws and regulations, increase our effective income tax rate, delay or interrupt distribution of our products, or make them more costly to produce, all of which could have a material adverse impact on our business.

For example, the Organisation for Economic Co-operation and Development ("OECD") has introduced a framework to implement a global minimum corporate income tax of 15%, referred to as "Pillar Two." Certain countries in which we operate have enacted, or are in the process of enacting, domestic legislation aligned with OECD's Pillar Two "Model Rules." Pillar Two legislation in effect for our fiscal 2025 and 2026 has been incorporated into our consolidated financial statements. However, Pillar Two remains an evolving regime, and as additional jurisdictions adopt these rules, existing rules are revised, or administrative guidance and enforcement practices develop, we could experience adverse impacts on our global effective tax rate and an increase in the cost and complexity of compliance.

As additional tax or financial regulatory guidance is issued by the applicable authorities and accounting treatment is clarified, we perform additional analysis on the application of the law and we refine our estimates. Our final analysis may be different from provisional amounts, which could materially affect our tax obligations, effective tax rate and operating results in the period completed.

***Increased focus and expectations on climate change and other sustainability matters could have a material adverse effect on our business, financial condition and results of operations and damage our reputation.***

Increased focus and expectations on sustainability are emerging trends with governmental and non-governmental organizations, consumers, shareholders, retail customers, communities, and other stakeholders. These trends have led to, among other things, increased public and private social accountability reporting requirements relating to labor practices, climate change, human trafficking and other sustainability matters and greater demands on our packaging and products. The increased focus on sustainability matters may also lead to new or more regulations and customer, shareholder and consumer demands that could require us to incur additional costs or make changes to our operations to comply with new regulations or address these demands. We expect that these trends will continue. If we are unable to adequately respond to, or we are not perceived as adequately responding to, existing or new requirements or demands, customers and consumers may choose to purchase products from another company or a competitor. Increased requirements and costs to comply with these requirements, such as climate change regulations and international accords may also cause disruptions in or higher costs associated with manufacturing or distributing our products. Any failure to achieve our sustainability goals or a perception of our failure to act responsibly or to effectively respond to new, or changes in, legal or regulatory requirements relating to sustainability matters could adversely affect our business, financial condition, results of operations and reputation.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Significant changes in or our compliance with regulations, interpretations or product certification requirements could adversely impact our operations.***

As a global company, we are subject to U.S. and foreign regulations, including environmental, health and safety laws, and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. For example, thermometers distributed by our Beauty & Wellness segment must comply with various regulations governing the production and distribution of medical devices.

We are encountering increasingly burdensome and costly requirements relating to the regulation of our company and our products. Significant new regulations, material changes to existing regulations, or greater oversight, enforcement or changes in interpretation of existing regulations, could further delay or interrupt distribution of our products in the U.S. and other countries, result in fines or penalties or cause our costs of compliance to increase. We cannot guarantee that our products will receive regulatory approval in all countries. Some of our Beauty & Wellness segment's customers require that our hair appliances comply with various safety certifications, including UL certifications. Significant new certification requirements or changes to existing certification requirements could further delay or interrupt distribution of our products or make them more costly to produce.

We are not able to predict the nature of potential changes to, or enforcement of, laws, regulations, product certification requirements, repeals or interpretations. Nor are we able to predict the impact that any of these changes would have on our business in the future. Further, if we were found to be noncompliant with applicable laws and regulations in these or other areas, we could be subject to private rights of action and similar proceedings seeking to enforce regulatory requirements and governmental or regulatory actions, including fines, import detentions, injunctions, product withdrawals or recalls or asset seizures, any of which could have a material adverse effect on our business, results of operations and financial condition.

Additionally, some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the EPA, U.S. Customs and Border Protection, the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission and the EU. As discussed elsewhere in this Annual Report, during fiscal 2022 and 2023, we were in discussions with the EPA regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. We continue to have ongoing settlement discussions with the EPA related to this matter. As of February 28, 2026, we accrued an estimated liability of $4.4 million, which represents our best estimate of probable settlement costs related to this matter. As a result, our business, results of operations and financial condition could be adversely and materially impacted in ways that we are not able to predict today. For additional information refer to Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "EPA Compliance Costs" in this Annual Report.

***Global legal developments regarding privacy and data security could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business.***

As a global company, we are subject to global privacy and data security laws, regulations, and codes of conduct that apply to our various business units. These laws and regulations may be inconsistent across jurisdictions and are subject to evolving and differing interpretations. Government regulators, privacy advocates and class action attorneys are increasingly scrutinizing how companies collect, process, use,

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

store, share and transmit personal data. This increased scrutiny may result in new interpretations of existing laws, thereby further impacting our business.

New and emerging global and local laws on privacy, data and related technologies, as well as industry self-regulatory codes, are creating new compliance obligations and expanding the scope of potential liability, either jointly or severally with our customers and suppliers. While we have invested in readiness to comply with applicable requirements, these new and emerging laws, regulations and codes may affect our ability to reach current and prospective consumers, to respond to consumer requests under such laws (such as individual rights of access, correction, and deletion of their personal information), and to implement our business models effectively. The costs of compliance or failure to comply with such laws, regulations, codes of conduct and expectations could have a material adverse impact on our financial condition and results of operations.

***Our business involves the potential for product recalls, product liability and other claims against us, which could materially and adversely affect our business, operating results and financial condition.***

From time to time, we are involved in various claims, litigation matters and regulatory proceedings that arise in the ordinary course of our business and that could have a material adverse effect on us. These matters may include personal injury (including asbestos and similar claims) and other tort claims, deceptive trade practice disputes, intellectual property disputes, product recalls, contract disputes, private rights of action and similar proceedings seeking to enforce regulatory requirements, warranty disputes, employment and tax matters and other proceedings and litigation, including class actions. Litigation, in general, and securities, derivative action, class action and multi-district litigation, in particular, can be expensive and disruptive. These matters may include many plaintiffs, may involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years.

Establishing loss reserves for any such matters is subject to uncertainties because of many factors, including adverse changes to the personal injury and tort environment (such as increased litigation, expanded theories of liability, higher jury awards and lawsuit abuse and third-party litigation finance, among others) and evolving judicial interpretations, including application of various theories of joint and several liabilities. Because of these uncertainties, additional liabilities may arise for amounts in excess of any loss reserves that we may establish. In addition, estimates of loss reserves may change with any of the developments noted. These additional liabilities or increases in estimates, or a range of either, could vary significantly from period to period and could materially and adversely affect our results of operations and/or our financial position.

It is not possible to predict the outcome of pending or future litigation. As with any litigation, it is possible that some of the actions could be decided unfavorably, resulting in significant liability and, regardless of the ultimate outcome, can be costly to defend. Our results and our business could also be negatively impacted if one of our brands suffers substantial damage to its reputation due to a significant product recall or other product-related litigation and if we are unable to effectively manage real or perceived concerns about the safety, quality, or efficacy of our products. The Company's more significant legal proceedings are described in Item 3., "Legal Proceedings," and in Note 12 to the accompanying consolidated financial statements.

Although we maintain liability insurance in amounts that we believe are reasonable, that insurance is, in most cases, subject to large self-insured retentions for which we are responsible. We cannot provide assurance that we will be able to maintain such insurance on acceptable terms, if at all in the future, or that product liability or other claims will not exceed the amount of insurance coverage, or that all such matters would be covered by our insurance. For example, asbestos and similar claims are generally

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

excluded from coverage. As a result, these types of claims could have a material adverse effect on our business, operating results and financial condition.

***Under current U.S. federal income tax law, tax treatment of our non-U.S. income is dependent on whether we are classified as a "controlled foreign corporation" for U.S. federal income tax purposes. Changes in the composition of our stock ownership could have an impact on our classification. If our classification were to change, it could have a material adverse effect on the largest U.S. shareholders and, in turn, on our business.***

A non-U.S. corporation, such as ours, will constitute a "controlled foreign corporation" or "CFC" for U.S. federal income tax purposes if its largest U.S. shareholders together own more than 50 percent of the stock outstanding. A U.S. shareholder is defined as any U.S. person who owns directly, indirectly, or constructively: (1) 10 percent or more of the total combined voting power of all classes of stock, or (2) 10 percent or more of the total value of shares of all classes of stock. If the Internal Revenue Service or a court determined that we were a CFC at any time during the tax year, then each of our U.S. shareholders as defined above would be required to include in gross income for U.S. federal income tax purposes its pro rata share of our "subpart F income" (and the subpart F income of any of our subsidiaries determined to be a CFC) for the period during which we (and our non-U.S. subsidiaries) were deemed a CFC. In addition, any gain on the sale of our shares realized by such a shareholder may be treated as ordinary income to the extent of the shareholder's proportionate share of our and our CFC subsidiaries' undistributed earnings and profits accumulated during the shareholder's holding period of the shares while we were deemed to be a CFC.

***Changes in economic substance, tax governance and related regulatory regimes in Bermuda could adversely affect our operations.***

We are organized in Bermuda, which previously adopted economic substance legislation in response to the EU's review of potentially harmful tax practices. Bermuda's economic substance regime requires entities that conduct "relevant activities" to demonstrate compliance with the Economic Substance Act 2018 and related regulations, which require core income generating activities to be undertaken in Bermuda and impose obligations relating to personnel, premises, governance and annual regulatory filings.

Although Bermuda is currently classified as a cooperative jurisdiction and does not appear on the EU list of noncooperative tax jurisdictions in the most recently published updates, future changes to how the jurisdiction is assessed under international tax governance standards, or changes in guidance or enforcement practices, could increase our compliance costs or require us to modify aspects of our operations. Any such changes could adversely affect our business, financial condition or results of operations.

***Our judgments regarding the accounting for tax positions and the resolution of tax disputes may impact our net earnings and cash flow.***

Significant judgment is required to determine our effective tax rate and evaluate our tax positions. We provide for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement criteria prescribed by applicable accounting standards. Fluctuations in federal, state, local and foreign taxes or a change to uncertain tax positions, including related interest and penalties, may impact our effective tax rate and financial results. Additionally, we are subject to audits in the various taxing jurisdictions in which we conduct business. In cases where audits are conducted and issues are raised, a number of years may elapse before such issues are finally resolved. Unfavorable resolution of any tax matter could increase the effective tax rate, which could have an adverse effect on our operating results and cash flow. For additional information regarding our taxes, see Note 18 to the accompanying consolidated financial statements.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Financial Risks**

***Our business, liquidity or cost of capital may be materially adversely affected by constraints or changes in the capital and credit markets, interest rates and limitations under and compliance with our credit facility, including our debt covenants.***

We need sufficient sources of liquidity to fund our working capital requirements, service our outstanding indebtedness and finance business opportunities. We may also assume or incur additional debt, including secured debt, in the future in connection with, or to fund, future acquisitions or for other operating needs. Without sufficient liquidity, we could be forced to curtail our operations, or we may not be able to pursue business opportunities. The principal sources of our liquidity are funds generated from operating activities, available cash, and borrowings under our credit facility. If our sources of liquidity do not satisfy our requirements, we may need to seek additional financing. The future availability of financing will depend on a variety of factors, such as economic and market conditions, the reaction by banks and financial institutions to a public health crisis (such as pandemics and epidemics), the regulatory environment for banks and other financial institutions, the availability of credit, our financial health and our reputation with potential lenders. Further, disruptions in national and international credit markets, including adverse developments impacting the financial services industry such as bank closures and investor concerns regarding the U.S. or international financial systems, could result in limitations on credit availability, tighter lending standards, higher interest rates on consumer and business loans and higher fees associated with obtaining and maintaining credit availability. Disruptions may also materially limit consumer credit availability and restrict credit availability to us and our customer base. In addition, in the event of disruptions in the financial markets, current or future lenders may become unwilling or unable to continue to advance funds under any agreements in place, increase their commitments under existing credit arrangements, or enter into new financing arrangements. In an economic downturn, we may also be unable to raise capital through debt or equity financings on terms acceptable to us or at all. Additionally, in challenging and uncertain economic environments, we cannot predict when macroeconomic uncertainty may arise, whether or when such circumstances may improve or worsen or what impact such circumstances could have on our business and our liquidity requirements. These factors could materially adversely affect our liquidity, costs of borrowing and our ability to pursue business opportunities or grow our business, and threaten our ability to meet our obligations as they become due.

Our credit facility contains financial covenants and other covenants that restrict or limit our ability to, among other things, incur debt or liens, make investments and dispose of assets. A breach of any of these covenants, including the failure to meet or maintain ratios or tests, may result in a default under our credit facility. In fiscal 2026, we amended our credit facility to, among other things, extend the leverage ratio holiday and change the interest coverage ratio to provide us with more flexibility as we navigate a continuation of negative sales trends and the unfavorable impact of tariffs and other macroeconomic conditions. If we are unable to comply with our financial or other covenants under our credit facility or obtain any necessary amendments to our credit facility in the future, an event of default could result. If an event of default occurs and is not cured or waived, the lenders under our credit facility may elect to accelerate the payment of our borrowings, together with accrued interest, terminate any commitments they have to provide further borrowings and to exercise any other rights they have under the facility or applicable law. The covenants, including financial covenants, in our credit facility could also restrict or delay our ability to obtain additional financing, potentially limiting our ability to adjust to rapidly changing market conditions or respond to business opportunities. If any of these events occur, it could have a material adverse effect on our business, financial condition, liquidity and ability to meet our obligations as they become due.

We currently have a substantial amount of indebtedness, which could adversely affect our financial condition and could have important consequences to our business. For example, it could make it more difficult for us to satisfy our obligations under our credit facility, increase our vulnerability to general adverse economic conditions, limit our ability to obtain necessary financing and to fund future working

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

capital and other general corporate requirements, require us to dedicate our cash flow to payments on our indebtedness and limit our flexibility in planning for, or reacting to, changes in our business, competition and the industry in which we operate. Any of these events could have a material adverse effect on our liquidity, financial condition and business.

The Federal Open Market Committee lowered the benchmark interest rate by 75 basis points and 100 basis points during fiscal 2026 and 2025, respectively, compared to an increase of 75 basis points during fiscal 2024. Our variable rate debt and related interest rate swaps use the Secured Overnight Financing Rate ("SOFR"), a rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate), as a benchmark for establishing interest rates. SOFR is a backward-looking measure, calculated based on short-term repurchase agreements, backed by U.S. Treasury securities. As such, if interest rates were to increase, our debt service obligations on variable rate debt subject to SOFR would increase, which could negatively impact our net income, cash flows and financial condition. Additionally, an increase in interest rates may impact our access to credit on favorable interest rate terms.

For additional information regarding our liquidity and the amendment to our credit facility, refer to Note 13 to the accompanying consolidated financial statements and Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "Amended Credit Agreement" in this Annual Report.

***If our goodwill, indefinite-lived and definite-lived intangible assets, or other long-lived assets become further impaired, we will be required to record additional impairment charges, which may be significant.***

A significant portion of our non-current assets consists of goodwill and intangible assets recorded as a result of past acquisitions. We do not amortize goodwill and indefinite-lived intangible assets, but rather review them for impairment on an annual basis or more frequently whenever events or changes in circumstances indicate that their carrying value may not be recoverable. We review intangible assets with definite lives and long-lived assets held and used for impairment if a triggering event occurs during the reporting period. We evaluate any long-lived assets held for sale quarterly to determine if fair value less cost to sell has changed during the reporting period. We record impairment charges to the extent the carrying values of these assets are not recoverable in accordance with the applicable accounting standards.

During each quarter of fiscal 2026, we concluded a goodwill impairment triggering event had occurred due to a further sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company's total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to these conclusions included downward revisions to our internal forecasts and strategic long-term plans, which reflect the tariff policies in effect, timing of corresponding price increases and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders. These factors were applicable to all of our reporting units, indefinite-lived trademark licenses and trade names and definite-lived trademark licenses, trade names, and certain other intangible assets. Thus, we performed quantitative impairment testing on our goodwill and intangible assets described above during each quarter of fiscal 2026.

As a result of such testing, we recorded pre-tax asset impairment charges during fiscal 2026 of $885.9 million, consisting of $332.6 million in our Home & Outdoor segment and $553.3 million in our Beauty & Wellness segment. Total pre-tax asset impairment charges included charges to reduce the carrying value of our goodwill, indefinite-lived intangible assets and definite-lived intangible assets by $706.5 million, $97.0 million and $82.4 million, respectively. Asset impairment charges recognized during fiscal 2026 for our Home & Outdoor segment included charges for our Hydro Flask and Osprey

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

businesses of $184.4 million and $148.1 million, respectively. Asset impairment charges recognized during fiscal 2026 for our Beauty & Wellness segment included charges for our Health & Wellness, Drybar, Curlsmith and Revlon businesses of $242.2 million, $154.5 million, $133.0 million and $23.5 million, respectively. Such charges have had and may continue to have a significant negative impact on our results of operations.

During fiscal 2026, management sequentially reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect, timing of corresponding price increases inclusive of the impact of stop shipment actions to support consistent adoption and the related macroeconomic environment at the end of each of quarter, including the corresponding impact on consumer spending, retailer orders and China cross border ecommerce due to a shift to localized distribution, as applicable. The revised forecasts also resulted in management selecting lower residual growth rates, which were also reflective of revised long-term industry growth expectations, and royalty rates, as applicable.

For additional information regarding our impairment testing, refer to "Critical Accounting Policies and Estimates" in Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 1 and Note 7 to the accompanying consolidated financial statements.

Considerable management judgment is necessary in reaching a conclusion regarding the reasonableness of fair value estimates, evaluating the most likely impact of a range of possible external conditions, considering the resulting operating changes and their impact on estimated future cash flows, determining the appropriate discount factors to use, and selecting and weighting appropriate comparable market level inputs. The recoverability of these non-current assets is dependent upon achievement of our projections and the continued execution of key initiatives related to revenue growth and profitability. The net sales revenue and profitability growth rates used in our projections are management's estimate of the most likely results over time, given a wide range of potential outcomes. The assumptions and estimates used in our impairment testing involve significant elements of subjective judgment and analysis by our management. Some of the inherent estimates and assumptions used in determining the fair value of these non-current assets are outside of the control of management, including interest rates, cost of capital, tax rates, tariff rates, strength of retail economies and industry growth. Certain future events and circumstances, including higher tariffs, deterioration of retail economic conditions, higher cost of capital, a decline in actual and expected consumer demand, among others, could result in changes to these assumptions and judgments. While we believe that the estimates and assumptions we use are reasonable at the time made, changes in business conditions or other unanticipated events and circumstances may occur that cause actual results to differ materially from projected results, and this could potentially require future adjustments to our asset valuations and recognition of additional impairment charges.

Events and changes in circumstances that may indicate there is impairment and which may indicate interim impairment testing is necessary include, but are not limited to: strategic decisions to exit a business or dispose of an asset made in response to changes in economic, political and competitive conditions; the impact of the economic environment on our customer base and on broad market conditions that drive valuation considerations by market participants; a further sustained decline in our stock price and market capitalization; our internal expectations with regard to future revenue growth, operating results and the assumptions we make when performing our impairment reviews including execution of strategic initiatives, such as tariff mitigation plans; a significant decrease in the market price of our assets; a significant adverse change in the extent or manner in which our assets are used; a significant adverse change in legal factors or the business climate that could affect our assets; an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset; changes in tariff rates; and significant changes in the cash flows associated with an asset. As a result of such circumstances, we may be required to revise certain accounting estimates and judgments related to the valuation of goodwill, indefinite-lived and definite-lived intangible assets and other long-

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

lived assets, which could result in additional material impairment charges. Any such impairment charges could have a material adverse effect on our results of operations.

***Our projections of product demand, sales and net income are highly subjective in nature and our future sales and net income could vary by a material amount from our projections.***

From time to time, we may provide financial projections to our shareholders, lenders, investment community, and other stakeholders of our future sales and net income. Since we do not require long-term purchase commitments from our major customers and the customer order and ship process is very short, it is difficult for us to accurately predict the demand for many of our products, or the amount and timing of our future sales, related net income and cash flows.

Our projections are based on management's best estimate of sales using historical sales data and other relevant information available at the time. These projections are highly subjective since sales to our customers can fluctuate substantially based on the demand of their retail consumers and related ordering patterns, as well as other risks described in this Annual Report. Additionally, changes in consumer demand, retailer inventory management strategies, global trade and tariff policies, transportation lead times, supplier capacity and raw material availability could make our inventory management and sales forecasting more difficult. Due to these factors, our future sales and net income could vary materially from our projections.

We are dependent on discretionary spending, which is affected by, among other things, economic and political conditions, consumer confidence, interest, inflation and tax rates, a public health crisis (such as pandemics and epidemics), and financial and housing markets, which are all outside of our control. Consequently, these and other potential impacts we are not currently aware of could also cause future sales and net income to vary materially from our projections.

***Increased costs of raw materials, energy and transportation may adversely affect our operating results and cash flow.***

Significant increases in the costs and availability of raw materials, energy and transportation may negatively affect our operating results. Our suppliers purchase significant amounts of metals and plastics to manufacture our products, some of which are or may become subject to the recent tariffs imposed by the U.S. government. In addition, they also purchase significant amounts of electricity to supply the energy required in their production processes. Global political instabilities and tensions and many other factors may increase fuel prices resulting in higher transportation prices and product costs. We are heavily dependent on inbound sea, rail and truck freight. In the past, disruptions in the global supply chain and freight networks increased our cost of goods sold and certain operating expenses, and any future disruptions could have a material adverse impact on our costs. Most recently, the outcome of the ongoing Israel-United States and Iran conflict is highly unpredictable and could lead to significant market and other disruptions, including significant volatility in the commodity prices and supply of energy resources and supply chain interruptions.

The cost of raw materials, energy and transportation, in the aggregate, represents a significant portion of our cost of goods sold and certain operating expenses, which we may not be able to pass on to our customers. Our operating results could be adversely affected by future increases in these costs. Additionally, the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, restricted transportation or increased freight costs, reduced workforce, or other manufacturing and distribution disruption could adversely impact our ability to meet our customers' needs.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Our operating results may be adversely affected by foreign currency exchange rate fluctuations.***

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries. Changes in the relation of other foreign currencies to the U.S. Dollar will affect our sales and profitability and can result in exchange losses because we have operations and assets located outside the U.S. We transact a portion of our international business in currencies other than the U.S. Dollar ("foreign currencies"). Such transactions include sales and operating expenses. As a result, portions of our cash, accounts receivable and accounts payable are denominated in foreign currencies. Accordingly, foreign operations will continue to expose us to foreign currency exchange rate fluctuations, which may result in the recognition of foreign exchange losses upon remeasurement to U.S. Dollars. Additionally, we purchase a substantial amount of our products from Chinese manufacturers in U.S. Dollars, who source a significant portion of their labor and raw materials in Chinese Renminbi. The Chinese Renminbi has fluctuated against the U.S. Dollar in recent years. During fiscal 2026, the average exchange rate of the Chinese Renminbi strengthened against the U.S. dollar by approximately 1%, compared to the average rate during fiscal 2025. Chinese Renminbi currency fluctuations have the potential to add volatility to our product costs over time.

Where operating conditions permit, we seek to reduce foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars. We use derivative financial instruments including forward contracts to mitigate certain foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. It is not practical for us to mitigate all our exposures, nor are we able to accurately project the possible effect of foreign currency remeasurement on our operating results or future net income due to our constantly changing exposure to various foreign currencies, difficulty in predicting fluctuations in foreign currency exchange rates relative to the U.S. Dollar and the significant number of currencies involved.

The impact of future foreign currency exchange rate fluctuations on our results of operations cannot be accurately predicted. Accordingly, there can be no assurance that foreign currency exchange rates:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• will be stable in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• can be mitigated with currency hedging or other risk management strategies; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• will not have a material adverse effect on our business, operating results and financial condition.

**Item 1B. Unresolved Staff Comments**

None.

**Item 1C. Cybersecurity**

**Risk Management and Strategy**

The Company relies on electronic information systems, networks and technologies to conduct and support its operations and other functions and activities within the Company. We rely on commercially available systems, software, tools, third-party service providers and monitoring to provide security for processing, transmission and storage of confidential information and data. We have an enterprise-grade information security management program designed to identify, protect, detect and respond to and manage reasonably foreseeable material cybersecurity threats. To protect our information systems from cybersecurity threats, we use various security tools that help prevent, identify, escalate, investigate, remediate, respond and recover from identified vulnerabilities and cybersecurity incidents.

As part of the Company's cybersecurity risk management program, we follow the NIST Cybersecurity Framework ("CSF") to assess, identify and manage risks that arise from cybersecurity threats. The CSF is closely tied to the Company's enterprise risk management processes to identify and document cybersecurity threats and prioritize responses. Included in the CSF process is the identification and

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

assessment of cybersecurity risks to systems, assets, data and resources. The Company also has a vulnerability management process in place. This vulnerability management process helps us to detect and identify threats and vulnerabilities and once identified, to remediate, respond and recover. In addition, our cybersecurity team subscribes to expert and industry standard security feeds and reports, which we use to identify new risks and new vulnerabilities in different systems and infrastructures. Our cybersecurity risk management program also includes cybersecurity awareness training for our associates and an incident response team ("IRT").

The Company engages third-party service providers to perform 24/7 proactive monitoring, correlation and triage of logs and activity throughout our systems, networks and infrastructures. These processes are performed by cybersecurity service providers as well as automated detection. These processes include detection and response, as well as vulnerability management and remediation. The Company also has a vendor risk management process to assess risks related to technology third-party service providers where we initially assess their cybersecurity posture upon engaging their services. We annually review these vendors to update our risk assessment and to monitor for any changes that could present additional risks.

We also maintain a cyber incident response plan ("IRP") with the objective of (1) providing a structured and systematic incident response process for cybersecurity threats that affect any of our electronic information systems and networks, (2) timely and effectively identifying, resolving and communicating cybersecurity incidents and (3) managing internal and external communications and reporting. Under the IRP, a dedicated information security coordinator is responsible for implementing the IRP, as well as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• identifying the IRT and any appropriate sub-teams to address specific cybersecurity incidents or categories of cybersecurity incidents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• coordinating IRT activities, including developing, maintaining and following appropriate procedures to respond to, communicate and document identified cybersecurity incidents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• conducting post-incident reviews to gather feedback on cybersecurity incident response procedures and address any identified gaps in security measures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• providing training and conducting periodic exercises to promote associate and stakeholder preparedness and awareness of the IRP; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• reviewing the IRP at least annually, or whenever there is a material change in our business practices that may reasonably affect our cyber incident response procedures.

If a cybersecurity incident occurs, under the IRP, the information security coordinator or a designee is required to notify, as necessary and applicable, the IRT and senior executives and organizational leadership, including our General Counsel, our business partners or service providers and other authorities. Our General Counsel, working with senior executives, is required under the IRP, as appropriate, to notify the Audit Committee of any cybersecurity incident. As discussed below, the Audit Committee of our Board of Directors oversees risk management relating to cybersecurity.

We and our third-party service providers have experienced and expect to continue to experience actual or attempted cyber-attacks of our information systems and networks. We do not believe we have experienced any material system security breach that to date has had a material impact on our operations or financial condition. However, if any such event, whether actual or perceived, were to occur, it could have a material adverse effect on our business, operating results and financial condition. For more information regarding the risks we face from cybersecurity threats, see Item 1A., "Risk Factors."

**Cybersecurity Governance**

Cybersecurity is an important part of our enterprise risk management processes and an area of focus for our Board of Directors and management. The Company has a dedicated role in the Vice President of Cloud, Infrastructure and Security Operations, who reports to our Head of Information Technology ("Head of IT"). Our current Head of IT has significant experience in information technology across a variety of

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

industries, including consumer goods, pharma, logistics, manufacturing and outsourcing. Our current Head of IT and Vice President of Cloud, Infrastructure and Security Operations also have experience in cybersecurity, information security, policy, architecture, engineering and incident response. The Head of IT works with other functions within the Company to implement controls, procedures and practices to help minimize the Company's risks, as well as to introduce security by design. Our Head of IT provides regular updates on cybersecurity matters to our senior management.

The Audit Committee assists the Board of Directors in its oversight of risks related to cybersecurity and directly oversees risk management relating to cybersecurity. The Audit Committee is also responsible for assessing the steps management has taken to monitor and control these risks and exposures and evaluating guidelines and policies with respect to our risk assessment and risk management. Our General Counsel, working with the Head of IT and other senior management, is responsible for determining and coordinating reports and updates to the Audit Committee or the Board of Directors, or as requested by the Audit Committee or the Board of Directors. The Audit Committee reviews our cybersecurity program with management and reports to the Board of Directors with respect to, and its review of, the program. Cybersecurity reviews by the Audit Committee generally occur at least annually, or more frequently as determined to be necessary or advisable. The Board of Directors receives an update on the Company's risk management processes and the risk trends related to cybersecurity at least annually.

**Item 2. Properties**

As of February 28, 2026, we own, lease or otherwise utilize through third-party management service agreements various properties worldwide for sales, procurement, research and development, administrative and distribution facilities. We lease our U.S. headquarters, which is located in El Paso, Texas, and we own three main distribution facilities, two of which are located in Southaven and Olive Branch, Mississippi, and one located in Gallaway, Tennessee, which became operational during the first quarter of fiscal 2024. Our distribution facilities in Gallaway, Tennessee, and Southaven, Mississippi, currently service our Home & Outdoor segment and Beauty & Wellness segment, respectively. Our distribution facility in Olive Branch, Mississippi, currently services both of our segments. On April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi which serviced our Beauty business. As a result, our Beauty business is now serviced by our distribution facility in Olive Branch, Mississippi. We believe our facilities are adequate to conduct our business. See Note 4 to the accompanying consolidated financial statements for additional information.

**Item 3. Legal Proceedings**

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described in Note 12 to the accompanying consolidated financial statements and described below.

**EPA Regulatory Matter**

During fiscal 2022 and 2023, we were in discussions with the EPA regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. We continue to have ongoing settlement discussions with the EPA related to this matter. As of February 28, 2026, we accrued an estimated liability of $4.4 million, which represents our best estimate of probable settlement costs related to this matter.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

See Note 12 to the accompanying consolidated financial statements for further discussion.

**Item 4. Mine Safety Disclosures**

Not applicable.

**PART II**

**Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**

**Market Information for Common Stock**

Our common stock is listed on the NASDAQ Global Select Market under symbol: HELE.

**Approximate Number of Equity Security Holders of Record** 

Our common stock is our only class of equity security outstanding at February 28, 2026. As of April 16, 2026, there were 95 holders of record of our common stock. A substantially greater number of holders of our common stock are "street name" or beneficial holders whose shares are held of record by banks, brokers and other financial institutions.

**Cash Dividends**

Our current policy is to retain earnings to provide funds for the operation and expansion of our business, common stock repurchases and for potential acquisitions. We have not paid any cash dividends on our common stock since inception. Any change in dividend policy will depend upon future conditions, including earnings and financial condition, general business conditions, any applicable contractual limitations, and other factors deemed relevant by our Board of Directors.

**Issuer Purchases of Equity Securities**

In August 2024, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 20, 2024, for a period of three years, and replaced our former repurchase authorization. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. See Note 10 to the accompanying consolidated financial statements for additional information.

Our current equity-based compensation plans include provisions that allow for the "net exercise" of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as repurchases of shares.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Share repurchase activity during the three-month period ended February 28, 2026, was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of<br>Shares Purchased (1)** | **Average Price<br>Paid per Share** | **Total Number of<br>Shares Purchased<br>as Part of Publicly<br>Announced Plans<br>or Programs (1)** | **Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs <br>(in thousands) (2)** |
| December 1 through December 31, 2025 | 9058 | $21.12 | 9058 | $498031 |
| January 1 through January 31, 2026 |  |  |  | 498031 |
| February 1 through February 28, 2026 | 1003 | 17.73 | 1003 | 498013 |
| Total | 10061 | $20.78 | 10061 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)The number of shares includes shares of common stock acquired from associates who tendered shares to satisfy the tax withholding on equity awards as part of our long-term incentive plans. For the periods presented, there were no common stock open market repurchases.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Reflects the remaining dollar value of shares that could be purchased under our current stock repurchase authorization through the expiration or termination of the plan. For additional information, see Note 10 to the accompanying consolidated financial statements.

**Performance Graph**

The graph below compares the cumulative total return of our Company to the NASDAQ Composite Index and a Peer Group Index, assuming $100 was invested on February 28, 2021. The Peer Group Index is the Dow Jones U.S. Personal Products Index. The comparisons in this table are required by the SEC and are not intended to forecast or be indicative of the possible future performance of our common stock.

![Item 5 Graph - jpeg for filing FY26.jpg](hele-20260228_g2.jpg)

The Performance Graph shall not be deemed to be "soliciting material" or to be "filed" with the SEC or subject to the liabilities of Section 18 under the Exchange Act. In addition, it shall not be deemed

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

incorporated by reference by any statement that incorporates this Annual Report by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that we specifically incorporate this information by reference.

**Item 6. [Reserved]**

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") should be read in conjunction with the other sections of this Annual Report, including Item 1., "Business" and Item 8., "Financial Statements and Supplementary Data." The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in Item 1A.,"Risk Factors," and in the section entitled "Information Regarding Forward-Looking Statements" following this MD&A, and in Item 7A., "Quantitative and Qualitative Disclosures About Market Risk."* 

Management uses the following key financial measures, some of which are non-GAAP, as further described below: net sales revenue, organic business sales revenue, adjusted operating margin and adjusted diluted earnings per share ("EPS"). Management uses these measures to evaluate historical performance on a comparable basis, predict future performance and benchmark our performance against our competitors. We believe these measures provide management and investors with important information that is useful in understanding our business results and trends.

This MD&A, including the tables under the headings "Operating (Loss) Income, Operating Margin, Adjusted Operating Income (non-GAAP) and Adjusted Operating Margin (non-GAAP) by Segment" and "Net (Loss) Income, Diluted (Loss) Earnings Per Share, Adjusted Income (non-GAAP) and Adjusted Diluted Earnings Per Share (non-GAAP)," reports operating (loss) income, operating margin, net (loss) income and diluted (loss) earnings per share without the impact of acquisition-related expenses, asset impairment charges, a discrete tax charge to revalue existing deferred tax liabilities due to Barbados enacting domestic corporate income tax legislation ("Barbados tax reform"), costs incurred in connection with the departure of our former Chief Executive Officer ("CEO") primarily related to severance and recruitment costs ("CEO succession costs"), settlement costs related to EPA packaging and labeling compliance for certain products in the air filtration, water filtration and humidification categories ("EPA compliance costs"), a transitional income tax benefit resulting from the recognition of deferred tax assets in connection with the reorganization of our intangible assets in fiscal 2025 and income tax expense from the recognition of valuation allowances in fiscal 2026 on the related deferred tax assets ("intangible asset reorganization"), restructuring charges, amortization of intangible assets and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based financial measures presented in our consolidated statements of (loss) income. We believe that adjusted operating income, adjusted operating margin, adjusted income and adjusted diluted earnings per share provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges and benefits on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures reflect the operating performance of our business and facilitate a more direct comparison of our performance to our competitors. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income and adjusted diluted earnings per share are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. These non-GAAP financial measures are discussed further and reconciled to their applicable GAAP-based financial measures contained in this MD&A beginning on page 49.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Overview**

We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. Our portfolio of brands includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June, among others. We have built leading market positions through new product innovation, product quality and competitive pricing. As of February 28, 2026, we operated two reportable segments: Home & Outdoor and Beauty & Wellness.

During fiscal 2026, we made significant organizational and operational changes designed to stabilize our business. The Board of Directors appointed a new Chief Executive Officer with transformation experience needed to help drive our next phase of value creation. Under this new leadership, we are currently engaged in a comprehensive review of our strategic priorities as we re-position our Company to deliver sustained revenue and profit growth, increase market share and create superior long-term value for all stakeholders.

We are taking steps to modernize our business model designed to move at the speed of the consumer and excel in a rapidly evolving environment with fragmented consumer attention and shifting value perceptions. Our strategy includes the following priorities: reenergize our brands and our people, adapt our organizational structure to put the consumer at the center of everything we do, strengthen our brand portfolio for predictable long-term growth, and improve asset efficiency. As part of our strategy, we plan to sharpen our focus on fewer, more impactful initiatives, which include investing more in product innovation, strengthening brand loyalty, and advancing commercial excellence. We intend to energize our brands through a disciplined investment approach focusing on impactful opportunities that generate competitive advantages and deliver product solutions and world-class innovation to our consumers. In addition, we believe our consumer-centric approach will enable us to better understand our consumers, allocate resources more efficiently, and accelerate the time to market for new products and brands with the best opportunities for long-term sustainable growth. We expect this will strengthen our portfolio of brands to provide a pathway for strong cash flow generation to further invest back into our business. We remain focused on improving balance sheet health and productivity, by prioritizing our capital expenditures, optimizing our working capital, and monetizing less productive assets. While we are finalizing this strategy reset, we have already implemented many of the foundational changes intended to drive long-term performance, and we have taken immediate actions we believe will accelerate our product innovation, sharpen our go-to-market execution, strengthen our cash flow, and pay down our debt.

During fiscal 2026 and fiscal 2025, we concluded a goodwill impairment triggering event occurred during certain quarterly interim periods due to a sustained decline in our stock price, and performed quantitative impairment testing on our goodwill and certain intangible assets. As a result of such testing, we recorded pre-tax asset impairment charges as follows:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** |
| Home & Outdoor (1) | $**332565** | $— |
| Beauty & Wellness (2) | **553296** | 51455 |
| Total | $**885861** | $51455 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Asset impairment charges recognized for our Home & Outdoor segment included charges for our Hydro Flask and Osprey businesses of $184.4 million and $148.1 million, respectively, during fiscal 2026.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Asset impairment charges recognized for our Beauty & Wellness segment included charges for our Health & Wellness, Drybar, Curlsmith and Revlon businesses of $242.2 million, $154.5 million, $133.0 million and $23.5 million, respectively, during fiscal 2026, and a charge for our Drybar business of $51.5 million during fiscal 2025.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

For additional information regarding the testing and analysis performed, refer to "Critical Accounting Policies and Estimates" in this Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations."

On December 16, 2024, we completed the acquisition of Olive & June, LLC ("Olive & June"), an innovative, omni-channel nail care brand. Olive & June products deliver a salon-quality experience at home and include nail polish, press-on nails, manicure and pedicure systems, grooming tools and nail care essentials. The Olive & June brand and products were added to the Beauty & Wellness segment. The total purchase consideration consists of initial cash consideration of $224.7 million, which is net of cash acquired and a favorable post-closing adjustment of $3.9 million, and contingent cash consideration of up to $15.0 million subject to Olive & June's performance during calendar years 2025, 2026, and 2027, payable annually. We incurred pre-tax acquisition-related expenses of $3.0 million during fiscal 2025, which were recognized in SG&A within our consolidated statement of income.

Subsequent to fiscal 2026, on April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi for a total sales price of $82.0 million, less costs to sell of $3.8 million. Accordingly, we recognized a gain on the sale of $54.9 million within SG&A during the first quarter of fiscal 2027, which was recognized by our Beauty & Wellness segment. We used the proceeds from the sale to repay amounts outstanding under our credit facility.

**Significant Trends Impacting the Business**

***Impact of Tariffs***

Since 2019, the Office of the U.S. Trade Representative ("USTR") has imposed, and in certain cases subsequently reduced or suspended, additional tariffs on products imported from China. Additionally, the current U.S. presidential administration has promoted and implemented plans to raise tariffs even further and pursue other trade policies intended to restrict imports. Our purchases of products from unaffiliated manufacturers located in China and other regions exposes us to higher costs of doing business from increases in tariffs.

Under the International Emergency Economic Powers Act ("IEEPA"), the U.S. presidential administration began implementing fentanyl-related IEEPA tariffs ("Fentanyl IEEPA Tariff") and additional tariffs ("Reciprocal IEEPA Tariff") during calendar year 2025. As of April 9, 2025, the U.S. had imposed (i) an aggregate additional 145% tariff on imports from China, consisting of a 20% Fentanyl IEEPA Tariff and 125% Reciprocal IEEPA Tariff and (ii) a global 10% Reciprocal IEEPA Tariff on imports from other countries including Mexico, Vietnam and other U.S. trading partners. The Reciprocal IEEPA Tariff on imports from China was subsequently lowered to 10% effective May 12, 2025, resulting in an aggregate additional 30% tariff. On July 31, 2025, the U.S. president signed an executive order imposing new IEEPA tariffs on a number of U.S. trading partners which became effective on August 7, 2025, including a 25% Fentanyl IEEPA Tariff on imports from Mexico and a 20% and 19% Reciprocal IEEPA Tariff on imports from Vietnam and Thailand, respectively. Effective November 10, 2025, the 10% Reciprocal IEEPA Tariff on imports from China, which was set to expire, was extended to remain in effect through November 10, 2026, and the Fentanyl IEEPA Tariff was reduced from 20% to 10%, reducing the aggregate additional tariff from 30% to 20%. On February 20, 2026, the U.S. Supreme Court ruled that tariffs imposed by the U.S. president under IEEPA were unconstitutional, and the U.S. president subsequently imposed a temporary global 10% Section 122 tariff under the Trade Act of 1974 ("Section 122 Tariff") effective February 24, 2026 through July 24, 2026. As a result, the aggregate additional tariff on imports from China, Vietnam, Mexico and Thailand of 20%, 20%, 25% and 19%, respectively, were replaced by the 10% Section 122 Tariff. Our imports manufactured in Mexico are not impacted since they qualify for duty-free preference under the United States-Mexico-Canada Agreement. Further, we benefit from certain exclusions from tariffs as a result of the COVID-19 pandemic, which were recently extended to November 9, 2026. We are monitoring regulatory guidance regarding the potential for tariff refunds as a result of the U.S. Supreme Court ruling. As of February 28, 2026, we did not recognize any tariff

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

refunds in our consolidated financial statements as we were unable to assert loss recovery is probable due to the uncertainty surrounding the tariff refund process and eligibility.

In March 2025, the U.S. president also implemented changes under Section 232 of the Trade Expansion Act of 1962 ("Section 232 Tariffs") which resulted in additional sectoral tariffs to aluminum and steel of 25%. On June 4, 2025, the Section 232 Tariffs related to aluminum and steel were increased to 50%, and effective August 1, 2025, expanded to include copper products and components. Section 232 Tariffs were previously imposed based solely on a metal content-based calculation. Effective April 6, 2026, Section 232 Tariffs were expanded to apply to the entire customs value of covered products with tiered rates based on metal content and origin. Currently, our products are not subject to the Section 232 Tariffs on copper products and components. Our products are currently subject to (i) a Section 232 Tariff on aluminum and steel products of 25% to 50%, which primarily impacts certain products within our Home and Wellness businesses and (ii) the Section 122 Tariff or Section 301 Tariffs (defined below). In addition, the U.S. presidential administration is considering additional tariffs as a remedy for unfair trade practices under Section 301 of the Trade Act of 1974 ("Section 301 Tariffs"); however, no official Section 301 Tariffs have been published since the review process is ongoing.

U.S. tariff policies continue to evolve, as well as the corresponding impacts on global trade policies. As a result, our risks and mitigation plans, as further described below, will also continue to evolve as further developments arise. Any further alteration of trade agreements and terms between China, Vietnam, Mexico and the U.S., including limiting trade with China, Vietnam and Mexico, imposing additional tariffs on imports from China, Vietnam or Mexico and potentially imposing other restrictions on imports from China, Vietnam or Mexico, to the U.S., may result in further or higher tariffs or retaliatory trade measures by China, Vietnam or Mexico, all of which could have a material adverse effect on our business and operating results.

We are continuing to assess our incremental tariff cost exposure in light of continuing changes to global tariff policies and the full extent of our potential mitigation plans, as well as the associated timing to implement such plans and realize the anticipated benefits. To mitigate our risk of ongoing exposure to tariffs, we have initiated significant efforts to diversify our production outside of China into regions where we expect tariffs or overall costs to be lower and to source the same product in more than one region, to the extent it is possible and not cost-prohibitive. We are also continuing to implement other mitigation actions, which include cost reductions from suppliers and price increases to customers on products subject to tariffs. In addition to the uncertainty from evolving global tariff policies, we expect unfavorable cascading impacts on inflation, consumer confidence, employment and overall macroeconomic conditions, all of which may adversely impact our sales, results of operations and cash flows.

During fiscal 2026, the impact of the tariffs adversely impacted our cost of goods sold and had cascading adverse impacts on our net sales revenue, interest expense, business, results of operations and cash flows. Our cost of goods sold during fiscal 2026 included $50.7 million of additional pre-tax costs related to the changes in tariffs described above. Our net sales revenue during fiscal 2026 was also negatively impacted by a combination of factors including the pause or cancellation of direct import orders from China by certain of our key retailers in response to increased tariff rates, a slowdown in retailer orders following pull forward activity in the fourth quarter of fiscal 2025 due to tariff uncertainty and lower consumer confidence and demand. Sales were also negatively impacted by evolving dynamics in the China market, including a shift toward localized fulfillment models and heightened competition from domestic sellers benefiting from government subsidies. Net sales revenue during the second half of fiscal 2026 was unfavorably impacted by stop shipment actions in support of consistent adoption of tariff related price increases by our retail partners, which primarily impacted our Beauty & Wellness segment. We also incurred higher interest expense during fiscal 2026 due to the impact of tariffs resulting in higher inventory carrying costs and higher capital expenditures to diversify our production outside of China. In addition to the uncertainty from evolving global tariff policies, we experienced and expect continued unfavorable cascading impacts on inflation, consumer confidence, employment and overall

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

macroeconomic conditions, all of which may continue to adversely impact our sales, results of operations and cash flows.

In the first quarter of fiscal 2026, we adjusted our measures to reduce costs and preserve cash flow as the environment continued to evolve. While we resumed targeted growth investments during the second and third quarters of fiscal 2026, we remain disciplined in our approach given continued tariff volatility. The measures in place continue to include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Suspension of projects and capital expenditures that are not critical or in support of supplier diversification or dual sourcing initiatives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Actions to reduce overall personnel costs and pause most project and travel expenses remain in place;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A resumption of optimized marketing, promotional and new product development investments focused on opportunities with the highest returns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A measured approach to inventory purchases in expectation of softer consumer demand in the short to intermediate term; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Actions to optimize working capital and balance sheet productivity.

***Impact of Macroeconomic Trends***

The Federal Open Market Committee lowered the benchmark interest rate by 75 basis points during fiscal 2026. As a result, during fiscal 2026, we incurred lower average interest rates compared to fiscal 2025. As of February 28, 2026, $325 million of the outstanding principal balance under the Amended Credit Agreement (as defined below) was hedged with interest rate swaps to fix the interest rate we pay. While the actual timing and extent of additional future changes in interest rates remains unknown, lower average interest rates would reduce interest expense on our outstanding variable rate debt not subject to the interest rate swaps. The financial markets, the global economy and global supply chain may also be adversely affected by the current or anticipated impact of military conflicts or other geopolitical events, as well as recent U.S. tariff policies, that are continuing to evolve and the corresponding impacts on global trade. Most recently, the outcome of the ongoing Israel-United States and Iran conflict is highly unpredictable and could lead to significant market and other disruptions, including significant volatility in the commodity prices and supply of energy resources and supply chain interruptions. High inflation and interest rates have also negatively impacted consumer disposable income, credit availability and spending, among others, which have adversely impacted our business, financial condition, cash flows and results of operations during fiscal 2026 and may continue to have an adverse impact in fiscal 2027. The evolving global tariff policies could adversely impact inflation and interest rates which could further negatively impact consumer disposable income, credit availability and spending. See further discussion below under "Consumer Spending and Changes in Shopping Preferences." We expect continued uncertainty in our business and the global economy due to pressure from inflation, tariffs and consumer confidence, any of which may adversely impact our results.

***Consumer Spending and Changes in Shopping Preferences***

Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 72% of our consolidated net sales revenue in fiscal 2026 was from U.S. shipments, compared to 71% of consolidated net sales revenue in fiscal 2025.

Among other things, high levels of inflation, interest rates, military conflicts or other geopolitical events, and tariffs may negatively impact consumer disposable income, credit availability and spending. Consumer purchases of discretionary items, including some of the products that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Dynamic changes in consumer spending and shopping patterns are also having an impact on retailer inventory levels. Our ability to sell to retailers

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

is predicated on their ability to sell to the end consumer. During fiscal 2026, we experienced increased competition within our Beauty & Wellness segment and in the insulated beverageware category, which led to some declines in retail distribution. In addition, during fiscal 2026 we experienced and we continue to experience lower replenishment orders in line with softer consumer demand and discretionary spending and continued competition, which adversely impacted our sales, results of operations and cash flows. If orders from our retail customers continue to be adversely impacted, our sales, results of operations and cash flows may continue to be adversely impacted. We expect continued uncertainty in our business and the global economy due to inflation, evolving global tariff policies, continued competition and changes in consumer spending patterns. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today. For additional information on our related material risks, see Item 1A., "Risk Factors."

Our concentration of sales reflects the continued evolution of consumer shopping preferences. For fiscal 2026 and 2025, our net sales to pure-play online retailers and retail customers fulfilling end-consumer online orders, as well as our own online sales directly to consumers (collectively "online channel net sales") comprised approximately 26% and 27%, respectively, of our total consolidated net sales revenue and declined approximately 10.0% and 5.5% in fiscal 2026 and 2025, respectively.

With the continued importance of online sales in the retail landscape, many brick and mortar retailers are aggressively looking for ways to improve their customer delivery capabilities to be able to meet customer expectations. As a result, it has become increasingly important for us to leverage our distribution capabilities in order to meet the changing demands of our customers, including increasing our online capabilities to support our direct-to-consumer sales channels and online channel sales by our retail customers. To meet these needs, we completed the construction of an additional distribution facility in Gallaway, Tennessee, that became operational during fiscal 2024. During the first quarter of fiscal 2025, we experienced automation system startup issues at the facility which impacted some of our Home & Outdoor segment's small retail customer and direct-to-consumer orders. As a result, our sales during the first quarter of fiscal 2025 were adversely impacted due to shipping disruptions, and we incurred additional costs and lost efficiency during both the first and second quarters of fiscal 2025 as we worked to remediate the issues. As a result of the remediation efforts performed, the automation system began to operate as designed during the third quarter of fiscal 2025, and we achieved targeted efficiency levels by the end of fiscal 2025.

Additionally, we have invested in a centralized cloud-based e-commerce platform, which most of our brands are currently utilizing. The centralized cloud-based e-commerce platform enables us to leverage a common system and rapidly deploy new capabilities across all of our brands, as well as more easily integrate new brands. We believe this platform enhances the customer experience by strengthening the digital presentation and product browsing capabilities and improving the checkout process, order delivery and post-order customer care.

***Project Pegasus***

During fiscal 2023, we initiated a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and effectiveness and reduce costs (referred to as "Project Pegasus"). During the fourth quarter of fiscal 2025, we completed Project Pegasus, but still expect to realize the targeted savings through fiscal 2027. Project Pegasus included initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate and amplify cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending and improve our cash flow and working capital, as well as other activities. These initiatives have created operating efficiencies, as well as provided a platform to fund growth investments. During fiscal 2025 and 2024, we incurred restructuring charges in connection with Project Pegasus primarily for professional fees and severance and employee related costs, which were recorded as "Restructuring charges" in the consolidated statements of (loss) income. Restructuring charges primarily represented cash expenditures and were substantially paid by the end of fiscal 2025, with a remaining liability of $7.7

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

million as of February 28, 2025, which was paid during fiscal 2026. See Note 11 to the accompanying consolidated financial statements for additional information.

We continue to have the following expectations regarding Project Pegasus savings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which began in fiscal 2024 and we expect to be substantially achieved by the end of fiscal 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Estimated cadence of the recognition of the savings will be approximately 25%, 35% and 25% in fiscal 2024, 2025 and 2026, respectively, all of which were achieved, and approximately 15% in fiscal 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.

During fiscal 2026 and 2025, our gross margin and operating margins were favorably impacted by lower commodity and product costs driven by our cost of goods savings projects. Expectations regarding our Project Pegasus initiatives and our ability to realize targeted savings are based on management's estimates available at the time and are subject to a number of assumptions that could materially impact our estimates.

***Water Filtration Patent Litigation***

On December 23, 2021, Brita LP filed a complaint against Kaz USA, inc. and Helen of Troy Limited in the U.S. District Court for the Western District of Texas (the "Patent Litigation"), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. Brita LP simultaneously filed a complaint with the U.S. International Trade Commission ("ITC") against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the "ITC Action"). The complaint in the ITC Action also alleged patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. This action sought injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory already in the U.S. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against the Company and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including the Company, filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company's favor. The ITC determined there was no violation by the Company and terminated the investigation. Brita LP subsequently appealed the ITC's decision to the Federal Circuit ("CAFC Appeal") and filed its Notice of Appeal on October 24, 2023. The Company intervened in the CAFC Appeal and oral argument occurred on August 5, 2025.

In connection with the CAFC Appeal, on October 15, 2025, the Federal Circuit issued a precedential opinion affirming the ITC's decision that Brita LP's claims were invalid. Following the ITC's determinations with respect to the ITC Action and the Federal Circuit's opinion in the CAFC Appeal, on December 22, 2025, Brita filed a notice to dismiss the Patent Litigation in the District Court, ending the Patent Litigation in the Company's favor. For additional information regarding the Patent Litigation and the ITC Action, see Note 12 to the accompanying consolidated financial statements.

***EPA Compliance Costs***

Some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the EPA, U.S. Customs and Border Protection, the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission and the EU.

During fiscal 2022 and 2023, we were in discussions with the EPA regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. We continue to have ongoing settlement discussions with the EPA related to this matter. As of February 28, 2026, we accrued an estimated liability of $4.4 million, which represents our best estimate of probable settlement costs related to this matter. See Note 12 to the accompanying consolidated financial statements for additional information and Item 1A., "Risk Factors" in this Annual Report for additional information on our related material risks.

***Talcum Powder Litigation***

In fiscal 2022, we completed the sale of our North America personal care business to HRB Brands LLC ("HRB Brands"). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, we learned that HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands' position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. As of February 28, 2026, we had accrued an estimated liability of $1.5 million for potential settlements of these cases. We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant's share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the several possible developments that may occur that could affect the Company's estimate of the liability. For additional information, see Note 12 to the accompanying consolidated financial statements.

***Foreign Currency Exchange Rate Fluctuations***

Due to the nature of our operations, we have exposure to the impact of fluctuations in exchange rates from transactions that are denominated in a currency other than our functional currency (the U.S. Dollar). Such transactions include sales and operating expenses. The most significant currencies affecting our operating results are the Euro, British Pound and Canadian Dollar.

Changes in foreign currency exchange rates had a favorable impact on consolidated U.S. Dollar reported net sales revenue of approximately $5.6 million, or 0.3% for fiscal 2026, and an unfavorable impact of approximately $2.5 million, or 0.1% for fiscal 2025.

***Variability of the Cough/Cold/Flu Season***

Sales in several of our Beauty & Wellness categories are highly correlated to the severity of winter weather and cough/cold/flu incidence. In the U.S., the cough/cold/flu season historically runs from November through March, with peak activity normally in January to March. The 2025-2026 and 2024-2025 cough/cold/flu seasons were below historical averages seen prior to the impact of COVID-19.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Results of Operations**

This section provides an analysis of our results of operations for fiscal year 2026 as compared to fiscal year 2025 including discussion of material changes. <u>[Refer to Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our 2025 Annual Report on Form 10-K, filed with the SEC on April 24, 2025, for an analysis and discussion of our fiscal year 2025 financial condition and results of operations as compared to fiscal year 2024, which such discussion is hereby incorporated by reference.](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000916789/000091678925000012/hele-20250228.htm)</u>

The following table provides selected operating data, in U.S. Dollars, as a percentage of net sales revenue, and as a year-over-year percentage change.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fiscal Years Ended <br>Last Day of February,** | **Fiscal Years Ended <br>Last Day of February,** | **% of Sales Revenue, net** | **% of Sales Revenue, net** | **% Change** |
| ***(in thousands)*** | **2026 (1)** | **2025 (1)** | **2026** | **2025** | **26/25** |
| Sales revenue by segment, net |  |  |  |  |  |
| &nbsp;&nbsp;Home & Outdoor | $**832870** | $906331 | 46.6% | 47.5% | (8.1)% |
| &nbsp;&nbsp;Beauty & Wellness | **953420** | 1001334 | 53.4% | 52.5% | (4.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales revenue, net | **1786290** | 1907665 | 100.0% | 100.0% | (6.4)% |
| Cost of goods sold | **970596** | 993259 | 54.3% | 52.1% | (2.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | **815694** | 914406 | 45.7% | 47.9% | (10.8)% |
| Selling, general and administrative expense ("SG&A") | **708909** | 705381 | 39.7% | 37.0% | 0.5% |
| Asset impairment charges | **885861** | 51455 | 49.6% | 2.7% | \* |
| Restructuring charges | **3005** | 14822 | 0.2% | 0.8% | (79.7)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | **(782081)** | 142748 | (43.8)% | 7.5% | \* |
| Non-operating income, net | **982** | 838 | 0.1% | —% | 17.2% |
| Interest expense | **57739** | 51922 | 3.2% | 2.7% | 11.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;(Loss) income before income tax | **(838838)** | 91664 | (47.0)% | 4.8% | \* |
| Income tax expense (benefit) | **60144** | (32087) | 3.4% | (1.7)% | \* |
| Net (loss) income | $**(898982)** | $123751 | (50.3)% | 6.5% | \* |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Fiscal 2026 includes a full year of operating results from Olive & June, acquired on December 16, 2024, compared to approximately eleven weeks of operating results in fiscal 2025. For additional information see Note 6 to the accompanying consolidated financial statements.

\*&nbsp;&nbsp;&nbsp;&nbsp;Calculation is not meaningful.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Comparison of Fiscal 2026 to Fiscal 2025 Financial Results**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated net sales revenue decreased 6.4%, or $121.4 million, to $1,786.3 million, compared to $1,907.7 million for the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated operating loss was $782.1 million, compared to consolidated operating income of $142.7 million for the same period last year. Consolidated operating loss for fiscal 2026 includes pre-tax asset impairment charges of $885.9 million, pre-tax EPA compliance costs of $4.4 million, pre-tax CEO succession costs of $3.5 million and pre-tax restructuring charges of $3.0 million. Consolidated operating income for fiscal 2025 included pre-tax asset impairment charges of $51.5 million, pre-tax restructuring charges of $14.8 million related to Project Pegasus and pre-tax acquisition-related expenses of $3.0 million. Consolidated operating margin decreased to (43.8)% of consolidated net sales revenue, compared to 7.5% for the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated adjusted operating income decreased 41.1% to $148.6 million, or 8.3% of net sales revenue, compared to $252.3 million, or 13.2% of net sales revenue, for the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net loss was $899.0 million, compared to net income of $123.8 million for the same period last year. Diluted loss per share was $39.08, compared to diluted earnings per share of $5.37 for the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted income decreased 50.4%, or $83.3 million, to $82.1 million, compared to $165.4 million for the same period last year. Adjusted diluted earnings per share decreased 50.5% to $3.55, compared to $7.17 for the same period last year.

***Consolidated and Segment Net Sales Revenue***

The following table summarizes the impact that Organic business, foreign currency and acquisitions had on our net sales revenue by segment:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended Last Day of February,** | **Fiscal Year Ended Last Day of February,** | **Fiscal Year Ended Last Day of February,** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & Wellness** | **Total** |
| Fiscal 2025 sales revenue, net | $906331 | $1001334 | $1907665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Organic business | (77700) | (155967) | (233667) |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of foreign currency | 4239 | 1355 | 5594 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition (1) |  | 106698 | 106698 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in sales revenue, net | (73461) | (47914) | (121375) |
| Fiscal 2026 sales revenue, net  | $832870 | $953420 | $1786290 |
| Total net sales revenue growth (decline) | (8.1)% | (4.8)% | (6.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Organic business | (8.6)% | (15.6)% | (12.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of foreign currency | 0.5% | 0.1% | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition | —% | 10.7% | 5.6% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)On December 16, 2024, we completed the acquisition of Olive & June. Olive & June sales prior to the first annual anniversary of the acquisition are reported in Acquisition for the Beauty & Wellness segment in fiscal 2026 and consist of approximately forty-one weeks of operating results. For additional information see Note 6 to the accompanying consolidated financial statements.

In the above table, Organic business refers to our net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand was acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Consolidated Net Sales Revenue***

*Comparison of Fiscal 2026 to 2025*

Consolidated net sales revenue decreased $121.4 million, or 6.4%, to $1,786.3 million, compared to $1,907.7 million. The decline was driven by a decrease from Organic business of $233.7 million, or 12.2%, due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decline in Beauty & Wellness primarily due to a decrease in sales of thermometers and fans primarily due to reduced replenishment and direct import orders from retail customers in Wellness, and a decline in Beauty driven by softer consumer demand, increased competition, a net distribution loss year-over-year, and the cancellation of direct import orders from China in Beauty; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decline in Home & Outdoor primarily due to continued competition and a net distribution loss year-over-year in the insulated beverageware category, lower replenishment orders from retail customers, softer consumer demand, and a decrease in club channel sales.

These factors were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• strong demand for technical, travel and lifestyle packs in Home & Outdoor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• incremental sales from new product launches in the insulated beverageware category within Home & Outdoor; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the favorable comparative impact of shipping disruption at our Tennessee distribution facility due to automation startup issues affecting Home & Outdoor during the first quarter of fiscal 2025.

The Olive & June acquisition contributed $106.7 million, or 5.6%, to consolidated net sales revenue growth. Consolidated net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $5.6 million, or 0.3%.

***Segment Net Sales Revenue***

**<u>Home & Outdoor</u>**

*Comparison of Fiscal 2026 to 2025*

Net sales revenue decreased $73.5 million, or 8.1%, to $832.9 million, compared to $906.3 million. The decrease was primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• softer consumer demand and lower replenishment orders from retail customers, partially due to retailer inventory rebalancing in response to demand trends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continued competition, a net distribution loss year-over-year, lower closeout channel sales, and cancellation of direct import orders in response to higher tariffs in the insulated beverageware category;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decrease in club channel sales in response to higher tariffs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the unfavorable impact of retailer pull-forward activity in the fourth quarter of fiscal 2025 in response to tariff uncertainty and anticipated supply disruption.

These factors were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• strong demand for technical, travel and lifestyle packs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• incremental sales from new product launches in the insulated beverageware category;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher sales from expanded distribution in the home category; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the favorable comparative impact of shipping disruption at our Tennessee distribution facility due to automation startup issues during the first quarter of fiscal 2025.

Segment net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $4.2 million, or 0.5%.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**<u>Beauty & Wellness</u>**

*Comparison of Fiscal 2026 to 2025*

Net sales revenue decreased $47.9 million, or 4.8%, to $953.4 million, compared to $1,001.3 million. The decrease was primarily driven by a decrease from Organic business of $156.0 million, or 15.6%, due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decline in Beauty primarily due to softer consumer demand, increased competition, a net distribution loss year-over-year, the cancellation of direct import orders from China in response to higher tariffs and lower closeout channel sales;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decline in thermometry primarily due to evolving dynamics in the China market, including a shift away from cross-border ecommerce toward localized fulfillment models, heightened competition from domestic sellers benefiting from government subsidies, and lower replenishment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decrease in fan sales primarily driven by reduced replenishment orders from retail customers due to a decline in consumer demand and the cancellation of direct import orders from China in response to higher tariffs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an overall decrease in Wellness due to stop shipment actions in support of consistent adoption of tariff related price increases by our retail partners and softer consumer demand; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of below average illness season on the humidification and thermometry categories.

These factors were partially offset by an increase in organic net sales revenue from Olive & June and the favorable comparative impact of the shipping disruption from the Curlsmith system integration during the first quarter of fiscal 2025.

The Organic business decline was partially offset by the inorganic contribution from the Olive & June acquisition of $106.7 million, or 10.7%, to segment net sales revenue growth. Segment net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $1.4 million, or 0.1%.

***Consolidated Gross Profit Margin***

*Comparison of Fiscal 2026 to 2025*

Consolidated gross profit margin decreased 2.2 percentage points to 45.7%, compared to 47.9%. The decrease in consolidated gross profit margin was primarily due to the net unfavorable impact of tariffs, higher retail trade and promotional expense, and a less favorable inventory obsolescence impact year-over-year.

These factors were partially offset by the favorable impact of the acquisition of Olive & June within the Beauty & Wellness segment and lower commodity and product costs, partly driven by Project Pegasus initiatives.

***Consolidated SG&A***

*Comparison of Fiscal 2026 to 2025*

Consolidated SG&A ratio increased 2.7 percentage points to 39.7%, compared to 37.0%. The increase in the consolidated SG&A ratio was primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an increase in annual incentive compensation expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher outbound freight costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of the Olive & June acquisition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• EPA compliance costs of $4.4 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• CEO succession costs of $3.5 million; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of unfavorable operating leverage due to the decrease in net sales.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

These factors were partially offset by the favorable comparative impact of higher distribution center expense in the prior year primarily due to additional costs and lost efficiency associated with automation startup issues at our Tennessee distribution facility.

***Asset Impairment Charges***

*Fiscal 2026*

During fiscal 2026, we recorded asset impairment charges of $885.9 million ($866.1 million after tax) to reduce our goodwill by $706.5 million and our other intangible assets by $179.4 million.

*Fiscal 2025*

During the fourth quarter of fiscal 2025, we recorded asset impairment charges of $51.5 million ($47.6 million after tax) to reduce the goodwill and definite-lived trade name of our Drybar business, which is

included within our Beauty & Wellness segment.

For additional information regarding the testing and analysis performed, refer to "Critical Accounting Policies and Estimates" in this Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations."

***Restructuring Charges***

*Fiscal 2026*

During fiscal 2026, we incurred $3.0 million of pre-tax restructuring charges for severance and employee related costs as a result of personnel reductions outside of the scope of Project Pegasus.

During fiscal 2026, we made the remaining cash restructuring payments related to Project Pegasus of $7.7 million.

*Fiscal 2025*

We incurred $14.8 million of pre-tax restructuring costs related primarily to severance and employee related costs, professional fees and contract termination costs under Project Pegasus. During fiscal 2025, we made total cash restructuring payments related to Project Pegasus of $11.9 million and had a remaining liability of $7.7 million as of February 28, 2025.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Operating (Loss) Income, Operating Margin, Adjusted Operating Income (non-GAAP) and Adjusted Operating Margin (non-GAAP) by Segment***

In order to provide a better understanding of the impact of certain items on our operating (loss) income, the tables that follow report the comparative pre-tax impact of acquisition-related expenses, asset impairment charges, CEO succession costs, EPA compliance costs, restructuring charges, amortization of intangible assets and non-cash share-based compensation, as applicable, on operating (loss) income and operating margin for each segment and in total for the periods presented below. Adjusted operating income and adjusted operating margin may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management's decision to present this non-GAAP financial information, see the introduction to this Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** |
| ***(in thousands)*** | **Home & Outdoor** | **Home & Outdoor** | **Beauty & Wellness (1)** | **Beauty & Wellness (1)** | **Total** | **Total** |
| Operating loss, as reported (GAAP) | $**(269744)** | **(32.4)%** | $**(512337)** | **(53.7)%** | $**(782081)** | **(43.8)%** |
| &nbsp;&nbsp;Asset impairment charges | **332565** | **39.9%** | **553296** | **58.0%** | **885861** | **49.6%** |
| &nbsp;&nbsp;&nbsp;CEO succession costs | **1742** | **0.2%** | **1742** | **0.2%** | **3484** | **0.2%** |
| &nbsp;&nbsp;&nbsp;EPA compliance costs | **—** | **— %** | **4354** | **0.5%** | **4354** | **0.2%** |
| &nbsp;&nbsp;&nbsp;Restructuring charges | **1501** | **0.2%** | **1504** | **0.2%** | **3005** | **0.2%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | **66064** | **7.9%** | **48559** | **5.1%** | **114623** | **6.4%** |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **5977** | **0.7%** | **11082** | **1.2%** | **17059** | **1.0%** |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | **6781** | **0.8%** | **10104** | **1.1%** | **16885** | **0.9%** |
| Adjusted operating income (non-GAAP) | $**78822** | **9.5%** | $**69745** | **7.3%** | $**148567** | **8.3%** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** |
| ***(in thousands)*** | **Home & Outdoor** | **Home & Outdoor** | **Beauty & Wellness (1)** | **Beauty & Wellness (1)** | **Total** | **Total** |
| Operating income, as reported (GAAP) | $119601 | 13.2% | $23147 | 2.3% | $142748 | 7.5% |
| &nbsp;&nbsp;&nbsp;Acquisition-related expenses |  | —% | 3035 | 0.3% | 3035 | 0.2% |
| &nbsp;&nbsp;&nbsp;Asset impairment charges |  | —% | 51455 | 5.1% | 51455 | 2.7% |
| &nbsp;&nbsp;&nbsp;Restructuring charges | 4855 | 0.5% | 9967 | 1.0% | 14822 | 0.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 124456 | 13.7% | 87604 | 8.7% | 212060 | 11.1% |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 7064 | 0.8% | 11811 | 1.2% | 18875 | 1.0% |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | 10402 | 1.1% | 10974 | 1.1% | 21376 | 1.1% |
| Adjusted operating income (non-GAAP) | $141922 | 15.7% | $110389 | 11.0% | $252311 | 13.2% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Fiscal 2026 includes a full year of operating results from Olive & June, acquired on December 16, 2024, compared to approximately eleven weeks of operating results in fiscal 2025. For additional information see Note 6 to the accompanying consolidated financial statements.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Consolidated Operating (Loss) Income***

*Comparison of Fiscal 2026 to 2025*

Consolidated operating loss was $782.1 million, or (43.8)% of net sales revenue, compared to consolidated operating income of $142.7 million, or 7.5% of net sales revenue. Fiscal 2026 includes pre-tax asset impairment charges of $885.9 million, pre-tax restructuring charges of $3.0 million, pre-tax EPA compliance costs of $4.4 million and pre-tax CEO succession costs of $3.5 million. Fiscal 2025 includes pre-tax acquisition-related expenses of $3.0 million, pre-tax asset impairment charges of $51.5 million and pre-tax restructuring charges of $14.8 million. The combined effect of these items unfavorably impacted the year-over-year comparison of consolidated operating margin by a combined 46.6 percentage points. The remaining 4.7 percentage point decrease in consolidated operating margin was primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the net unfavorable impact of higher tariffs on our gross profit;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher retail trade and promotional expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a less favorable inventory obsolescence impact year-over-year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an increase in annual incentive compensation expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased outbound freight costs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of unfavorable operating leverage due to the decrease in net sales.

These factors were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the favorable impact of the acquisition of Olive & June within Beauty & Wellness;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• lower commodity and product costs, partly driven by Project Pegasus initiatives; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the favorable comparative impact of higher distribution center expense in the prior year primarily due to additional costs and lost efficiency associated with automation startup issues at our Tennessee distribution facility.

Consolidated adjusted operating income decreased 41.1% to $148.6 million, or 8.3% of net sales revenue, compared to $252.3 million, or 13.2% of net sales revenue.

**<u>Home & Outdoor</u>**

*Comparison of Fiscal 2026 to 2025*

Operating loss was $269.7 million, or (32.4)% of segment net sales revenue, compared to operating income of $119.6 million, or 13.2% of segment net sales revenue. Operating loss in fiscal 2026 included $332.6 million of pre-tax asset impairment charges. The remaining 5.7 percentage point decrease in segment operating margin was primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* the net unfavorable impact of higher tariffs on our gross profit;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher retail trade and promotional expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* less favorable inventory obsolescence impact year-over-year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* an increase in annual incentive compensation expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher outbound freight costs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of unfavorable operating leverage due to the decrease in net sales.

These factors were partially offset by lower commodity and product costs, partly driven by Project Pegasus initiatives, and the favorable comparative impact of higher distribution center expense in the prior year.

Adjusted operating income decreased 44.5% to $78.8 million, or 9.5% of segment net sales revenue, compared to $141.9 million, or 15.7% of segment net sales revenue.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**<u>Beauty & Wellness</u>**

*Comparison of Fiscal 2026 to 2025*

Operating loss was $512.3 million, or (53.7)% of segment net sales revenue, compared to operating income of $23.1 million, or 2.3% of segment net sales revenue. Operating loss in fiscal 2026 included $553.3 million of pre-tax asset impairment charges, compared to $51.5 million in fiscal 2025. The remaining 3.1 percentage point decrease in segment operating margin was primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the net unfavorable impact of higher tariffs on our gross profit;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a less favorable inventory obsolescence impact year-over-year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an increase in annual incentive compensation expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased marketing expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• EPA compliance costs of $4.4 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher outbound freight costs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of unfavorable operating leverage due to the decrease in net sales.

These factors were partially offset by the favorable impact of the acquisition of Olive & June and lower commodity and product costs, partly driven by Project Pegasus initiatives.

Adjusted operating income decreased 36.8% to $69.7 million, or 7.3% of segment net sales revenue, compared to $110.4 million, or 11.0% of segment net sales revenue.

***Interest Expense***

*Comparison of Fiscal 2026 to 2025*

Interest expense was $57.7 million, compared to $51.9 million. The increase in interest expense was primarily due to higher average borrowings outstanding to fund the acquisition of Olive & June and the cost of tariffs in working capital and capital expenditures, partially offset by a lower average effective interest rate inclusive of the impact of our interest rate swaps compared to the prior year.

***Income Tax Expense***

The comparison of our effective tax rate between periods is often impacted by the geographic mix of earnings among our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intangible assets are primarily owned by foreign affiliates, resulting in proportionally higher earnings in jurisdictions with statutory tax rates lower than that of the U.S.

In July 2025, a reconciliation bill, commonly referred to as the One Big Beautiful Bill Act, was signed into law. The legislation includes a broad range of U.S. tax reform provisions. There were no discrete effects upon enactment in the second quarter of fiscal 2026 or material impacts on our fiscal 2026 consolidated financial statements. This legislation is not expected to have a material impact on our consolidated financial statements in the foreseeable future.

The OECD has introduced a framework to implement a global minimum corporate income tax of 15%, referred to as "Pillar Two." Certain countries in which we operate have enacted, or are in the process of enacting, domestic legislation aligned with OECD's Pillar Two "Model Rules." Pillar Two legislation in effect for our fiscal 2025 and 2026 has been incorporated into our consolidated financial statements. Differences in how Pillar Two rules are implemented and administered across jurisdictions may increase compliance complexity and could impact our future global effective tax rate.

In June 2025, the Group of Seven, comprised of Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S., announced an agreement under which U.S. multinational companies would be

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

excluded from certain elements of the Pillar Two global minimum tax framework in exchange for the U.S. withdrawing planned retaliatory tax measures. In January 2026, the OECD released administrative guidance detailing a side-by-side ("SbS") package that reflects this agreement and establishes a framework permitting U.S. multinational enterprise groups to coexist with the Pillar Two rules. Under this guidance, U.S. parented groups may qualify for the Side by Side Safe Harbour and the Ultimate Parent Entity Safe Harbour, which can eliminate top-up taxes under the Income Inclusion Rule and the Undertaxed Profits Rule when elected, while leaving Qualified Domestic Minimum Top-up Taxes unaffected.

The SbS package also includes additional administrative guidance, such as a permanent simplified effective tax rate safe harbour, an extension of the transitional country by country reporting safe harbour and a new substance-based tax incentive safe harbour. We do not expect the SbS package to materially affect our Pillar Two related tax positions or liabilities going forward. We will continue to monitor the implications of the OECD guidance and domestic adoption as jurisdictions implement these rules.

In response to Pillar Two, on May 24, 2024, Barbados enacted a domestic corporate income tax rate of 9%, effective for our fiscal 2025 and a domestic minimum top-up tax ("DMTT") of 15% which was effective beginning with our fiscal 2026. During the first quarter of fiscal 2025, we incorporated the corporate income tax into our estimated annual effective tax rate and revalued our existing deferred tax liabilities subject to the Barbados legislation, which resulted in a discrete tax charge of $6.0 million. However, as a result of the reorganization of our intangible assets in the fourth quarter of 2025 described below, the Barbados corporate income tax and DMTT did not have a material impact on our consolidated financial statements in fiscal 2026 and is not expected to in the foreseeable future.

Like Barbados, the government of Bermuda enacted a 15% corporate income tax that was effective for us beginning in fiscal 2026. This Bermuda tax did not have a material impact on our consolidated financial statements in fiscal 2026 and is not expected to in the foreseeable future.

In the fourth quarter of fiscal 2025, we implemented a reorganization involving the transfer of intangible assets previously held by Helen of Troy Limited (Barbados) to our subsidiary in Switzerland. The reorganization resulted in the consolidation of the ownership of intangible assets, supporting streamlined internal licensing and centralized management of the intangible assets. Further, the reorganization resulted in a transitional income tax benefit of $64.6 million from the recognition of deferred tax assets of $74.0 million, partially offset by taxes associated with the transfer. As described below, a full valuation allowance was recorded on these deferred tax assets as of the end of the third quarter of fiscal 2026.

During fiscal 2026 and 2025, we recognized goodwill and other intangible asset impairment charges of $885.9 million and $51.5 million, respectively, which included $602.2 million and $22.5 million, respectively, that will not result in a tax benefit. Tax benefits, net of valuation allowances, of $19.8 million and $3.9 million on the impairment charges were recognized in fiscal 2026 and 2025, respectively.

The downward revisions to our internal forecasts utilized in our impairment testing during fiscal 2026 negatively impacted our assessment of the realizability of net deferred tax assets for our Switzerland subsidiary as of the beginning of the fiscal year and deferred tax assets generated by asset impairments during fiscal 2026. Based on these revisions and in accordance with ASC 740, *Income Taxes*, we recorded discrete partial valuation allowances during the first and second quarters of fiscal 2026. As fiscal 2026 progressed, impairment-related losses resulted in a cumulative loss position over recent periods, which constituted significant objective negative evidence under ASC 740 and ultimately led to the recording of a full valuation allowance beginning in the third quarter of fiscal 2026. As a result, we recognized a cumulative valuation allowance of $106.6 million during fiscal 2026. We expect to maintain a full valuation allowance on these net deferred tax assets until we have objective factors that demonstrate the likelihood of realizing these deferred tax benefits.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Fiscal 2026 income tax expense was $60.1 million on a pre-tax loss of $838.8 million, compared to an income tax benefit of $32.1 million on pre-tax income of $91.7 million for fiscal 2025. The increase in the tax expense relative to pre-tax (loss) income is primarily due to non-deductible impairment charges and valuation allowances on deferred tax assets recorded during fiscal 2026, as described above, and the unfavorable comparative impacts of the transitional tax benefit resulting from the intangible asset reorganization and a tax benefit related to a resolution of an uncertain tax position in the prior year.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Net (Loss) Income, Diluted (Loss) Earnings Per Share, Adjusted Income (non-GAAP) and Adjusted Diluted Earnings Per Share (non-GAAP)***

In order to provide a better understanding of the impact of certain items on our (loss) income and diluted (loss) earnings per share, the tables that follow report the comparative after-tax impact of acquisition-related expenses, asset impairment charges, Barbados tax reform, CEO succession costs, EPA compliance costs, intangible asset reorganization, restructuring charges, amortization of intangible assets and non-cash share-based compensation, as applicable, on (loss) income and diluted (loss) earnings per share for the periods presented below. Adjusted income and adjusted diluted earnings per share may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management's decision to present this non-GAAP financial information, see the introduction to this Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** |
| | **(Loss) Income** | **(Loss) Income** | **(Loss) Income** | **Diluted (Loss) Earnings Per Share** | **Diluted (Loss) Earnings Per Share** | **Diluted (Loss) Earnings Per Share** |
| ***(in thousands, except per share data)*** | **Before Tax** | **Tax** | **Net of Tax** | **Before Tax** | **Tax** | **Net of Tax** |
| As reported (GAAP) | $**(838838)** | $**60144** | $**(898982)** | $**(36.47)** | $**2.61** | $**(39.08)** |
| &nbsp;&nbsp;Asset impairment charges | **885861** | **19788** | **866073** | **38.35** | **0.86** | **37.49** |
| &nbsp;&nbsp;&nbsp;CEO succession costs | **3484** | **153** | **3331** | **0.15** | **0.01** | **0.14** |
| &nbsp;&nbsp;&nbsp;EPA compliance costs | **4354** | **(1114)** | **5468** | **0.19** | **(0.05)** | **0.24** |
| &nbsp;&nbsp;Intangible asset reorganization | **—** | **(74015)** | **74015** | **—** | **(3.20)** | **3.20** |
| &nbsp;&nbsp;&nbsp;Restructuring charges | **3005** | **421** | **2584** | **0.13** | **0.02** | **0.11** |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | **57866** | **5377** | **52489** | **2.51** | **0.23** | **2.27** |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **17059** | **2933** | **14126** | **0.74** | **0.13** | **0.61** |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | **16885** | **1444** | **15441** | **0.73** | **0.06** | **0.67** |
| Adjusted (non-GAAP) | $**91810** | $**9754** | $**82056** | $**3.97** | $**0.42** | $**3.55** |
| Weighted average shares of common stock used in computing: | Weighted average shares of common stock used in computing: | Weighted average shares of common stock used in computing: | Weighted average shares of common stock used in computing: | Weighted average shares of common stock used in computing: | Weighted average shares of common stock used in computing: |  |
| Diluted loss per share, as reported |  |  |  |  |  | **23002** |
| Adjusted diluted earnings per share (non-GAAP) | Adjusted diluted earnings per share (non-GAAP) | Adjusted diluted earnings per share (non-GAAP) | Adjusted diluted earnings per share (non-GAAP) | Adjusted diluted earnings per share (non-GAAP) | Adjusted diluted earnings per share (non-GAAP) | **23099** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** |
| | **Income** | **Income** | **Income** | **Diluted Earnings Per Share** | **Diluted Earnings Per Share** | **Diluted Earnings Per Share** |
| ***(in thousands, except per share data)*** | **Before Tax** | **Tax** | **Net of Tax** | **Before Tax** | **Tax** | **Net of Tax** |
| As reported (GAAP) | $91664 | $(32087) | $123751 | $3.97 | $(1.39) | $5.37 |
| &nbsp;&nbsp;&nbsp;Acquisition-related expenses | 3035 |  | 3035 | 0.13 |  | 0.13 |
| &nbsp;&nbsp;&nbsp;Asset impairment charges | 51455 | 3895 | 47560 | 2.23 | 0.17 | 2.06 |
| &nbsp;&nbsp;Barbados tax reform |  | (6045) | 6045 |  | (0.26) | 0.26 |
| &nbsp;&nbsp;&nbsp;Intangible asset reorganization |  | 64604 | (64604) |  | 2.80 | (2.80) |
| &nbsp;&nbsp;&nbsp;Restructuring charges | 14822 | 1433 | 13389 | 0.64 | 0.06 | 0.58 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 160976 | 31800 | 129176 | 6.98 | 1.38 | 5.60 |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 18875 | 2798 | 16077 | 0.82 | 0.12 | 0.70 |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | 21376 | 1240 | 20136 | 0.93 | 0.05 | 0.87 |
| Adjusted (non-GAAP) | $201227 | $35838 | $165389 | $8.72 | $1.55 | $7.17 |
| Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | Weighted average shares of common stock used in computing reported and non-GAAP diluted earnings per share | 23065 |

---

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

*Comparison of Fiscal 2026 to 2025*

Net loss was $899.0 million, compared to net income of $123.8 million. Diluted loss per share was $39.08, compared to diluted earnings per share of $5.37. The decrease is primarily due to the recognition of after-tax asset impairment charges of $866.1 million during fiscal 2026, higher income tax expense primarily from the recognition of valuation allowances on deferred tax assets in fiscal 2026 and the comparative impact of the recognition of a transitional income tax benefit in fiscal 2025, both related to our intangible asset reorganization in fiscal 2025, lower operating income exclusive of asset impairment charges and an increase in interest expense.

Adjusted income decreased $83.3 million, or 50.4%, to $82.1 million, compared to $165.4 million. Adjusted diluted earnings per share decreased 50.5% to $3.55, compared to $7.17.

**Liquidity and Capital Resources**

We principally rely on our cash flow from operations and borrowings under our Amended Credit Agreement to finance our operations, capital and intangible asset expenditures, acquisitions and share repurchases. Historically, our principal uses of cash to fund our operations have included operating expenses, primarily SG&A, and working capital, predominantly for inventory purchases and the extension of credit to our retail customers. We have typically been able to generate positive cash flow from operations sufficient to fund our operating activities. In the past, we have utilized a combination of available cash and existing, or additional, sources of financing to fund strategic acquisitions, share repurchases and capital investments. We generated $171.1 million in cash from operations during fiscal 2026 and had $18.9 million in cash and cash equivalents at February 28, 2026. As of February 28, 2026, the amount of cash and cash equivalents held by our foreign subsidiaries was $16.4 million. We have no existing activities involving special purpose entities or off-balance sheet financing.

Our anticipated material cash requirements in fiscal 2027 include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• operating expenses, primarily SG&A and working capital predominately for inventory purchases and to carry normal levels of accounts receivable on our balance sheet;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• repayment of a current maturity of long term debt of $25.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• estimated interest payments of approximately $46.8 million based on scheduled outstanding debt obligations, weighted average interest rates and interest rate swaps in effect at February 28, 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• minimum operating lease payments under existing obligations of approximately $10.3 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• minimum royalty payments under existing license agreements of approximately $6.2 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• contingent consideration payment of $5.0 million as a result of Olive & June achieving an annual adjusted EBITDA target in calendar year 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• capital and intangible asset expenditures between approximately $28 million to $32 million to support ongoing operations and future infrastructure needs, including investments to transfer sourcing of certain products out of China and support new product development.

Our anticipated material cash requirements beyond fiscal 2027 include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• operating expenses, primarily SG&A and working capital predominately for inventory purchases and to carry normal levels of accounts receivable on our balance sheet;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• outstanding long-term debt obligations maturing during fiscal 2028 and fiscal 2029, in an aggregate principal value of approximately $760.5 million, with $735.5 million of that amount maturing in fiscal 2029 (refer to Note 13 to the accompanying consolidated financial statements for additional information);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• estimated interest payments of approximately $46.3 million and $42.8 million in fiscal 2028 and fiscal 2029, respectively, based on scheduled outstanding debt obligations, weighted average interest rates and interest rate swaps in effect at February 28, 2026 (refer to Note 13 to the accompanying consolidated financial statements for additional information);

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• minimum operating lease payments of approximately $71.7 million over the term of our existing operating lease arrangements (refer to Note 3 to the accompanying consolidated financial statements for additional information);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• minimum royalty payments of approximately $19.8 million over the term of the existing license agreements (refer to Note 12 to the accompanying consolidated financial statements for additional information); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• capital and intangible asset expenditures to support ongoing operations and future infrastructure needs.

Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements. In the short-term we plan to prioritize repaying our debt outstanding.

Subsequent to fiscal 2026, on April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi for a total sales price of $82.0 million, less costs to sell of $3.8 million. We used the proceeds from the sale to repay amounts outstanding under our credit facility. See Note 4 to the accompanying consolidated financial statements for additional information.

As part of our long-term strategy, we will continue to evaluate acquisition opportunities. We may finance acquisitions with available cash, the issuance of shares of common stock, additional debt, including secured debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.

Also, as part of our long-term strategy, we may elect to repurchase additional shares of common stock under our Board of Directors' authorization, subject to limitations contained in our debt agreement and based upon our assessment of a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations and other factors, including alternative investment opportunities. We may finance share repurchases with available cash, additional debt, including secured debt, or other sources of financing. For additional information, see Item 5., "Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities" in this Annual Report.

**Operating Activities**

*Comparison of Fiscal 2026 to 2025*

Operating activities provided net cash of $171.1 million, compared to $113.2 million. The increase was primarily driven by decreases in cash used primarily for accounts receivable, annual incentive compensation, income taxes and restructuring activities, partially offset by a decrease in cash earnings and increases in payments for interest.

**Investing Activities**

Investing activities used cash of $34.4 million and $263.1 million in fiscal 2026 and 2025, respectively.

*Highlights from Fiscal 2026*

&nbsp;&nbsp;&nbsp;&nbsp;• We made investments in capital and intangible asset expenditures of $39.2 million, partially offset by a favorable net working capital settlement during the first quarter of fiscal 2026 related to the acquisition of Olive & June. Capital and intangible asset expenditures included expenditures for tooling, molds, and other production equipment, primarily driven by manufacturing diversification outside of China, software, computer, furniture and other equipment, and buildings and improvements.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

*Highlights from Fiscal 2025*

&nbsp;&nbsp;&nbsp;&nbsp;• We paid $229.4 million, net of cash acquired before final working capital adjustments, to acquire Olive & June and made investments in capital and intangible asset expenditures of $30.1 million, of which $5.6 million primarily related to the implementation of an automation system at our new two million square foot distribution facility. Capital and intangible asset expenditures also included expenditures for computer, furniture and other equipment and tooling, molds, and other production equipment.

**Financing Activities**

Financing activities used cash of $136.7 million and provided cash of $150.2 million in fiscal 2026 and 2025, respectively.

*Highlights from Fiscal 2026*

&nbsp;&nbsp;&nbsp;&nbsp;• we had proceeds of $566.4 million from revolving loans under our Amended Credit Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;• we repaid $936.3 million of revolving loans drawn under our Amended Credit Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;• we received proceeds of $250.0 million from term loans under our Amended Credit Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;• we repaid $16.4 million of long-term debt.

*Highlights from Fiscal 2025*

&nbsp;&nbsp;&nbsp;&nbsp;• we had proceeds of $1,096.6 million from revolving loans under our Credit Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;• we repaid $840.5 million of revolving loans drawn under our Credit Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;• we repaid $6.3 million of long-term debt; and

&nbsp;&nbsp;&nbsp;&nbsp;• we repurchased and retired 1,038,696 shares of common stock at an average price of $99.34 per share for a total purchase price of $103.2 million through a combination of open market purchases and the settlement of certain stock awards.

**Amended Credit Agreement**

***Amended Credit Agreement***

On February 15, 2024, we entered into a credit agreement (the "Credit Agreement") with Bank of America, N.A., as administrative agent, and other lenders that provides for aggregate commitments of $1.5 billion, which are available through (i) a $1.0 billion revolving credit facility, which includes a $50 million sublimit for the issuance of letters of credit, (ii) a $250 million term loan facility and (iii) a committed $250 million delayed draw term loan facility, which permitted multiple drawdowns until August 15, 2025. Proceeds can be used for working capital and other general corporate purposes, including funding permitted acquisitions. At the closing date, February 15, 2024, we borrowed $457.5 million under the revolving credit facility and $250.0 million under the term loan facility and utilized the proceeds to repay all debt outstanding under our prior credit agreement. During the first quarter of fiscal 2026, we borrowed $250.0 million under the delayed draw term loan facility and utilized the proceeds to repay debt outstanding under the revolving credit facility. During the first quarter of fiscal 2026, we capitalized $0.4 million of lender fees and a de minimis amount of third-party fees incurred in connection with the delayed draw term loan facility borrowing, which were recorded as prepaid financing fees in long-term debt.

On November 25, 2025, we entered into an amendment to the Credit Agreement (the "Amendment", or as amended, the "Amended Credit Agreement"), which provides for the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reduces the commitment under the revolving credit facility from $1.0 billion to $750.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adds a maximum tier level pursuant to which, if the Net Leverage Ratio is greater than or equal to 4.00 to 1.00, then borrowings under the Amended Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin of 1.375% and 2.375% for Base Rate and Term

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings (as those terms are defined in the Amended Credit Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amends the minimum Interest Coverage Ratio financial covenant to replace the numerator with a Consolidated EBITDA measure instead of a Consolidated EBIT measure (as those terms are defined in the Amended Credit Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amends the maximum Leverage Ratio financial covenant so that it is not permitted to be greater than as set forth below as of the end of the fiscal quarter:

---

| | |
|:---|:---|
| **Fiscal Quarter Ending** | ***Maximum***<br>**Leverage Ratio** |
| November 30, 2025 | 4.50 to 1.00 |
| February 28, 2026 through August 31, 2026 | 4.50 to 1.00 |
| November 30, 2026 | 4.00 to 1.00 |
| February 28, 2027 through May 31, 2027 | 3.75 to 1.00 |
| August 31, 2027 and each fiscal quarter thereafter | 3.50 to 1.00 |

---

We may elect to use the Leverage Holiday in connection with the consummation of a Qualified Acquisition after August 31, 2027, if we are in compliance with the terms of the Amended Credit Agreement and meet the other terms and conditions relating to a Qualified Acquisition (as those terms are defined in the Amended Credit Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Until August 31, 2027, the following negative covenants are reduced, as described in the Amendment, a general investments basket, an unsecured indebtedness basket and the Permitted Receivables Financings (as defined in the Amended Credit Agreement) basket.

In connection with the Amendment, we recognized a $0.9 million charge within "Interest expense" to write-off unamortized prepaid financing fees related to the revolver due to the reduced commitment and capitalized $1.0 million of lender and third-party fees during the third quarter of fiscal 2026, which were recorded as prepaid financing fees in long-term debt.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The Amended Credit Agreement includes an accordion feature, which permits the Company to request to increase its borrowing capacity by an additional $300 million plus an unlimited amount when the Leverage Ratio, on a pro-forma basis, is less than 3.25 to 1.00. The Company's exercise of the accordion is subject to certain conditions being met, including lender approval. The Amended Credit Agreement matures on February 15, 2029. We are able to repay amounts borrowed at any time without penalty. Borrowings accrue interest under one of two alternative methods pursuant to the Amended Credit Agreement as described below. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment and letter of credit fees under the Amended Credit Agreement ranging from 0.1% to 0.45% per annum and 1.0% to 2.375% per annum, respectively, based on our Net Leverage Ratio pursuant to the below table. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% through February 28, 2025, 0.9375% through February 28, 2026, and 1.25% thereafter of the original principal balance of the term loans, which began in the first quarter of fiscal 2025 for the term loan facility and began in the second quarter of fiscal 2026 for the delayed draw term loan facility, with the remaining balance due at the maturity date. Borrowings under the Amended Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin based on the Net Leverage Ratio of 0% to 1.375% and 1.0% to 2.375% for Base Rate and Term SOFR borrowings, respectively, pursuant to the below table.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Pricing Level** | **Net Leverage Ratio** | **Revolving Commitment Fee and Delayed Draw Commitment Fee** | **Term SOFR for Loans &** <br>**Letter of Credit Fees** | **Base Rate for Loans** |
| I | Less than 1.00 to 1.00 | 0.100% | 1.000% | 0.000% |
| II | Greater than or equal to 1.00 to <br>1.00 but less than 1.50 to 1.00 | 0.150% | 1.125% | 0.125% |
| III | Greater than or equal to 1.50 to <br>1.00 but less than 2.00 to 1.00 | 0.200% | 1.250% | 0.250% |
| IV | Greater than or equal to 2.00 to <br>1.00 but less than 2.50 to 1.00 | 0.250% | 1.500% | 0.500% |
| V | Greater than or equal to 2.50 to <br>1.00 but less than 3.00 to 1.00 | 0.300% | 1.750% | 0.750% |
| VI | Greater than or equal to 3.00 to <br>1.00 but less than 3.50 to 1.00 | 0.350% | 2.000% | 1.000% |
| VII | Greater than or equal to 3.50 to <br>1.00 but less than 4.00 to 1.00 | 0.400% | 2.125% | 1.125% |
| VIII | Greater than or equal to 4.00 to 1.00 | 0.450% | 2.375% | 1.375% |

---

The floating interest rates on our borrowings under the Amended Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $325 million and $550 million of the outstanding principal balance under the Amended Credit Agreement as of February 28, 2026 and February 28, 2025, respectively. For additional information regarding our interest rate swaps, see Notes 14, 15, and 16 to the accompanying consolidated financial statements.

As of February 28, 2026, the outstanding Amended Credit Agreement principal balance was $785.5 million (excluding prepaid financing fees) and the balance of outstanding letters of credit was $9.5 million. The weighted average interest rate on borrowings outstanding under the Amended Credit Agreement was 5.7% at February 28, 2026.

***Debt Covenants***

Our debt under our Amended Credit Agreement is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our Amended Credit Agreement requires the maintenance of certain key financial covenants, defined in the table below. Our Amended Credit Agreement also contains other customary covenants, including, among other things, covenants restricting or limiting us, except under certain conditions set forth therein, from (1) incurring liens on our properties,

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

(2) making certain types of investments, (3) incurring additional debt, and (4) assigning or transferring certain licenses. Our Amended Credit Agreement also contains customary events of default, including failure to pay principal or interest when due, among others. Upon an event of default under our Amended Credit Agreement, the lenders may, among other things, accelerate the maturity of any amounts outstanding. The commitments of the lenders to make loans to us under the Amended Credit Agreement are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender's commitments under the Amended Credit Agreement.

As of February 28, 2026, the amount available for revolving loans under the Amended Credit Agreement was $432.3 million, and the amount available per the maximum Leverage Ratio was $91.1 million. Covenants in the Amended Credit Agreement limit the amount of total indebtedness we can incur. As of February 28, 2026, these covenants effectively limited our ability to incur more than $91.1 million of additional debt from all sources, including the Amended Credit Agreement. As of February 28, 2026, we were in compliance with all covenants as defined under the terms of the Amended Credit Agreement.

The table below provides the formulas currently in effect for certain key financial covenants as defined under our Amended Credit Agreement:

---

| | |
|:---|:---|
| **Applicable Financial Covenant** | **Amended Credit Agreement** |
| **Minimum Interest Coverage Ratio** | EBITDA (1) ÷ Interest Expense (1) |
| **Minimum Interest Coverage Ratio** | Minimum Required: 3.00 to 1.00 |
| **Maximum Leverage Ratio** | Total Current and Long Term Debt (2) ÷<br>EBITDA (1) + Pro Forma Effect of Transactions |
| **Maximum Leverage Ratio** | Maximum Currently Allowed: 4.50 to 1.00 (3) |

---

**<u>Key Definitions:</u>**

---

| | |
|:---|:---|
| EBITDA: | Earnings + Interest Expense + Taxes + Depreciation + Amortization Expense + Non-Cash Charges (4) + Certain Allowed Addbacks (4) - Certain Non-Cash Income (4) |
| Pro Forma Effect of Transactions: | For any acquisition, pre-acquisition EBITDA of the acquired business is included so that the<br>EBITDA of the acquired business included in the computation equals its twelve month trailing total. In addition, the amount of certain pro forma run-rate cost savings for acquisitions or dispositions may be added to EBITDA. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Computed using totals for the latest reported four consecutive fiscal quarters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Computed using the ending debt balances as of the latest reported fiscal quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)In the event a qualified acquisition is consummated after August 31, 2027, the maximum leverage ratio is 4.50 to 1.00 for the first four fiscal quarters after the qualified acquisition is consummated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)As defined in the Amended Credit Agreement.

**Critical Accounting Policies and Estimates**

The SEC defines critical accounting estimates as those made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on a company's financial condition or results of operations. We consider the following estimates to meet this definition and represent our more critical estimates and assumptions used in the preparation of our consolidated financial statements.

***Income Taxes***

We must make certain estimates and judgments in determining our provision for income tax expense. The provision for income tax expense is calculated on reported (loss) income before income taxes based on current tax law and includes, in the current period, the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Tax laws may require items to be included in the determination of taxable income at different times from when the items are reflected in the financial statements. Deferred tax balances reflect the effects of temporary differences between the financial statement carrying amounts of assets and liabilities and their tax bases, as well as from net

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

operating losses and tax credit carryforwards, and are stated at enacted tax rates in effect for the year taxes are expected to be paid or recovered.

Deferred tax assets represent tax benefits for tax deductions or credits available in future years and require certain estimates and assumptions to determine whether it is more likely than not that all or a portion of the benefit will not be realized. The recoverability of these future tax deductions and credits is determined by assessing the adequacy of future expected taxable income from all sources, including the future reversal of existing taxable temporary differences, taxable income in carryback years, estimated future taxable income and available tax planning strategies. In projecting future taxable income, we begin with historical results and incorporate assumptions including future operating income, the reversal of temporary differences and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and are consistent with the plans and estimates we are using to manage our underlying business. Should a change in facts or circumstances, such as changes in our business plans, economic conditions or future tax legislation, lead to a change in judgment about the ultimate recoverability of a deferred tax asset, we record or adjust the related valuation allowance in the period that the change in facts and circumstances occurs, along with a corresponding increase or decrease in income tax expense. Additionally, if future taxable income varies from projected taxable income, we may be required to adjust our valuation allowance in future years.

In addition, the calculation of our tax liabilities requires us to account for uncertainties in the application of complex and evolving tax regulations. We recognize liabilities for uncertain tax positions based on the two-step process prescribed within GAAP. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained upon examination by the tax authority based upon its technical merits assuming the tax authority has full knowledge of all relevant information. To be recognized in the financial statements, the tax position must meet this more-likely-than-not threshold. For positions meeting this recognition threshold, the second step requires us to estimate and measure the tax benefit as the largest amount that has greater than a 50 percent likelihood of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible outcomes. We reevaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, historical experience with similar tax matters, guidance from our tax advisors, and new audit activity. For tax positions that do not meet the threshold requirement, we record liabilities for unrecognized tax benefits as a tax expense or benefit in the period recognized or reversed and disclose as a separate liability in our financial statements, including related accrued interest and penalties. A change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision in the period in which the change occurs.

***Valuation of Inventory***

We record inventory on our balance sheet at the lower of average cost or net realizable value. We write down a portion of our inventory to net realizable value based on the historical sales trends of products and estimates about future demand and market conditions, among other factors. We regularly review our inventory for slow-moving items and for items that we are unable to sell at prices above their original cost. When we identify such an item, we use net realizable value as the basis for recording such inventory and base our estimates on expected future selling prices less expected disposal costs. These estimates entail a significant amount of inherent subjectivity and uncertainty. As a result, these estimates could vary significantly from the amounts that we may ultimately realize upon the sale of inventories if future economic conditions, product demand, product discontinuances, competitive conditions or other factors differ from our estimates and expectations. Additionally, changes in consumer demand, retailer inventory management strategies, transportation lead times, supplier capacity and raw material availability could make our inventory management and reserves more difficult to estimate.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Acquisitions, Goodwill and Indefinite-Lived Intangibles, and Related Impairment Testing***

A significant portion of our non-current assets consists of goodwill and intangible assets recorded as a result of past acquisitions. Accounting for business combinations requires the use of estimates and assumptions in determining the fair value of assets acquired and liabilities assumed in order to properly allocate the purchase price. Goodwill is recorded as the difference, if any, between the aggregate consideration paid and the fair value of the net tangible and intangible assets acquired in the acquisition of a business. Our intangible assets acquired primarily include trade names and customer relationships. The fair value of our assets acquired and liabilities assumed are typically based upon valuations performed by independent third-party appraisers using the income approach, including estimated future discounted cash flow models ("DCF Models"), the relief from royalty method for trade names, and the distributor method for customer relationships. The fair value of our trade names and customer relationships acquired involved significant estimates and assumptions, including revenue growth rates, gross profit and operating profit margins, discount rates and royalty and customer attrition rates (as applicable). We believe that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use.

We review goodwill and indefinite-lived intangible assets for impairment on an annual basis or more frequently whenever events or changes in circumstances indicate that their carrying value may not be recoverable. We consider whether circumstances or conditions exist which suggest that the carrying value of our goodwill and indefinite-lived intangible assets might be impaired. If such circumstances or conditions exist, we perform a qualitative assessment to determine whether it is more likely than not that the assets are impaired. We evaluate goodwill at the reporting unit level (operating segment or one level below an operating segment). We operate two reportable segments, Home & Outdoor and Beauty & Wellness, which are comprised of eight reporting units, one of which did not have any goodwill recorded as of the beginning of fiscal 2026 and two of which were fully impaired during fiscal 2026. If the results of the qualitative assessment indicate that it is more likely than not that the assets are impaired, further steps are required in order to determine whether the carrying value of each reporting unit and indefinite-lived intangible assets exceeds its fair market value. An impairment charge is recognized to the extent the goodwill or indefinite-lived intangible asset recorded exceeds the reporting unit's or asset's fair value. We perform our annual impairment testing for goodwill and indefinite-lived assets as of the beginning of the fourth quarter of our fiscal year.

We use an enterprise premise to determine the fair value and carrying amount of our reporting units. All assets and liabilities that are employed in or relate to the operations of a reporting unit and will be considered in determining the fair value of the reporting unit are included in the carrying value of the reporting unit. Our reporting units' net assets primarily consist of goodwill and intangible assets, which are assigned to a reporting unit upon acquisition, and accounts receivable and inventory which are directly identifiable. Assets and liabilities employed in or related to the operations of multiple reporting units as well as corporate assets and liabilities are primarily allocated to the reporting units based on specific identification or a percentage of net sales revenue.

We estimate the fair value of our reporting units using an income approach based upon projected future DCF Models. Under the DCF Model, the fair value of each reporting unit is determined based on the present value of estimated future cash flows, discounted at a risk-adjusted rate of return. We use internal forecasts and strategic long-term plans to estimate future cash flows, including net sales revenue, gross profit margin, and earnings before interest and taxes margins. Our internal forecasts and strategic long-term plans take into consideration historical and recent business results, industry trends and macroeconomic conditions. Other key estimates used in the DCF Model include, but are not limited to, discount rates, statutory tax rates, terminal growth rates, as well as working capital and capital expenditures needs. The discount rates are based on a weighted-average cost of capital utilizing industry market data of our peer group companies. Our goodwill impairment analysis also includes a reconciliation of the aggregate estimated fair values of our reporting units to the Company's total enterprise value (market capitalization plus long-term debt).

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We estimate the fair value of our indefinite-lived trade names and trademark licenses using the relief from royalty method income approach which is based upon a DCF Model. The relief-from-royalty method estimates the fair value of a trade name or trademark license by discounting the hypothetical avoided royalty payments to their present value over the economic life of the asset. The determination of fair value using this method entails a significant number of estimates and assumptions, which require management judgment, and include net sales revenue growth rates, discount rates, royalty rates, and residual growth rates. We use internal forecasts and strategic long-term plans to estimate net sales revenue growth rates and royalty rates. We utilize a constant growth model to determine the residual growth rates which are based upon long-term industry growth expectations and long-term expected inflation.

Considerable management judgment is necessary in determining the fair value of goodwill and intangible assets (initially acquired and as part of our impairment testing), including the reasonableness of fair value estimates, evaluating the most likely impact of a range of possible external conditions, considering the resulting operating changes and their impact on estimated future cash flows, determining the appropriate discount factors to use, and selecting and weighting appropriate comparable market level inputs. When estimating expected future cash flows judgment is necessary in evaluating the impact of operational and external economic factors on future cash flows, all of which are subject to uncertainty. The recoverability of these assets is dependent upon achievement of our projections and the continued execution of key initiatives related to revenue growth and profitability. The assumptions and estimates used in our fair value analysis involve significant elements of subjective judgment and analysis by management. Certain future events and circumstances, including higher tariffs, deterioration of retail economic conditions, higher cost of capital, a decline in actual and expected consumer demand, among others, could result in changes to these assumptions and judgments. While we believe that the estimates and assumptions we use are reasonable at the time made, changes in business conditions or other unanticipated events and circumstances may occur that cause actual results to differ materially from projected results and this could potentially require future adjustments to our asset valuations.

During each quarter of fiscal 2026, we concluded that a goodwill impairment triggering event had occurred due to a further sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company's total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to these conclusions included downward revisions to our internal forecasts and strategic long-term plans, which reflect the tariff policies in effect, timing of corresponding price increases and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders. These factors were applicable to all of our reporting units, indefinite-lived trademark licenses and trade names and definite-lived trademark licenses, trade names and certain other intangible assets. Thus, we performed quantitative impairment testing on our goodwill and intangible assets described above during each quarter of fiscal 2026.

During the first quarter of fiscal 2026, in connection with our annual budgeting and forecasting process, management reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect and the related macroeconomic environment at the end of our first quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders, as applicable. The revised forecasts also resulted in management selecting lower residual growth rates, which were also reflective of revised long-term industry growth expectations. During the second, third and fourth quarters of fiscal 2026, management further reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect, timing of corresponding price increases inclusive of the impact of stop shipment actions to support consistent adoption and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the impact on consumer spending, retailer orders and China cross border ecommerce due to a shift to localized distribution, as applicable. Our forecasts for fiscal 2027 were also updated during the fourth quarter of fiscal 2026, in connection with our annual budgeting process, which primarily resulted in an

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

increase in operating expense, shifts in sales forecasts between brands and a reduction to the residual growth rate assumption for one of our reporting units.

The quantitative assessments performed resulted in total pre-tax goodwill impairment charges of $706.5 million during fiscal 2026, which includes impairment charges of $229.1 million in our Home & Outdoor segment and $477.4 million in our Beauty & Wellness segment. The Beauty & Wellness segment includes goodwill impairment charges related to our Health & Wellness, Drybar and Curlsmith reporting units of $235.2 million, $134.3 million and $107.9 million, respectively, during fiscal 2026. The Home & Outdoor segment includes goodwill impairment charges related to our Hydro Flask and Osprey reporting units of $115.9 million and $113.1 million, respectively, during fiscal 2026.

The remaining carrying values of the Osprey, Health & Wellness and Curlsmith reporting units' goodwill as of February 28, 2026 were $96.6 million, $49.7 million and $9.2 million, respectively. The goodwill impairment charges recognized for the Hydro Flask and Drybar reporting units reduced the carrying values of their goodwill to zero.

Our indefinite-lived intangible asset testing resulted in total impairment charges of $97.0 million during fiscal 2026, which includes $55.0 million related to our Hydro Flask trade name, $35.0 million related to our Osprey trade name and $7.0 million related to our PUR trade name. The remaining carrying values of the Osprey and PUR trade names as of February 28, 2026 were $135.0 million and $47.0 million, respectively. The remaining carrying value of the Hydro Flask trade name of $4.0 million was reclassified to a definite-lived trade name as of November 30, 2025 and was subsequently fully impaired during the fourth quarter of fiscal 2026. See further discussion below under "Impairment of Long-Lived Assets." Our Hydro Flask and Osprey intangible assets are included within our Home & Outdoor segment. Our PUR intangible asset is included within our Beauty & Wellness segment.

The fair value of our OXO reporting unit, within our Home & Outdoor reportable segment, represented 104% of its carrying value as of February 28, 2026. We performed a sensitivity analysis on key assumptions used in the valuation. A hypothetical adverse change of 10% in the forecasted sales used to estimate the fair value of the OXO reporting unit would have resulted in an impairment charge of approximately $166.1 million, reducing its goodwill carrying value to zero.

The fair value of our Osprey reporting unit, within our Home & Outdoor reportable segment, represented 104% of its carrying value as of February 28, 2026. We performed a sensitivity analysis on key assumptions used in the valuation. A hypothetical adverse change of 10% in the forecasted sales used to estimate the fair value of the Osprey reporting unit would have resulted in an impairment charge of approximately $96.6 million reducing its goodwill carrying value to zero.

As of February 28, 2026, our remaining reporting unit, Olive & June had a fair value that exceeded its carrying value by at least 10%.

The fair value of our PUR indefinite-lived trade name, within our Beauty & Wellness reportable segment, represented 104% of its carrying value as of February 28, 2026. We performed a sensitivity analysis on key assumptions used in the valuation. A hypothetical adverse change of 10% in the forecasted sales used to estimate the fair value of the PUR trade name would have resulted in an impairment charge of approximately $3.0 million against its carrying value of $47.0 million as of February 28, 2026.

The fair value of our Osprey indefinite-lived trade name, within our Home & Outdoor reportable segment, represented 101% of its carrying value as of February 28, 2026. We performed a sensitivity analysis on key assumptions used in the valuation. A hypothetical adverse change of 10% in the forecasted sales used to estimate the fair value of the Osprey trade name would have resulted in an impairment charge of approximately $12.0 million against its carrying value of $135.0 million as of February 28, 2026.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

As of February 28, 2026, all of our other indefinite-lived intangible assets had a fair value that exceeded their carrying value by at least 10%.

Refer to "Impairment of Long-Lived Assets" below for discussion of our definite-lived trademark license and trade name testing.

During the second and fourth quarters of fiscal 2025, we concluded a goodwill impairment triggering event had occurred due to a continued sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company's total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to this conclusion included downward revisions to our internal forecasts and strategic long-term plans. These factors were applicable to all of our reporting units and indefinite-lived trademark licenses and trade names. The quantitative assessments performed during the fourth quarter of fiscal 2025 resulted in an impairment charge of $38.7 million to reduce the goodwill of our Drybar reporting unit, which is included within our Beauty & Wellness segment. The quantitative assessments performed during the second quarter of fiscal 2025 did not result in impairment of our goodwill or indefinite-lived intangible assets.

We performed our annual impairment testing of our goodwill and indefinite-lived intangible assets during the fourth quarter of fiscal 2024 and determined based on our qualitative assessment that it is not more likely than not that the fair value of each reporting unit and indefinite-lived intangible asset is lower than its carrying value. Therefore, quantitative impairment testing in fiscal 2024 was not required. Accordingly, no impairment changes were recorded during fiscal 2024.

Some of the inherent estimates and assumptions used in determining the fair value of our reporting units and indefinite-lived intangible assets are outside of the control of management, including interest rates, cost of capital, tax rates, tariff rates, strength of retail economies and industry growth. While we believe that the estimates and assumptions we use are reasonable at the time made, it is possible changes could occur. The recoverability of our goodwill and indefinite-lived intangible assets is dependent upon discretionary consumer demand and the execution of our strategic plan, which includes investing in our brands, growing internationally, new product introductions and expanded distribution to drive revenue growth and profitability and achieve our projections, and our tariff mitigation plans. The net sales revenue and profitability growth rates used in our projections are management's estimate of the most likely results over time, given a wide range of potential outcomes. Actual results may differ from those assumed in forecasts; thereby, an inability to achieve expected revenue and profitability in line with our internal projections could result in further declines in the fair value, which could result in material impairment charges. We will continue to monitor our reporting units and indefinite-lived intangible assets for any triggering events or other signs of impairment including consideration of changes in tariff rates and the macroeconomic environment, significant declines in operating results, further significant sustained decline in market capitalization from current levels, and other factors, which could result in impairment charges in the future.

***Impairment of Long-Lived Assets***

We review intangible assets with definite lives and long-lived assets held and used for impairment whenever a triggering event occurs that indicates their carrying value may not be recoverable. If such circumstances or conditions exist, we assess recoverability based on estimated future pre-tax undiscounted cash flows. If the carrying value exceeds the estimated future pre-tax undiscounted cash flows, further steps are required in order to determine whether the carrying value of each of the individual assets exceeds its fair value. If our analysis indicates that an individual asset's carrying value does exceed its fair market value, the next step is to record a loss equal to the excess of the individual asset's carrying value over its fair value. We evaluate any long-lived assets held for sale quarterly to determine if estimated fair value less cost to sell has changed during the reporting period.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We estimate the fair value of our trade names and trademark licenses using the relief from royalty method income approach (described above) which is based upon a DCF Model. We estimate the fair value of our customer relationships and lists using the distributor method income approach which is based upon a DCF Model. The distributor method uses financial margin information for distributors within the applicable industry and most representative of the Company to estimate a royalty rate. The determination of fair value using these methods entails a significant number of estimates and assumptions, which require management judgment, and include net sales revenue growth rates, discount rates, royalty rates, residual growth rates (as applicable) and customer attrition rates (as applicable). We use internal forecasts and strategic long-term plans (which are described above) to estimate net sales revenue growth rates and royalty rates. We utilize a constant growth model to determine the residual growth rates which are based upon long-term industry growth expectations and long-term expected inflation.

The assumptions and estimates used in determining the fair value of our definite-lived intangible assets and long-lived assets involve significant elements of subjective judgment and analysis by management. Certain future events and circumstances, including higher tariffs, deterioration of retail economic conditions, higher cost of capital, a decline in actual and expected consumer demand, could result in changes to these assumptions and judgments. A revision of these estimates and assumptions could cause the fair values of the definite-lived intangible assets and long-lived assets to fall below their respective carrying values, resulting in impairment charges, which could have a material adverse effect on our results of operations.

As described above, during each quarter of fiscal 2026, we concluded that an impairment triggering event had occurred and concluded to perform quantitative impairment analyses on our definite-lived trademark licenses, trade names and certain other intangibles, which were determined to not be recoverable.

During the first quarter of fiscal 2026, in connection with our annual budgeting and forecasting process, management reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect and the related macroeconomic environment at the end of our first quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders, as applicable. The revised forecasts also resulted in management selecting lower residual growth rates, which were also reflective of revised long-term industry growth expectations, and royalty rates, as applicable. During the second, third and fourth quarters of fiscal 2026, management further reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect, timing of corresponding price increases inclusive of the impact of stop shipment actions to support consistent adoption and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the impact on consumer spending, retailer orders and China cross border ecommerce due to a shift to localized distribution, as applicable. Our forecasts for fiscal 2027 were also updated during the fourth quarter of fiscal 2026, in connection with our annual budgeting process, which primarily resulted in an increase in operating expense, shifts in sales forecasts between brands and a reduction in the residual growth rate assumption for one of our reporting units. An inability to achieve expected revenue and profitability in line with our internal projections could result in further declines in the fair value that may result in additional impairment charges to these intangible assets.

Our definite-lived trademark license and trade name testing resulted in total impairment charges of $49.6 million during fiscal 2026, which includes $23.5 million related to our Revlon trademark license, $15.4 million related to our Curlsmith trade name, $6.7 million related to our Drybar trade name and $3.9 million related to our Hydro Flask trade name. The Hydro Flask trade name impairment charges reflect charges recorded during the fourth quarter of fiscal 2026, as its remaining carrying value was reclassified to a definite-lived trade name as of November 30, 2025. Impairment charges recognized during fiscal 2026 on the Hydro Flask trade name prior to November 30, 2025 are discussed above under "Acquisitions, Goodwill and Indefinite-Lived Intangibles, and Related Impairment Testing." The remaining carrying values of the Revlon trademark license and Curlsmith trade name as of February 28, 2026 were

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

$39.4 million and $1.9 million, respectively. The impairment charges recognized for the Drybar and Hydro Flask trade names reduced the carrying values of these assets to zero.

Our definite-lived customer relationships and lists assessment resulted in a total impairment charge of $29.2 million, during fiscal 2026, which includes $10.7 million, $9.7 million and $8.8 million related to our Drybar, Curlsmith and Hydro Flask customer relationships, respectively, which reduced the carrying values of these assets to zero.

Our other intangible assets assessment resulted in a total impairment charge of $3.6 million, during fiscal 2026, which includes $2.8 million and $0.8 million related to Drybar and Hydro Flask other intangibles, respectively, which reduced the carrying values of these assets to zero.

Our Hydro Flask intangible assets are included within our Home & Outdoor segment. Our Revlon, Curlsmith and Drybar intangible assets are included within our Beauty & Wellness segment.

As described above, during the second and fourth quarters of fiscal 2025, we concluded that an impairment triggering event had occurred and concluded to perform quantitative impairment analyses on our definite-lived trademark licenses and trade names and certain other intangible assets, as applicable. The quantitative assessments performed during the fourth quarter of fiscal 2025 resulted in an impairment charge of $12.8 million to reduce the carrying value of our Drybar definite-lived trade name to an estimated fair value of $7.0 million. The quantitative assessments performed during the second quarter of fiscal 2025 did not result in impairment of our definite-lived intangible assets.

During fiscal 2024 we determined no changes in circumstances or conditions or events occurred that would indicate the carrying value of our definite-lived intangible assets may not be recoverable.

The estimates and assumptions inherent in determining the fair value of our definite-lived intangible assets are subject to the same risks described above for determining the fair value of our goodwill and indefinite-lived intangible assets. Further declines in anticipated consumer spending or an inability to achieve expected revenue growth and profitability in line with our strategic long-term plans, including our tariff mitigation plans, could result in declines in the fair value that may result in impairment charges to our definite-lived intangible assets. We will continue to monitor our definite-lived intangible assets and long-lived assets for any triggering events or other signs of impairment including consideration of changes in tariff rates and the macroeconomic environment, significant declines in sales or operating results and other factors, which could result in impairment charges in the future. For additional information, refer to Note 1 and Note 7 to the accompanying consolidated financial statements.

***Economic Useful Lives of Intangible Assets***

We amortize intangible assets, such as trademark licenses, trade names, customer relationships and lists, patents and non-compete agreements over their economic useful lives, unless those assets' economic useful lives are indefinite. If an intangible asset's economic useful life is deemed indefinite, that asset is not amortized. The determination of the economic useful life of an intangible asset requires a significant amount of judgment and entails significant subjectivity and uncertainty. When we acquire an intangible asset, we consider factors such as our plans for the asset, the market for products associated with the asset, economic factors, any legal, regulatory or contractual provisions and industry trends. We consider these same factors when reviewing the economic useful lives of our previously acquired intangible assets as well. We review the economic useful lives of our intangible assets at least annually. We complete our analysis of the remaining useful economic lives of our intangible assets during the fourth quarter of each fiscal year or when a triggering event occurs.

In connection with the impairment testing described above, the remaining carrying value of the Hydro Flask trade name of $4.0 million was reclassified to a definite-lived trade name and assigned a useful life of 10 years as of November 30, 2025 and was subsequently fully impaired during the fourth quarter of

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

fiscal 2026. The remaining useful life of the Revlon trademark license was revised from 35 years to 10 years as of November 30, 2025, which will increase annual amortization expense by approximately $2.9 million.

***Share-Based Compensation***

We grant share-based compensation awards to non-employee directors and certain associates under our equity plans. We measure the cost of services received in exchange for equity awards, which include grants of restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance stock awards ("PSAs"), and performance stock units ("PSUs"), based on the fair value of the awards on the grant date. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions.

We grant PSAs and PSUs to certain officers and associates, which cliff vest after three years and are contingent upon meeting one or more defined operational performance metrics over the three year performance period ("Performance Condition Awards"). The quantity of shares ultimately awarded can range from 0% to 200% of "Target", as defined in the award agreement as 100%, based on the level of achievement against the defined operational performance metrics. We recognize compensation expense for Performance Condition Awards over the requisite service period to the extent performance conditions are considered probable. Estimating the number of shares of Performance Condition Awards that are probable of vesting requires judgment, including assumptions about future operating performance. While the assumptions used to estimate the probability of achievement against the defined operational performance metrics are management's best estimates, such estimates involve inherent uncertainties. The extent actual results or updated estimates differ from our current estimates, such amounts will be recorded as a cumulative adjustment to share-based compensation expense in the period estimates are revised.

The critical accounting estimates described above supplement the description of our accounting policies disclosed in Note 1 to the accompanying consolidated financial statements. Note 1 describes several other policies that are important to the preparation of our consolidated financial statements, but do not meet the SEC's definition of critical accounting estimates.

**Information Regarding Forward-Looking Statements**

Certain written and oral statements in this Annual Report may constitute "forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this Annual Report, in other filings with the SEC, in press releases, and in certain other oral and written presentations. Generally, the words "anticipates", "assumes", "believes", "expects", "plans", "may", "will", "might", "would", "should", "seeks", "estimates", "project", "predict", "potential", "currently", "continue", "intends", "outlook", "forecasts", "targets", "reflects", "could", and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate may occur in the future, including statements related to sales, expenses, including cost reduction measures, EPS results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We currently believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are only as of the date they are made and are subject to risks, many of which are beyond our control, that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include but are not limited to the risks described in this Annual Report under Item 1A., "Risk Factors" and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**

Changes in currency exchange rates and interest rates are our primary financial market risks.

***Foreign Currency Risk***

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar ("foreign currencies"). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, accounts receivable and accounts payable are denominated in foreign currencies. Approximately 15% of our net sales revenue was denominated in foreign currencies during fiscal 2026 and approximately 14% during both fiscal 2025 and 2024. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

In our consolidated statements of (loss) income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign income tax receivables and payables, and deferred income tax assets and liabilities are recognized in income tax expense (benefit), and all other foreign currency exchange rate gains and losses are recognized in SG&A. We recorded in income tax expense (benefit) a foreign currency exchange rate net gain of $0.4 million during fiscal 2026, a net loss of $0.7 million during fiscal 2025 and a net gain of $0.3 million during fiscal 2024. We recorded in SG&A a foreign currency exchange rate net gain of $3.2 million during fiscal 2026 and net losses of $1.5 million and $0.5 million during fiscal 2025 and 2024, respectively.

We identify foreign currency risk by regularly monitoring our foreign currency denominated transactions and balances. Where operating conditions permit, we reduce our foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars.

We mitigate certain foreign currency exchange rate risk by using a series of forward contracts to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. Our primary objective in holding derivatives is to reduce the volatility of net earnings, cash flows and the net asset value associated with changes in foreign currency exchange rates. Our foreign currency risk management strategy includes both hedging instruments and derivatives that are not designated as hedging instruments, which have terms of generally 12 to 24 months. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. We expect that as currency market conditions warrant, and our foreign currency denominated transaction exposure grows, we will continue to execute additional contracts in order to hedge against certain potential foreign currency exchange rate losses.

As of February 28, 2026 and February 28, 2025, a hypothetical adverse 10% change in foreign currency exchange rates would reduce the carrying and fair values of our derivatives by $16.0 million and $7.9 million on a pre-tax basis, respectively. This calculation is for risk analysis purposes and does not purport to represent actual losses or gains in fair value that we could incur. It is important to note that the change in value represents the estimated change in fair value of the contracts. Actual results in the future may differ materially from these estimated results due to actual developments in the global financial markets. Because the contracts hedge an underlying exposure, we would expect a similar and opposite change in foreign currency exchange rate gains or losses over the same periods as the contracts. Refer to Note 15 to the accompanying consolidated financial statements for further information regarding these instruments.

A significant portion of the products we sell are purchased from third-party manufacturers in China, who source a significant portion of their labor and raw materials in Chinese Renminbi. The Chinese Renminbi has fluctuated against the U.S. Dollar in recent years and in fiscal 2026 the average exchange rate of the

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Chinese Renminbi strengthened against the U.S. Dollar by approximately 1.0%, compared to the average rate during fiscal 2025. If China's currency continues to fluctuate against the U.S. Dollar in the short-to-intermediate term, we cannot accurately predict the impact of those fluctuations on our results of operations. Accordingly, there can be no assurance that foreign exchange rates will be stable in the future or that fluctuations in Chinese foreign currency markets will not have a material adverse effect on our business, results of operations and financial condition.

***Interest Rate Risk***

Interest on our outstanding debt as of February 28, 2026 and February 28, 2025 is based on variable floating interest rates. As such, we are exposed to changes in short-term market interest rates and these changes in rates will impact our net interest expense. We hedge against interest rate volatility by using interest rate swaps to hedge a portion of our outstanding floating rate debt. Additionally, our cash and short-term investments generate interest income that will vary based on changes in short-term interest.

As of February 28, 2026 and February 28, 2025, a hypothetical adverse 10% change in interest rates would reduce the carrying and fair values of the interest rate swaps by $1.5 million and $2.2 million on a pre-tax basis, respectively. This calculation is for risk analysis purposes and does not purport to represent actual losses or gains in fair value that we could incur. It is important to note that the change in value represents the estimated change in the fair value of the swaps. Actual results in the future may differ materially from these estimated results due to actual developments in the global financial markets. Because the swaps hedge an underlying exposure, we would expect a similar and opposite change in floating interest rates over the same periods as the swaps. Refer to Notes 13 and 15 to the accompanying consolidated financial statements for further information regarding our interest rate sensitive assets and liabilities.

As of February 28, 2026 and February 28, 2025, a hypothetical 1% increase in interest rates would increase our annual interest expense, net of the effect of our interest rate swaps, by approximately $4.6 million and $3.7 million, respectively. This calculation is for risk analysis purposes and does not purport to represent actual increases or decreases in interest expense that we could incur. Actual results in the future may differ materially from these estimated results due to actual developments in the global financial markets. Refer to Item 1A., "Risk Factors" and Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Annual Report for further information regarding our interest rate risks.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Item 8. Financial Statements and Supplementary Data**

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

AND FINANCIAL STATEMENT SCHEDULE

---

| | |
|:---|:---|
| | **<u>PAGE</u>** |
| <u>[Management's Report on Internal Control Over Financial Reporting](#i936101cd7c9141b1bfa0ebe7f99e49a9_133)</u>  | <u>[72](#i936101cd7c9141b1bfa0ebe7f99e49a9_133)</u> |
| <u>[Reports of Independent Registered Public Accounting Firm](#i936101cd7c9141b1bfa0ebe7f99e49a9_136)</u> (PCAOB ID Number 248) | <u>[73](#i936101cd7c9141b1bfa0ebe7f99e49a9_136)</u> |
| Consolidated Financial Statements: |  |
| <u>[Consolidated Balance Sheets as of February 28, 2026 and February 28, 2025](#i936101cd7c9141b1bfa0ebe7f99e49a9_139)</u> | <u>[76](#i936101cd7c9141b1bfa0ebe7f99e49a9_139)</u> |
| <u>[Consolidated Statements of (Loss) Income for each of the years in the three-year period ended February 28, 2026](#i936101cd7c9141b1bfa0ebe7f99e49a9_142)</u> | <u>[77](#i936101cd7c9141b1bfa0ebe7f99e49a9_142)</u> |
| <u>[Consolidated Statements of Comprehensive (Loss) Income for each of the years in the three-year period ended February 28, 2026](#i936101cd7c9141b1bfa0ebe7f99e49a9_145)</u> | <u>[78](#i936101cd7c9141b1bfa0ebe7f99e49a9_145)</u> |
| <u>[Consolidated Statements of Stockholders' Equity for each of the years in the three-year period ended February 28, 2026](#i936101cd7c9141b1bfa0ebe7f99e49a9_148)</u> | <u>[79](#i936101cd7c9141b1bfa0ebe7f99e49a9_148)</u> |
| <u>[Consolidated Statements of Cash Flows for each of the years in the three-year period ended February 28, 2026](#i936101cd7c9141b1bfa0ebe7f99e49a9_151)</u> | <u>[80](#i936101cd7c9141b1bfa0ebe7f99e49a9_151)</u> |
| <u>[Notes to Consolidated Financial Statements](#i936101cd7c9141b1bfa0ebe7f99e49a9_154)</u> | <u>[81](#i936101cd7c9141b1bfa0ebe7f99e49a9_154)</u> |
| &nbsp;&nbsp;<u>[Note 1 - Summary of Significant Accounting Policies and Related Information](#i936101cd7c9141b1bfa0ebe7f99e49a9_157)</u> | <u>[81](#i936101cd7c9141b1bfa0ebe7f99e49a9_154)</u> |
| &nbsp;&nbsp;<u>[Note 2 - New Accounting Pronouncements](#i936101cd7c9141b1bfa0ebe7f99e49a9_160)</u> | <u>[88](#i936101cd7c9141b1bfa0ebe7f99e49a9_160)</u> |
| &nbsp;&nbsp;<u>[Note 3 - Leases](#i936101cd7c9141b1bfa0ebe7f99e49a9_163)</u> | <u>[89](#i936101cd7c9141b1bfa0ebe7f99e49a9_163)</u> |
| &nbsp;&nbsp;<u>[Note 4 - Property and Equipment and Assets Held for Sale](#i936101cd7c9141b1bfa0ebe7f99e49a9_166)</u> | <u>[90](#i936101cd7c9141b1bfa0ebe7f99e49a9_166)</u> |
| &nbsp;&nbsp;<u>[Note 5 - Accrued Expenses and Other Current Liabilities](#i936101cd7c9141b1bfa0ebe7f99e49a9_169)</u> | <u>[91](#i936101cd7c9141b1bfa0ebe7f99e49a9_169)</u> |
| &nbsp;&nbsp;<u>[Note 6 - Acquisition of Olive & June](#i936101cd7c9141b1bfa0ebe7f99e49a9_172)</u> | <u>[91](#i936101cd7c9141b1bfa0ebe7f99e49a9_172)</u> |
| &nbsp;&nbsp;<u>[Note 7 - Goodwill and Intangibles](#i936101cd7c9141b1bfa0ebe7f99e49a9_175)</u> | <u>[93](#i936101cd7c9141b1bfa0ebe7f99e49a9_175)</u> |
| &nbsp;&nbsp;<u>[Note 8 - Share-Based Compensation Plans](#i936101cd7c9141b1bfa0ebe7f99e49a9_178)</u> | <u>[97](#i936101cd7c9141b1bfa0ebe7f99e49a9_178)</u> |
| &nbsp;&nbsp;<u>[Note 9 - Defined Contribution Plans](#i936101cd7c9141b1bfa0ebe7f99e49a9_181)</u> | <u>[100](#i936101cd7c9141b1bfa0ebe7f99e49a9_181)</u> |
| &nbsp;&nbsp;<u>[Note 10 - Repurchases of Common Stock](#i936101cd7c9141b1bfa0ebe7f99e49a9_184)</u> | <u>[100](#i936101cd7c9141b1bfa0ebe7f99e49a9_184)</u> |
| &nbsp;&nbsp;<u>[Note 11 - Restructuring Plan](#i936101cd7c9141b1bfa0ebe7f99e49a9_187)</u> | <u>[101](#i936101cd7c9141b1bfa0ebe7f99e49a9_187)</u> |
| &nbsp;&nbsp;<u>[Note 12 - Commitments and Contingencies](#i936101cd7c9141b1bfa0ebe7f99e49a9_190)</u> | <u>[102](#i936101cd7c9141b1bfa0ebe7f99e49a9_190)</u> |
| &nbsp;&nbsp;<u>[Note 13 - Long-Term Debt](#i936101cd7c9141b1bfa0ebe7f99e49a9_193)</u> | <u>[104](#i936101cd7c9141b1bfa0ebe7f99e49a9_193)</u> |
| &nbsp;&nbsp;<u>[Note 14 - Fair Value](#i936101cd7c9141b1bfa0ebe7f99e49a9_196)</u> | <u>[107](#i936101cd7c9141b1bfa0ebe7f99e49a9_196)</u> |
| &nbsp;&nbsp;<u>[Note 15 - Financial Instruments and Risk Management](#i936101cd7c9141b1bfa0ebe7f99e49a9_199)</u> | <u>[110](#i936101cd7c9141b1bfa0ebe7f99e49a9_199)</u> |
| &nbsp;&nbsp;<u>[Note 16 - Accumulated Other Comprehensive Income (Loss)](#i936101cd7c9141b1bfa0ebe7f99e49a9_202)</u> | <u>[113](#i936101cd7c9141b1bfa0ebe7f99e49a9_202)</u> |
| &nbsp;&nbsp;<u>[Note 17 - Segment and Geographic Information](#i936101cd7c9141b1bfa0ebe7f99e49a9_205)</u> | <u>[113](#i936101cd7c9141b1bfa0ebe7f99e49a9_205)</u> |
| &nbsp;&nbsp;<u>[Note 18 - Income Taxes](#i936101cd7c9141b1bfa0ebe7f99e49a9_208)</u> | <u>[116](#i936101cd7c9141b1bfa0ebe7f99e49a9_208)</u> |
| &nbsp;&nbsp;<u>[Note 19 - Earnings Per Share](#i936101cd7c9141b1bfa0ebe7f99e49a9_211)</u> | <u>[122](#i936101cd7c9141b1bfa0ebe7f99e49a9_211)</u> |
| Financial Statement Schedule: |  |
| <u>[Schedule II - Valuation and Qualifying Accounts for each of the years in the three-year period ended February 28, 2026](#i936101cd7c9141b1bfa0ebe7f99e49a9_214)</u> | <u>[123](#i936101cd7c9141b1bfa0ebe7f99e49a9_214)</u> |

---

All other schedules are omitted as the required information is included in the consolidated financial statements or is not applicable.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**<u>MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</u>**

Helen of Troy's management is responsible for establishing and maintaining adequate internal control over financial reporting as defined by Rules 13a-15(f) or 15d-15(f) under the Securities Exchange Act.

Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:

&nbsp;&nbsp;&nbsp;&nbsp;• pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect our transactions and dispositions of assets;

&nbsp;&nbsp;&nbsp;&nbsp;• provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and Board of Directors; and

&nbsp;&nbsp;&nbsp;&nbsp;• provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

There are inherent limitations in the effectiveness of internal control over financial reporting, including the possibility that misstatements may not be prevented or detected. Furthermore, the effectiveness of internal controls may become inadequate because of future changes in conditions or variations in the degree of compliance with our policies or procedures.

Our management assesses the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on our assessment, we have concluded that our internal control over financial reporting was effective as of February 28, 2026.

Our independent registered public accounting firm, Grant Thornton LLP, has issued an audit report on the effectiveness of our internal control over financial reporting. Their report appears on the following page.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**<u>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

Board of Directors and Stockholders

Helen of Troy Limited

**Opinion on internal control over financial reporting**

We have audited the internal control over financial reporting of Helen of Troy Limited and subsidiaries (the "Company") as of February 28, 2026, based on criteria established in the 2013 *Internal Control-Integrated Framework* issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of February 28, 2026, based on criteria established in the 2013 *Internal Control-Integrated Framework* issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the consolidated financial statements of the Company as of and for the year ended February 28, 2026, and our report dated April 23, 2026 expressed an unqualified opinion on those financial statements.

**Basis for opinion**

The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting ("Management's Report"). Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

**Definition and limitations of internal control over financial reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ GRANT THORNTON LLP

Dallas, Texas

April 23, 2026

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**<u>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

Board of Directors and Stockholders

Helen of Troy Limited

**Opinion on the financial statements** 

We have audited the accompanying consolidated balance sheets of Helen of Troy Limited and subsidiaries (the "Company") as of February 28, 2026 and 2025, the related consolidated statements of (loss) income, comprehensive (loss) income, stockholders' equity, and cash flows for each of the three years in the period ended February 28, 2026, and the related notes and financial statement schedule included under Schedule II – Valuation and Qualifying Accounts (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of February 28, 2026 and 2025, and the results of its operations and its cash flows for each of the three years in the period ended February 28, 2026, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the Company's internal control over financial reporting as of February 28, 2026, based on criteria established in the 2013 *Internal Control-Integrated Framework* issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"), and our report dated April 23, 2026 expressed an unqualified opinion.

**Basis for opinion** 

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical audit matter**

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

*Impairment of indefinite-lived intangible assets and goodwill*

As described further in Note 7 to the consolidated financial statements, management evaluates goodwill for impairment, at the reporting unit level, annually or more frequently if events or circumstances indicate the carrying value of a reporting unit that includes goodwill might exceed the fair value of that reporting unit. Due to the Company's sustained decline in stock price each quarter, interim triggering events were identified. Further sustained declines and a revision of the Company's forecasted financial performance at year-end indicated additional quantitative testing was required as of year-end. As a result of the quantitative testing performed during fiscal year 2026, management recognized goodwill impairment charges totaling $706.5 million and impairment expense related to indefinite-lived intangible assets

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

totaling $97.0 million. We identified the estimation of fair value related to each of the Company's reporting units other than Olive & June (which included goodwill of $150.7 million as of February 28, 2026) and the estimation of fair value of all indefinite-lived intangible assets excluding $7.4 million of trademark licenses as a critical audit matter.

The principal considerations for our determination that the estimation of fair values of the indefinite-lived intangible assets and reporting units is a critical audit matter are that there is high estimation uncertainty related to significant judgements and assumptions used to project the future cash flows, including revenue growth rates, royalty rates (as applicable to indefinite-lived intangible assets), operating expenses, and discount rates. Changes in these assumptions could materially affect the estimated fair values. This in turn led to a high degree of auditor judgment and subjectivity in performing procedures and evaluating audit evidence related to the aforementioned significant inputs and assumptions.

Our audit procedures related to the estimation of the fair values of the indefinite-lived intangible assets and reporting units included the following, among others.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We tested the design and operating effectiveness of controls related to the quantitative impairment assessments, including controls over the models and assumptions used in determining the fair values of the indefinite-lived intangible assets and reporting units.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We evaluated the qualifications and competence of the valuation specialist in developing the estimated fair value of each indefinite-lived intangible asset and reporting unit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We tested the mathematical accuracy of the fair value models utilized by the valuation specialist.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We identified significant inputs and assumptions applied in the estimation of the fair value of each reporting unit and evaluated whether the inputs and assumptions were complete and relevant in the circumstances and applied appropriately in the development of the fair value estimates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We evaluated the forecasted financial performance used as a basis for determining the fair value of each of the indefinite-lived intangible assets and reporting units by comparing the projected amounts of revenue, operating expense and cash flows to actual historical performance or relevant industry data and reconciling significant differences.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We reconciled the aggregate fair value of all of the Company's reporting units to the total enterprise value (market capitalization plus long-term debt) of the Company as of each testing date and reconciled any difference in value by comparing to representative control premiums.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We utilized valuation specialists to evaluate: the methodologies used, whether they were acceptable for the underlying fair value determinations and whether such methodologies had been applied appropriately; the appropriateness of the discount rate and royalty rate used by the valuation specialist by developing an independent expectation.

/s/ GRANT THORNTON LLP

We have served as the Company's auditor since 2007.

Dallas, Texas

April 23, 2026

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| ***(in thousands, except shares and par value)*** | **February 28, 2026** | **February 28, 2025** |
| **Assets** | | |
| Assets, current: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**18886** | $18867 |
| &nbsp;&nbsp;Receivables, less allowances of $4,923 and $4,294 | **361300** | 428330 |
| &nbsp;&nbsp;&nbsp;Inventory | **455812** | 452615 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **24146** | 26102 |
| &nbsp;&nbsp;&nbsp;Income taxes receivable | **5375** | 5798 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets, current | **865519** | 931712 |
| Property and equipment, net of accumulated depreciation of $193,622 and $200,176 | **308021** | 330029 |
| Goodwill | **472281** | 1182899 |
| Other intangible assets, net of accumulated amortization of $173,495 and $205,757 | **372850** | 566756 |
| Operating lease assets | **49371** | 35063 |
| Deferred tax assets, net | **4224** | 67660 |
| Assets held for sale | **23104** |  |
| Other assets | **20178** | 17964 |
| Total assets | $**2115548** | $3132083 |
| **Liabilities and Stockholders' Equity** |  |  |
| Liabilities, current: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $**256414** | $269405 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | **199606** | 160740 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | **23945** | 26739 |
| &nbsp;&nbsp;&nbsp;Long-term debt, current maturities | **25000** | 9375 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, current | **504965** | 466259 |
| Long-term debt, excluding current maturities | **755811** | 907519 |
| Lease liabilities, non-current | **52884** | 39949 |
| Deferred tax liabilities, net | **2699** | 29283 |
| Other liabilities, non-current | **992** | 5634 |
| Total liabilities | **1317351** | 1448644 |
| Commitments and contingencies |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued | **—** |  |
| &nbsp;&nbsp;Common stock, $0.10 par. Authorized 50,000,000 shares; 23,077,230 and 22,856,066 shares issued and outstanding | **2308** | 2286 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | **384979** | 367106 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive (loss) income | **(1877)** | 2278 |
| &nbsp;&nbsp;&nbsp;Retained earnings | **412787** | 1311769 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | **798197** | 1683439 |
| Total liabilities and stockholders' equity | $**2115548** | $3132083 |

---

*See accompanying notes to consolidated financial statements.*

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Consolidated Statements of (Loss) Income**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands, except per share data)*** | **2026** | **2025** | **2024** |
| Sales revenue, net | $**1786290** | $1907665 | $2005050 |
| Cost of goods sold | **970596** | 993259 | 1056390 |
| &nbsp;&nbsp;&nbsp;Gross profit | **815694** | 914406 | 948660 |
| Selling, general and administrative expense ("SG&A") | **708909** | 705381 | 669359 |
| Asset impairment charges | **885861** | 51455 |  |
| Restructuring charges | **3005** | 14822 | 18712 |
| &nbsp;&nbsp;&nbsp;Operating (loss) income | **(782081)** | 142748 | 260589 |
| Non-operating income, net | **982** | 838 | 1518 |
| Interest expense | **57739** | 51922 | 53065 |
| &nbsp;&nbsp;&nbsp;(Loss) income before income tax | **(838838)** | 91664 | 209042 |
| Income tax expense (benefit) | **60144** | (32087) | 40448 |
| Net (loss) income | $**(898982)** | $123751 | $168594 |
| (Loss) earnings per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**(39.08)** | $5.38 | $7.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **(39.08)** | 5.37 | 7.03 |
| Weighted average shares used in computing (loss) earnings per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | **23002** | 23012 | 23865 |
| &nbsp;&nbsp;&nbsp;Diluted | **23002** | 23065 | 23970 |

---

*See accompanying notes to consolidated financial statements.*

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Consolidated Statements of Comprehensive (Loss) Income**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| Net (loss) income | $**(898982)** | $123751 | $168594 |
| Other comprehensive (loss) income, net of tax: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash flow hedge activity - interest rate swaps | **(505)** | (1271) | (2477) |
| &nbsp;&nbsp;&nbsp;Cash flow hedge activity - foreign currency contracts | **(3650)** | 1450 | (371) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive (loss) income, net of tax | **(4155)** | 179 | (2848) |
| Comprehensive (loss) income | $**(903137)** | $123930 | $165746 |

---

*See accompanying notes to consolidated financial statements.*

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Consolidated Statements of Stockholders' Equity**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional Paid in Capital** | **Accumulated Other<br>Comprehensive Income (Loss)** | **Retained Earnings** | **Total Stockholders' Equity** |
| ***(in thousands, including shares)*** | **Shares** | **Par<br>Value** | **Additional Paid in Capital** | **Accumulated Other<br>Comprehensive Income (Loss)** | **Retained Earnings** | **Total Stockholders' Equity** |
| Balances at February 28, 2023 | 23994 | $2399 | $317277 | $4947 | $1164188 | $1488811 |
| &nbsp;&nbsp;Net income |  |  |  |  | 168594 | 168594 |
| &nbsp;&nbsp;Other comprehensive loss, net of tax |  |  |  | (2848) |  | (2848) |
| &nbsp;&nbsp;Exercise of stock options | 6 | 1 | 264 |  |  | 265 |
| &nbsp;&nbsp;Issuance and settlement of restricted stock | 142 | 14 | (14) |  |  |  |
| &nbsp;&nbsp;Issuance of common stock related to stock purchase plan | 42 | 4 | 3966 |  |  | 3970 |
| &nbsp;&nbsp;Common stock repurchased and retired | (433) | (43) | (6626) |  | (48553) | (55222) |
| &nbsp;&nbsp;Share-based compensation |  |  | 33872 |  |  | 33872 |
| Balances at February 29, 2024 | 23751 | $2375 | $348739 | $2099 | $1284229 | $1637442 |
| &nbsp;&nbsp;Net income |  |  |  |  | 123751 | 123751 |
| &nbsp;&nbsp;Other comprehensive income, net of tax |  |  |  | 179 |  | 179 |
| &nbsp;&nbsp;Exercise of stock options | 6 | 1 | 351 |  |  | 352 |
| &nbsp;&nbsp;Issuance and settlement of restricted stock | 85 | 9 | (9) |  |  |  |
| &nbsp;&nbsp;Issuance of common stock related to stock purchase plan | 53 | 5 | 3522 |  |  | 3527 |
| &nbsp;&nbsp;Common stock repurchased and retired | (1039) | (104) | (6873) |  | (96211) | (103188) |
| &nbsp;&nbsp;Share-based compensation |  |  | 21376 |  |  | 21376 |
| Balances at February 28, 2025 | 22856 | $2286 | $367106 | $2278 | $1311769 | $1683439 |
| &nbsp;&nbsp;Net loss | **—** | **—** | **—** | **—** | **(898982)** | **(898982)** |
| &nbsp;&nbsp;Other comprehensive loss, net of tax | **—** | **—** | **—** | **(4155)** | **—** | **(4155)** |
| &nbsp;&nbsp;Issuance and settlement of restricted stock | **177** | **18** | **(18)** | **—** | **—** | **—** |
| &nbsp;&nbsp;Issuance of common stock related to stock purchase plan | **95** | **9** | **2916** | **—** | **—** | **2925** |
| &nbsp;&nbsp;Common stock repurchased and retired | **(51)** | **(5)** | **(1910)** | **—** | **—** | **(1915)** |
| &nbsp;&nbsp;Share-based compensation | **—** | **—** | **16885** | **—** | **—** | **16885** |
| Balances at February 28, 2026 | **23077** | $**2308** | $**384979** | $**(1877)** | $**412787** | $**798197** |

---

*See accompanying notes to consolidated financial statements.*

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Consolidated Statements of Cash Flows**

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| Cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Net (loss) income | $**(898982)** | $123751 | $168594 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **53295** | 55048 | 51499 |
| &nbsp;&nbsp;&nbsp;Amortization of financing costs | **1564** | 1265 | 1235 |
| &nbsp;&nbsp;&nbsp;Non-cash operating lease expense | **9200** | 11100 | 10191 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses | **634** | (143) | 6103 |
| &nbsp;&nbsp;&nbsp;Non-cash share-based compensation | **16885** | 21376 | 33872 |
| &nbsp;&nbsp;&nbsp;Non-cash restructuring charges | **—** |  | 1772 |
| &nbsp;&nbsp;&nbsp;Asset impairment charges | **885861** | 51455 |  |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt | **855** |  | 489 |
| &nbsp;&nbsp;&nbsp;Gain on sale of distribution and office facilities | **—** |  | (34190) |
| &nbsp;&nbsp;&nbsp;Gain on the sale or disposal of property and equipment | **(286)** | (32) | (233) |
| &nbsp;&nbsp;&nbsp;Deferred income taxes and tax credits | **38009** | (75982) | 13210 |
| &nbsp;&nbsp;&nbsp;Changes in operating capital, net of effects of acquisition of businesses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables | **67949** | (23080) | (18668) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory | **(3197)** | (40599) | 58192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **(3968)** | 4351 | (2405) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities, net | **(345)** | 546 | (2830) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **(16454)** | 20459 | 54403 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | **25016** | (40227) | (36287) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | **(4900)** | 3925 | 1120 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | **171136** | 113213 | 306067 |
| Cash (used) provided by investing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Capital and intangible asset expenditures | **(39226)** | (30072) | (36644) |
| &nbsp;&nbsp;&nbsp;Net proceeds (payments) from business acquired | **3880** | (229428) |  |
| &nbsp;&nbsp;&nbsp;Payments for purchases of U.S. Treasury Bills | **(2156)** | (4531) | (9605) |
| &nbsp;&nbsp;&nbsp;Proceeds from maturities of U.S. Treasury Bills | **2560** | 2508 | 622 |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of distribution and office facilities | **—** |  | 49456 |
| &nbsp;&nbsp;&nbsp;Proceeds from the sale of property and equipment | **349** | 180 | 1620 |
| &nbsp;&nbsp;&nbsp;Proceeds (payments) from promissory note | **164** | (1750) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash (used) provided by investing activities | **(34429)** | (263093) | 5449 |
| Cash (used) provided by financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from revolving loans | **566350** | 1096610 | 1415511 |
| &nbsp;&nbsp;&nbsp;Repayment of revolving loans | **(936250)** | (840460) | (1686580) |
| &nbsp;&nbsp;&nbsp;Proceeds from term loans | **250000** |  | 248868 |
| &nbsp;&nbsp;&nbsp;Repayment of long-term debt | **(16406)** | (6250) | (246875) |
| &nbsp;&nbsp;&nbsp;Payment of financing costs | **(1392)** | (345) | (2025) |
| &nbsp;&nbsp;&nbsp;Proceeds from share issuances under share-based compensation plans | **2925** | 3879 | 4235 |
| &nbsp;&nbsp;&nbsp;Payments for repurchases of common stock | **(1915)** | (103188) | (55222) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash (used) provided by financing activities | **(136688)** | 150246 | (322088) |
| Net increase (decrease) in cash and cash equivalents | **19** | 366 | (10572) |
| Cash and cash equivalents, beginning balance | **18867** | 18501 | 29073 |
| Cash and cash equivalents, ending balance | $**18886** | $18867 | $18501 |
| Supplemental cash flow information: |  |  |  |
| Interest paid | $**55614** | $50154 | $52537 |
| Income taxes paid, net of refunds | **26525** | 40843 | 28855 |
| Supplemental non-cash investing activity: |  |  |  |
| &nbsp;&nbsp;Capital expenditures included in accounts payable and accrued expenses | **7433** | 6755 | 7491 |

---

*See accompanying notes to consolidated financial statements.*

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(***in thousands of U.S. Dollars, except share and per share data, unless indicated otherwise***)

**Note 1 - Summary of Significant Accounting Policies and Related Information**

**Corporate Overview**

When used in these notes within this Annual Report on Form 10-K (the "Annual Report"), unless otherwise indicated or the context suggests otherwise, references to "the Company", "our Company", "Helen of Troy", "we", "us", or "our" refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as "common stock." References to "fiscal" in connection with a numeric year number denotes our fiscal year ending on the last day of February, during the year number listed. References to "the FASB" refer to the Financial Accounting Standards Board. References to "GAAP" refer to accounting principles generally accepted in the United States of America (the "U.S."). References to "ASU" refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. Our portfolio of brands includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June, among others. As of February 28, 2026, we operated two reportable segments: Home & Outdoor and Beauty & Wellness.

Our Home & Outdoor segment offers a broad range of outstanding world-class brands that help consumers enjoy everyday living inside their homes and outdoors. Our innovative products for home activities include food preparation and storage, cooking, cleaning, organization and beverage service. Our outdoor performance range, on-the-go food storage and beverageware includes lifestyle hydration products, coolers and food storage solutions, backpacks and travel gear. The Beauty & Wellness segment provides consumers with a broad range of outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, liquid and aerosol personal care products and nail care solutions that help consumers look and feel more beautiful. In Wellness, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Vietnam, Mexico, and the U.S.

On December 16, 2024, we completed the acquisition of Olive & June, LLC ("Olive & June"), an innovative, omni-channel nail care brand. The Olive & June brand and products were added to the Beauty & Wellness segment. The total purchase consideration consists of initial cash consideration of $224.7 million, which is net of cash acquired and a favorable post-closing adjustment of $3.9 million, and contingent cash consideration of up to $15.0 million subject to Olive & June's performance during calendar years 2025, 2026, and 2027, payable annually. See Note 6 for additional information.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Principles of Consolidation**

The accompanying consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

**Cash and Cash Equivalents**

Cash equivalents include all highly liquid investments with an original maturity of three months or less. We maintain cash and cash equivalents at several financial institutions, which at times may not be federally insured or may exceed federally insured limits. We have not experienced any losses in such accounts and believe we are not exposed to any significant credit risks on such accounts. We consider money market accounts to be cash equivalents.

**Receivables**

Our receivables are comprised of trade receivables from customers, primarily in the retail industry, offset by an allowance for credit losses. Our allowance for credit losses reflects our best estimate of expected credit losses over the receivables' term, determined principally based on historical experience, specific allowances for known at-risk accounts and consideration of current economic conditions. Our policy is to write off receivables when we have determined they will no longer be collectible. Write-offs are applied as a reduction to the allowance for credit losses and any recoveries of previous write-offs are netted against bad debt expense in the period recovered.

We have a significant concentration of credit risk with three major customers at February 28, 2026, representing approximately 20%, 15%, and 13% of our gross trade receivables, respectively. As of February 28, 2025, our significant concentration of credit risk with three major customers represented approximately 21%, 17%, and 17% of our gross trade receivables, respectively. In addition, as of February 28, 2026 and February 28, 2025, approximately 55% and 62% of our gross trade receivables were due from our five top customers, respectively.

**Foreign Currency Transactions**

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company; therefore, we do not have a translation adjustment recorded through accumulated other comprehensive (loss) income. All our non-U.S. subsidiaries' transactions denominated in other currencies have been remeasured into U.S. Dollars using exchange rates in effect on the date each transaction occurred. In our consolidated statements of (loss) income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign income taxes receivables and payables and deferred income tax assets and liabilities are recognized in income tax expense (benefit), and all other foreign currency exchange rate gains and losses are recognized in SG&A.

We mitigate certain foreign currency exchange rate risk by using forward contracts to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. For additional information on our derivatives see "Financial Instruments" below.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Inventory and Cost of Goods Sold**

Our inventory consists almost entirely of finished goods. Inventories are stated at the lower of average cost or net realizable value. We write down a portion of our inventory to net realizable value based on the historical sales trends of products and estimates about future demand and market conditions, among other factors. Our average costs include the amounts we pay manufacturers for product, tariffs and duties associated with transporting product across national borders, freight costs associated with transporting the product from our manufacturers to our distribution facilities, and general and administrative expenses directly attributable to acquiring inventory, as applicable.

General and administrative expenses directly attributable to acquiring inventory include all the expenses of operating our sourcing activities and expenses incurred for packaging. We capitalized $28.6 million, $23.6 million, and $23.4 million of such general and administrative expenses into inventory during fiscal 2026, 2025 and 2024, respectively. We estimate that $10.6 million and $9.7 million of general and administrative expenses directly attributable to the procurement of inventory were included in our inventory balances on hand at February 28, 2026 and February 28, 2025, respectively.

The "Cost of goods sold" line item in the consolidated statements of (loss) income is comprised of the book value of inventory sold to customers during the reporting period and depreciation expense of tooling, molds and other production equipment. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.

For fiscal 2026, finished goods purchased from vendors in Asia comprised approximately 83% of total finished goods purchased, compared to 79% for both fiscal 2025 and 2024. For fiscal 2026, 2025 and 2024, finished goods purchased from vendors in China comprised approximately 57%, 63% and 62%, respectively, of total finished goods purchased. None of our vendors supplied more than 10% of our product requirements during fiscal 2026, compared to one vendor (located in Mexico) who fulfilled approximately 14% and 12% of our product requirements for fiscal 2025 and 2024, respectively. For fiscal 2026, 2025 and 2024, our top two vendors combined, one of which was located in China and the other in Mexico, fulfilled approximately 15%, 21% and 19% of our product requirements, respectively. For fiscal 2026, 2025 and 2024, our top five vendors fulfilled approximately 27%, 36% and 33% of our product requirements, respectively.

**Property and Equipment**

These assets are primarily recorded at cost or fair value, if acquired as part of a business combination. Depreciation is recorded on a straight-line basis over the estimated useful lives of the assets. Expenditures for repair and maintenance of property and equipment are expensed as incurred.

**Trademark License Agreements, Trade Names, Patents, and Other Intangible Assets**

A significant portion of our sales are made subject to trademark license agreements with various licensors. Our license agreements are reported on our consolidated balance sheets at cost, less accumulated amortization. The cost of our license agreements represent amounts paid to licensors to acquire the license or to alter the terms of the license in a manner that we believe to be in our best interest. Certain licenses have extension terms that may require additional payments to the licensor as part of the terms of renewal. We capitalize costs incurred to renew or extend the term of a license agreement and amortize such costs on a straight-line basis over the remaining term or economic life of the agreement, whichever is shorter. Royalty payments are not included in the cost of license agreements. Royalty expense under our license agreements is recognized as incurred and is included in our consolidated statements of (loss) income in SG&A. Net sales revenue subject to trademark license agreements, the majority of which require royalty payments, comprised approximately 32%, 36% and

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

37% of consolidated net sales revenue for fiscal 2026, 2025 and 2024, respectively. During fiscal 2026, one license agreement accounted for net sales revenue of approximately 10% of consolidated net sales revenue. No other trademark license agreements had associated net sales revenue that accounted for 10% or more of consolidated net sales revenue.

We also sell products under trade names that we own for which we have registered trademarks. Trade names that we acquire through acquisition from other entities are generally recorded on our consolidated balance sheets based upon the appraised fair value of the acquired asset, net of any accumulated amortization and impairment charges. Costs associated with developing trade names internally are recorded as expenses in the period incurred. In certain instances where trade names have readily determinable useful lives, we amortize their costs on a straight-line basis over such lives. In some instances, we have determined that such acquired assets have an indefinite useful life. In these cases, no amortization is recorded. Patents acquired through acquisition, if material, are recorded on our consolidated balance sheets based upon the appraised value of the acquired patents and amortized over the remaining life of the patent. Additionally, we incur certain costs in connection with the design and development of products to be covered by patents, which are capitalized as incurred and amortized on a straight-line basis over the life of the patent in the jurisdiction filed, typically 12 to 14 years.

Other intangible assets include customer relationships, customer lists and non-compete agreements that we acquired. These are recorded on our consolidated balance sheets based upon the fair value of the acquired asset and amortized on a straight-line basis over the remaining life of the asset as determined either by a third-party appraisal or the term of any controlling agreements.

**Goodwill, Intangible and Other Long-Lived Assets and Related Impairment Testing**

Goodwill is recorded as the difference, if any, between the aggregate consideration paid and the fair value of the net tangible and intangible assets acquired in the acquisition of a business. The fair value of our assets acquired and liabilities assumed, as well as liabilities arising from contingent consideration, are typically based upon valuations performed by independent third-party appraisers.

We review goodwill and indefinite-lived intangible assets for impairment on an annual basis or more frequently whenever events or changes in circumstances indicate that their carrying value may not be recoverable. We consider whether circumstances or conditions exist which suggest that the carrying value of our goodwill and indefinite-lived intangible assets might be impaired. If such circumstances or conditions exist, we perform a qualitative assessment to determine whether it is more likely than not that the assets are impaired. We evaluate goodwill at the reporting unit level (operating segment or one level below an operating segment). We operate two reportable segments, Home & Outdoor and Beauty & Wellness, which are comprised of eight reporting units, one of which did not have any goodwill recorded as of the beginning of fiscal 2026 and two of which were fully impaired during fiscal 2026. If the results of the qualitative assessment indicate that it is more likely than not that the assets are impaired, further steps are required in order to determine whether the carrying value of each reporting unit and indefinite-lived intangible assets exceeds its fair market value. An impairment charge is recognized to the extent the goodwill or indefinite-lived intangible asset recorded exceeds the reporting unit's or asset's fair value. We perform our annual impairment testing for goodwill and indefinite-lived intangible assets as of the beginning of the fourth quarter of our fiscal year (see Note 7).

We review intangible assets with definite lives and long-lived assets held and used for impairment whenever a triggering event occurs that indicates their carrying value may not be recoverable. If such circumstances or conditions exist, we assess recoverability based on estimated future pre-tax undiscounted cash flows. If the carrying value exceeds the estimated future pre-tax undiscounted cash flows, further steps are required in order to determine whether the carrying value of each of the individual assets exceeds its fair market value. If our analysis indicates that an individual asset's carrying value does exceed its fair value, an impairment charge is recognized equal to the excess of the carrying value

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

over the fair value. We evaluate any long-lived assets held for sale quarterly to determine if estimated fair value less cost to sell has changed during the reporting period.

The assumptions and estimates used in our impairment testing involve significant elements of subjective judgment and analysis by management. While we believe that the estimates and assumptions we use are reasonable at the time made, changes in business conditions or other unanticipated events and circumstances may occur that cause actual results to differ materially from projected results and this could potentially require future adjustments to our asset valuations.

**Economic Useful Lives and Amortization of Intangible Assets**

Intangible assets consist primarily of trademark license agreements, trade names, customer relationships and lists, patents, and non-compete agreements. We amortize intangible assets over their economic useful lives, unless those assets' economic useful lives are indefinite. If an intangible asset's economic useful life is deemed indefinite, that asset is not amortized. The determination of the economic useful life of an intangible asset requires a significant amount of judgment and entails significant subjectivity and uncertainty. When we acquire an intangible asset, we consider factors such as our plans for the asset, the market for products associated with the asset, economic factors, any legal, regulatory or contractual provisions and industry trends. We consider these same factors when reviewing the economic useful lives of our previously acquired intangible assets as well. We review the economic useful lives of our intangible assets at least annually, typically during the fourth quarter of each fiscal year, or when a triggering event occurs. For certain intangible assets subject to amortization, we use the straight-line method over appropriate periods ranging from 6 to 15 years for trademark licenses, 15 to 30 years for trade names, 4.5 to 19.5 years for customer relationships and lists, and 5 to 20 years for other definite-lived intangible assets (see Note 7).

**Financial Instruments**

We use foreign currency forward contracts to manage our exposure to changes in foreign currency exchange rates. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. Derivatives for which we have elected and qualify for hedge accounting include certain of our forward contracts ("foreign currency contracts") and interest rate swaps. Our foreign currency contracts and interest rate swaps are designated as cash flow hedges and changes in fair value are recorded in Other Comprehensive (Loss) Income ("OCI") until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive (Loss) Income ("AOCI") to our consolidated statements of (loss) income. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts, and any changes in the fair value of these derivatives are recorded in our consolidated statements of (loss) income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives and interest rate swaps are classified as cash flows from operating activities in our consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. Accordingly, we present interest paid net of cash flows from our interest rate swaps as supplemental information to our consolidated statements of cash flows. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. We also invest in U.S. Treasury Bills as a component of our capital management strategy, which are recorded at amortized cost. Our investments in U.S. Treasury Bills are classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. We invest in U.S. Treasury Bills with maturities ranging from two to five years. See Notes 14, 15 and 16 for more information on our fair value measurements, investments and derivatives.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Income Taxes and Uncertain Tax Positions**

The provision for income tax expense is calculated on reported (loss) income before income taxes based on current tax law and includes, in the current period, the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Tax laws may require items to be included in the determination of taxable income at different times from when the items are reflected in the financial statements. Deferred tax balances reflect the effects of temporary differences between the financial statement carrying amounts of assets and liabilities and their tax bases, as well as from net operating losses and tax credit carryforwards, and are stated at enacted tax rates in effect for the year taxes are expected to be paid or recovered.

Deferred tax assets represent tax benefits for tax deductions or credits available in future years and require certain estimates and assumptions to determine whether it is more likely than not that all or a portion of the benefit will not be realized. The recoverability of these future tax deductions and credits is determined by assessing the adequacy of future expected taxable income from all sources, including the future reversal of existing taxable temporary differences, taxable income in carryback years, estimated future taxable income and available tax planning strategies. Should a change in facts or circumstances lead to a change in judgment about the ultimate recoverability of a deferred tax asset, we record or adjust the related valuation allowance in the period that the change in facts and circumstances occurs, along with a corresponding increase or decrease in income tax expense.

We record tax benefits for uncertain tax positions based upon management's evaluation of the information available at the reporting date. To be recognized in the financial statements, the tax position must meet the more-likely-than-not threshold that the position will be sustained upon examination by the tax authority based on its technical merits assuming the tax authority has full knowledge of all relevant information. For positions meeting this recognition threshold, the benefit is measured as the largest amount that has greater than a 50 percent likelihood of being realized upon ultimate settlement. We reevaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, historical experience with similar tax matters, guidance from our tax advisors, and new audit activity. For tax positions that do not meet the threshold requirement, we record liabilities for unrecognized tax benefits as a tax expense or benefit in the period recognized or reversed in our consolidated financial statements, including related accrued interest and penalties.

**Revenue Recognition**

Our revenue is primarily generated from the sale of non-customized consumer products to customers. These products are promised goods that are distinct performance obligations. Revenue is recognized when control of, and title to, the product sold transfers to the customer in accordance with applicable shipping terms, which can occur on the date of shipment or the date of receipt by the customer, depending on the customer and the agreed upon shipping terms. Payment terms from the sale of our products are typically due to us in thirty to ninety days after the date of sale.

We measure revenue as the amount of consideration for which we expect to be entitled in exchange for transferring goods. We allow for sales returns for specified periods of time, which are accounted for as variable consideration. We recognize an accrual for sales returns to reduce sales to reflect our best estimate of future customer returns, determined principally based on historical experience and specific allowances for known pending returns.

Certain customers may receive cash incentives such as customer, trade, and advertising discounts, as well as other customer-related programs, which are also accounted for as variable consideration. In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration. Most of our variable consideration is classified as a reduction to net

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

sales. In instances when we purchase a distinct good or service from our customer and fair value can be reasonably estimated, these amounts are expensed in our consolidated statements of (loss) income in SG&A. The amount of consideration granted to customers recorded in SG&A was $30.6 million, $54.1 million, and $44.7 million for fiscal 2026, 2025 and 2024, respectively.

Sales taxes and other similar taxes are excluded from revenue. We have elected to account for shipping and handling activities as a fulfillment cost as permitted by the guidance. We generally do not have unsatisfied performance obligations since our performance obligations are satisfied at a single point in time.

**Advertising**

Advertising costs include cooperative retail advertising with our customers, traditional and digital media advertising and production expenses, and expenses associated with other promotional product messaging and consumer awareness programs. Advertising costs are expensed in the period in which they are incurred and included in our consolidated statements of (loss) income in SG&A. We incurred total advertising costs of $132.5 million, $134.8 million, and $106.8 million during fiscal 2026, 2025 and 2024, respectively, which is inclusive of the amounts described above for consideration granted to customers.

**Research and Development Expense**

Research and development expenses consist primarily of internal salary and employee benefit expenses and external contracted development efforts and expenses associated with development of products. Expenditures for research activities relating to product design, engineering, development and improvement are generally charged to expense as incurred and are included in our consolidated statements of (loss) income in SG&A. We incurred total research and development expenses of $54.0 million, $53.9 million, and $56.5 million during fiscal 2026, 2025 and 2024, respectively.

**Shipping and Handling Revenue and Expense**

Shipping and handling revenue and expense are included in our consolidated statements of (loss) income in SG&A. This includes distribution facility costs, third-party logistics costs and outbound transportation costs we incur. Our net expense for shipping and handling was $148.5 million, $156.6 million, and $156.7 million during fiscal 2026, 2025 and 2024, respectively.

**Share-Based Compensation Plans**

We grant share-based compensation awards to non-employee directors and certain associates under our equity plans. We measure the cost of services received in exchange for equity awards, which include grants of restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance stock awards ("PSAs"), and performance stock units ("PSUs"), based on the fair value of the awards on the grant date. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. Share-based compensation expense is recognized using an accelerated attribution method for awards subject to graded vesting, over the requisite service period during which the employee is required to provide service in exchange for the award. For awards subject to performance conditions ("Performance Condition Awards"), compensation expense is recognized ratably over the cliff vesting requisite service period to the extent the performance conditions are considered probable. Estimating the number of shares of Performance Condition Awards that are probable of vesting requires judgment, and to the extent actual results or updated estimates differ from our current estimates, such amounts will be recorded as a cumulative adjustment to share-based compensation expense in the period estimates are revised. Share-based compensation expense is recorded ratably for PSAs and PSUs subject to attainment of market conditions ("Market Condition Awards") during the cliff vesting requisite service

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

period and is not reversed, except for forfeitures, at the vesting date regardless of whether the market condition is met. We recognize forfeitures as they occur. All share-based compensation expense is recorded net of forfeitures in our consolidated statements of (loss) income.

The grant date fair value of RSAs, RSUs, PSAs, and PSUs is determined using the closing price of our common stock on the date of grant, except for Market Condition Awards, in which case we use a Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved and is applied to the closing price of our common stock on the date of grant. See Note 8 for further information on our share-based compensation plans.

**Note 2 - New Accounting Pronouncements**

**Adopted**

In July 2025, the FASB issued ASU 2025-05, *Financial Instruments – Credit Losses (Topic 326)*: *Measurement of Credit Losses for Accounts Receivable and Contract Assets*, which permits entities to elect a practical expedient to assume current conditions as of the balance sheet date will not change for the remaining life of accounts receivable and contract assets when developing forecasts as part of estimating expected credit losses. The amendments in ASU 2025-05 are effective for fiscal years beginning after December 15, 2025, and interim periods within those fiscal years, with early adoption permitted. The amendments should be applied prospectively. We adopted this ASU during the fourth quarter of fiscal 2026, and the adoption did not have a material impact on our consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU was effective for our Form 10-K for fiscal 2026. We adopted this ASU prospectively to the current annual period, and the adoption did not have a material impact on our consolidated financial statement disclosures. See Note 18 for further details.

**Not Yet Adopted**

In September 2025, the FASB issued ASU 2025-06, *Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40)*: *Targeted Improvements to the Accounting for Internal-Use Software*, which removes all references to software development project stages and requires entities to start capitalizing software costs when both of the following occur: (i) management has authorized and committed to funding the software project and (ii) it is probable that the project will be completed and the software will be used to perform the function intended. The amendments in ASU 2025-06 are effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted as of the beginning of a fiscal year. The amendments can be applied prospectively, retrospectively, or via a modified prospective transition method. This ASU will be effective for us in the first quarter of fiscal 2029. We are currently evaluating the impact this guidance may have on our consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, *Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires disaggregation of certain expenses in the notes to the financial statements in order to provide enhanced transparency into the expense captions presented on the face of the income

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

statement. The amendments in ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2028 and our Form 10-Q for the first quarter of fiscal 2029. We are currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.

**Note 3 - Leases**

We determine if an arrangement is or contains a lease at contract inception and determine its classification as an operating or finance lease at lease commencement. We primarily have leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments.

We include options to extend or terminate the lease in the lease term for accounting considerations when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of less than 1 year to 20 years. Operating lease expense for lease payments is recognized on a straight-line basis over the lease term. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the consolidated statements of (loss) income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating lease expense recognized within SG&A in the consolidated statements of (loss) income was $12.8 million, $15.8 million and $14.8 million for fiscal 2026, 2025 and 2024, respectively, and includes short-term lease expense of $3.5 million, $4.7 million and $4.6 million for fiscal 2026, 2025 and 2024, respectively. The non-cash component of lease expense is included as an adjustment to reconcile net income to net cash provided by operating activities in the consolidated statements of cash flows.

A summary of supplemental lease information was as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands, except lease term and discount rate)*** | **February 28, 2026** | **February 28, 2025** |
| Weighted average remaining lease term (years) | **10.2** | 7.1 |
| Weighted average discount rate | **6.01%** | 5.80% |
| Cash paid for amounts included in the measurement of lease liabilities | $**8569** | $10522 |
| Operating lease assets obtained in exchange for operating lease liabilities | $**19740** | $8963 |

---

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

A summary of our estimated lease payments, imputed interest and liabilities was as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **February 28, 2026** |
| Fiscal 2027 | $10309 |
| Fiscal 2028 | 9337 |
| Fiscal 2029 | 8730 |
| Fiscal 2030 | 8768 |
| Fiscal 2031 | 8347 |
| &nbsp;&nbsp;&nbsp;Thereafter | 36494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total future lease payments | 81985 |
| &nbsp;&nbsp;&nbsp;Less: imputed interest | (22062) |
| Present value of lease liability | $59923 |

---

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| Lease liabilities, current (1) | $**7039** | $6111 |
| Lease liabilities, non-current | **52884** | 39949 |
| Total lease liability | $**59923** | $46060 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Included as part of accrued expenses and other current liabilities on the consolidated balance sheets.

**Note 4 - Property and Equipment and Assets Held for Sale**

**Property and Equipment** 

A summary of property and equipment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in thousands)*** | **Estimated Useful** <br>**Lives (Years)** | **Estimated Useful** <br>**Lives (Years)** | **February 28, 2026** | **February 28, 2025** |
| Land |  |  | $**13716** | $16689 |
| Building and leasehold improvements | 3 | 40 | **211781** | 240578 |
| Software, computer, furniture and other equipment | 3 | 20 | **171852** | 179116 |
| Tooling, molds and other production equipment | 3 | 7 | **88053** | 87437 |
| Construction in progress |  |  | **16241** | 6385 |
| &nbsp;&nbsp;Property and equipment, gross |  |  | **501643** | 530205 |
| Less: accumulated depreciation |  |  | **(193622)** | (200176) |
| Property and equipment, net |  |  | $**308021** | $330029 |

---

We recorded $36.2 million, $36.2 million and $33.2 million of depreciation expense including $10.2 million, $11.9 million and $12.6 million in cost of goods sold and $26.0 million, $24.3 million and $20.6 million in SG&A in the consolidated statements of (loss) income for fiscal 2026, 2025 and 2024, respectively.

On September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas, for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimated to have a fair value of approximately $1.9 million. The transaction qualified for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and recognized a gain on the sale of $34.2 million within SG&A during fiscal 2024, of which $18.0 million and $16.2 million was recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. We used the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Assets Held for Sale** 

We record assets held for sale in accordance with ASC 360 "Property, Plant, and Equipment," and present them as single asset amounts in our consolidated financial statements. Assets held for sale consist of assets that we expect to sell within the next year. The assets are reported at the lower of carrying amount or fair value less costs to sell. We cease recording depreciation on assets that are classified as held for sale. If the determination is made that we no longer expect to sell an asset within the next year, the asset is reclassified out of held for sale. We review assets held for sale each reporting period to determine whether the existing carrying amounts are fully recoverable in comparison to estimated fair values less costs to sell.

On February 27, 2026, we entered into an agreement to sell our distribution facility in Southaven, Mississippi, which provides for closing subsequent to a due diligence period. Accordingly, we classified the associated property and equipment totaling $23.1 million, net of accumulated depreciation of $29.9 million, as held for sale as of February 28, 2026.

Subsequent to fiscal 2026, on April 14, 2026, we completed the sale of our distribution facility in Southaven, Mississippi for a total sales price of $82.0 million, less costs to sell of $3.8 million. Accordingly, we recognized a gain on the sale of $54.9 million within SG&A during the first quarter of fiscal 2027, which was recognized by our Beauty & Wellness segment. The final related property and equipment totaling $23.3 million, net of accumulated depreciation of $29.4 million, was derecognized from the consolidated balance sheet. We used the proceeds from the sale to repay amounts outstanding under our credit facility.

**Note 5 - Accrued Expenses and Other Current Liabilities**

A summary of accrued expenses and other current liabilities was as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| Accrued compensation, benefits and payroll taxes | $**33838** | $16096 |
| Accrued sales discounts and allowances | **44209** | 36600 |
| Accrued sales returns | **23234** | 20190 |
| Accrued advertising | **25961** | 25716 |
| Other | **72364** | 62138 |
| Total accrued expenses and other current liabilities | $**199606** | $160740 |

---

**Note 6 - Acquisition of Olive & June**

On December 16, 2024, we completed the acquisition of 100% of the membership interests of Olive & June, an innovative, omni-channel nail care brand. Olive & June products deliver a salon-quality experience at home and include nail polish, press-on nails, manicure and pedicure systems, grooming tools and nail care essentials. The acquisition of Olive & June complements and broadens our existing Beauty portfolio beyond the hair care category. The Olive & June brand and products were added to the Beauty & Wellness segment. The total purchase consideration consists of initial cash consideration of $224.7 million, which is net of cash acquired and a favorable post-closing adjustment of $3.9 million, and contingent cash consideration of up to $15.0 million subject to Olive & June's performance during calendar years 2025, 2026, and 2027, payable annually. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $3.0 million during fiscal 2025, which were recognized in SG&A within our consolidated statement of income.

The contingent cash consideration of up to $15.0 million is payable annually in three equal installments subject to Olive & June achieving certain annual adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") targets during calendar years 2025, 2026 and 2027. If the annual adjusted

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

EBITDA target is not met, no payment is required. As of the acquisition date, we recorded a liability for the estimated fair value of the contingent consideration of $4.1 million, of which $1.8 million and $2.3 million was included within accrued expenses and other current liabilities and other liabilities, non-current, respectively, in our consolidated balance sheet. This contingent consideration liability is remeasured at fair value each reporting period until the contingency is resolved, with changes in fair value recognized in SG&A. We made a contingent consideration payment of $5.0 million in April 2026 based upon Olive & June's achievement of the adjusted EBITDA target for calendar year 2025. See Note 14 for additional information regarding the estimated fair value of our contingent consideration liability.

We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our operational scale, existing customer relationships and distribution capabilities. The goodwill is deductible for income tax purposes and subject to valuation allowance analysis. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $51.0 million to trade names and are amortizing over a 15 year expected life. We assigned $8.0 million to customer relationships and are amortizing over a 8.5 year expected life, based on historical attrition rates. We assigned $1.6 million to non-compete agreements and are amortizing over a 5 year expected life.

During the first quarter of fiscal 2026, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net decrease to goodwill of $0.3 million. We also finalized the net working capital adjustment during the first quarter of fiscal 2026, which resulted in a $3.9 million reduction to the total purchase consideration and goodwill. During the third quarter of fiscal 2026, we made adjustments to a provisional current liability balance, which resulted in a corresponding de minimis increase to goodwill.

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:

---

| | |
|:---|:---|
| ***(in thousands)*** | |
| **Assets:** | |
| &nbsp;&nbsp;&nbsp;Receivables | $13182 |
| &nbsp;&nbsp;&nbsp;Inventory | 15121 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 3920 |
| &nbsp;&nbsp;&nbsp;Property and equipment | 1490 |
| &nbsp;&nbsp;&nbsp;Goodwill | 150726 |
| &nbsp;&nbsp;&nbsp;Trade names - definite | 51000 |
| &nbsp;&nbsp;Customer relationships - definite | 8000 |
| &nbsp;&nbsp;Other intangible assets - definite | 1600 |
| &nbsp;&nbsp;Other assets | 275 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | 245314 |
| **Liabilities:** |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | 5614 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 12731 |
| &nbsp;&nbsp;Other liabilities, non-current | 2300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 20645 |
| Net assets recorded | $224669 |

---

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The impact of the acquisition of Olive & June on our consolidated statement of income for fiscal 2025 was as follows:

---

| | |
|:---|:---|
| **December 16, 2024 (acquisition date) through February 28, 2025**<br>***(in thousands, except loss per share data)*** | **Fiscal Year Ended February 28, 2025 (1)** |
| Sales revenue, net | $23010 |
| Net loss | (1755) |
| Loss per share: |  |
| &nbsp;&nbsp;Basic | $(0.08) |
| &nbsp;&nbsp;Diluted | (0.08) |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Represents approximately eleven weeks of operating results from Olive & June, acquired December 16, 2024. Net loss and loss per share amounts include acquisition-related expenses, share-based compensation expense, amortization expense, interest expense and income tax expense.

The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Olive & June had occurred on March 1, 2023. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2023, and this information is not intended to be indicative of future results:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended the Last Day of February,** | **Fiscal Years Ended the Last Day of February,** |
| ***(in thousands, except earnings per share data)*** | **2025 (1)** | **2024** |
| Sales revenue, net | $1980423 | $2080566 |
| Net income | 123883 | 176893 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;Basic | $5.38 | $7.41 |
| &nbsp;&nbsp;Diluted | 5.37 | 7.38 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Pro forma net income and earnings per share amounts for fiscal 2025 include acquisition-related expenses incurred by Olive & June and the Company of $8.9 million and $3.0 million, respectively, amortization expense of $4.7 million, and interest expense of $2.4 million.

These amounts have been calculated after adjusting the results of Olive & June to reflect the effect of income taxes and amortization expense for definite-lived intangible assets recognized as part of the business combination as if the acquisition had occurred on March 1, 2023.

**Note 7 - Goodwill and Intangibles**

Amortization expense is recorded for intangible assets with definite useful lives and is reported within SG&A in our consolidated statements of (loss) income. Some of our goodwill is held in jurisdictions that allow deductions for tax purposes; however, in some of those jurisdictions we have no tax basis for the associated goodwill recorded. Accordingly, some of our goodwill is not deductible for tax purposes. We perform annual impairment testing each fiscal year and interim impairment testing, if necessary, as described in Note 1. We write down any asset deemed to be impaired to its fair value.

During each quarter of fiscal 2026, we concluded that a goodwill impairment triggering event had occurred due to a further sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company's total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to these conclusions included downward revisions to our internal forecasts and strategic long-term plans, which reflect the tariff policies in effect and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders. These factors were applicable to all of our reporting units, indefinite-lived trademark licenses and trade names and definite-lived trademark licenses, trade names and certain other intangible assets. Thus, we performed quantitative impairment testing on our

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

goodwill and intangible assets described above during each quarter of fiscal 2026, all of which resulted in the recognition of impairment charges, which are further described below.

During the second and fourth quarters of fiscal 2025, we concluded a goodwill impairment triggering event had occurred due to a continued sustained decline in our stock price, resulting in our carrying value (excluding long-term debt) exceeding the Company's total enterprise value (market capitalization plus long-term debt). Additional factors that contributed to this conclusion included downward revisions to our internal forecasts and strategic long-term plans. These factors were applicable to all of our reporting units, indefinite-lived and definite-lived trademark licenses and trade names and certain other intangible assets, as applicable. Thus, we performed quantitative impairment testing on our goodwill and intangible assets described above. The quantitative assessments performed during the second quarter of fiscal 2025 did not result in impairment of our goodwill or intangible assets. The quantitative assessments performed during the fourth quarter of fiscal 2025 resulted in the recognition of impairment charges, which are further described below.

We estimate the fair value of our trade names and trademark licenses using the relief from royalty method income approach which is based upon projected future discounted cash flows ("DCF Model"). We estimate the fair value of our customer relationships and lists using the distributor method income approach which is based upon a DCF Model. After adjusting the carrying values of our indefinite-lived and definite-lived intangible assets, the Company completed quantitative impairment testing for goodwill. We estimate the fair value of our reporting units using an income approach based upon projected future discounted cash flows.

Based on the outcome of these assessments, we recognized pre-tax asset impairment charges as follows:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February** | **Fiscal Years Ended Last Day of February** |
| ***(in thousands)*** | **2026** | **2025** |
| Home & Outdoor (1) | $**332565** | $— |
| Beauty & Wellness (2) | **553296** | 51455 |
| Total | $**885861** | $51455 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Asset impairment charges recognized for our Home & Outdoor segment included charges for our Hydro Flask and Osprey businesses of $184.4 million and $148.1 million, respectively, during fiscal 2026.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Asset impairment charges recognized for our Beauty & Wellness segment included charges for our Health & Wellness, Drybar, Curlsmith and Revlon businesses of $242.2 million, $154.5 million, $133.0 million and $23.5 million, respectively, during fiscal 2026, and a charge for our Drybar business of $51.5 million during fiscal 2025.

During the first quarter of fiscal 2026, in connection with our annual budgeting and forecasting process, management reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect and the related macroeconomic environment at the end of our first quarter of fiscal 2026, including the corresponding impact on consumer spending and retailer orders, as applicable. The revised forecasts also resulted in management selecting lower residual growth rates, which were also reflective of revised long-term industry growth expectations, and royalty rates, as applicable. During the second, third and fourth quarters of fiscal 2026, management further reduced its forecasts for net sales revenue, gross margin and earnings before interest and taxes to reflect the tariff policies in effect, timing of corresponding price increases inclusive of the impact of stop shipment actions to support consistent adoption and the related macroeconomic environment at the end of each quarter of fiscal 2026, including the impact on consumer spending, retailer orders and China cross border ecommerce due to a shift to localized distribution, as applicable. Our forecasts for fiscal 2027 were also updated during the fourth quarter of fiscal 2026, in connection with our annual budgeting process, which primarily resulted in an increase in operating expense, shifts in sales forecasts between brands and a reduction to the residual growth rate assumption for one of our reporting units.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

During fiscal 2025, our Drybar business continued to experience a decline in net sales revenue due to lower consumer demand, increased competition, and net distribution declines, all of which contributed to reduced earnings and cash flows. In connection with our annual budgeting and forecasting process during the fourth quarter of fiscal 2025, management reduced its forecasts of Drybar's net sales revenue growth, gross margin and earnings before interest and taxes which also resulted in management selecting a lower royalty rate.

Refer to Note 14 for additional information on our valuation method and related assumptions and estimates. For additional information regarding the testing and analysis performed, refer to Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "Critical Accounting Policies and Estimates" included within this Annual Report.

We performed our annual impairment testing of our goodwill and indefinite-lived intangible assets during the fourth quarter of fiscal 2024 and determined based on our qualitative assessment that it was not more likely than not that the fair value of each reporting unit and indefinite-lived intangible asset was lower than its carrying value. Therefore, quantitative testing in fiscal 2024 was not required. Accordingly, no impairment charges were recorded during fiscal 2024.

The following table summarizes the changes in our goodwill by segment for fiscal 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
| ***(in thousands)*** | **Home &<br> Outdoor** | **Beauty &<br>Wellness** | **Total** |
| Gross carrying amount as of February 29, 2024 | $491777 | $574953 | $1066730 |
| Accumulated impairment as of February 29, 2024 |  |  |  |
| Net carrying amount as of February 29, 2024 | $491777 | $574953 | $1066730 |
| &nbsp;&nbsp;Acquisitions (1) |  | 154839 | 154839 |
| &nbsp;&nbsp;Impairment charges (2) |  | (38670) | (38670) |
| Gross carrying amount as of February 28, 2025 | 491777 | 729792 | 1221569 |
| Accumulated impairment as of February 28, 2025  |  | (38670) | (38670) |
| Net carrying amount as of February 28, 2025 | $491777 | $691122 | $1182899 |
| &nbsp;&nbsp;Acquisitions (3) | **—** | **(4113)** | **(4113)** |
| &nbsp;&nbsp;Impairment charges (4) | **(229058)** | **(477447)** | **(706505)** |
| Gross carrying amount as of February 28, 2026 | **491777** | **725679** | **1217456** |
| Accumulated impairment as of February 28, 2026 | **(229058)** | **(516117)** | **(745175)** |
| Net carrying amount as of February 28, 2026 | $**262719** | $**209562** | $**472281** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Reflects the goodwill recorded in the Beauty & Wellness segment in connection with the acquisition of Olive & June on December 16, 2024. For additional information see Note 6.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Reflects the goodwill impairment charge of $38.7 million recorded in the Beauty & Wellness segment to reduce our Drybar's reporting unit's goodwill to $134.3 million as of February 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Reflects a favorable post-closing adjustment to goodwill recorded in the Beauty & Wellness segment during the first quarter of fiscal 2026, partially offset by an increase to goodwill for adjustments to a provisional current liability balance during the third quarter of fiscal 2026 in connection with the acquisition of Olive & June on December 16, 2024. For additional information see Note 6.

&nbsp;&nbsp;&nbsp;&nbsp;(4)Reflects the goodwill impairment charges of $115.9 million and $113.1 million related to our Hydro Flask and Osprey reporting units, respectively, recorded in the Home & Outdoor segment and $235.2 million, $134.3 million and $107.9 million related to our Heath & Wellness, Drybar and Curlsmith reporting units, respectively, recorded in the Beauty & Wellness segment. The remaining carrying values of the Osprey, Health & Wellness and Curlsmith reporting units' goodwill as of February 28, 2026 were $96.6 million, $49.7 million and $9.2 million, respectively. The goodwill impairment charges recognized for the Hydro Flask and Drybar reporting units reduced the carrying values of their goodwill to zero.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following table summarizes the components of our other intangible assets as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **February 28, 2026 (1)** | **February 28, 2026 (1)** | **February 28, 2026 (1)** | **February 28, 2025 (1)** | **February 28, 2025 (1)** | **February 28, 2025 (1)** |
| ***(in thousands)*** | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
| **Indefinite-lived:** | | | | | | |
| &nbsp;&nbsp;Trademark licenses | $**7400** | $**—** | $**7400** | $7400 | $— | $7400 |
| &nbsp;&nbsp;Trade names (2) | **257200** | **—** | **257200** | 358200 |  | 358200 |
| **Definite-lived:** |  |  |  |  |  |  |
| &nbsp;&nbsp;Trademark licenses (3) | **45385** | **(3757)** | **41628** | 75050 | (9454) | 65596 |
| &nbsp;&nbsp;Trade names (4) | **53004** | **(4246)** | **48758** | 89365 | (14030) | 75335 |
| &nbsp;&nbsp;Customer relationships and lists (5) | **125001** | **(115034)** | **9967** | 168201 | (120932) | 47269 |
| &nbsp;&nbsp;Other intangibles (6) | **58355** | **(50458)** | **7897** | 74297 | (61341) | 12956 |
| Total | $**546345** | $**(173495)** | $**372850** | $772513 | $(205757) | $566756 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Balances as of February 28, 2026 and February 28, 2025 include intangible assets recorded in connection with the acquisition of Olive & June on December 16, 2024. For additional information see Note 6.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Balances as of February 28, 2026 reflect total impairment charges of $97.0 million, which includes $55.0 million related to our Hydro Flask trade name, $35.0 million related to our Osprey trade name and $7.0 million related to our PUR trade name. The remaining carrying values of the Osprey and PUR trade names as of February 28, 2026 were $135.0 million and $47.0 million, respectively. The impairment charges were recorded in the Home & Outdoor segment for Hydro Flask and Osprey and in the Beauty & Wellness segment for PUR. The remaining carrying value of the Hydro Flask trade name of $4.0 million was reclassified to a definite-lived trade name as of November 30, 2025 and was subsequently fully impaired during the fourth quarter of fiscal 2026 as discussed below in footnote 4 to this table.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Balances as of February 28, 2026 reflect total impairment charges recorded in the Beauty & Wellness segment of $23.5 million related to our Revlon trademark license. The remaining carrying value of this trademark license as of February 28, 2026 was $39.4 million. As of November 30, 2025, the remaining useful life of the Revlon trademark license was revised from approximately 35 years to 10 years, which will increase annual amortization expense by approximately $2.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;(4)Balances as of February 28, 2026 reflect total impairment charges of $26.1 million, which includes $15.4 million related to our Curlsmith trade name, $6.7 million related to our Drybar trade name and $3.9 million related to our Hydro Flask trade name. The Hydro Flask trade name impairment charge was recorded during the fourth quarter of fiscal 2026, as its remaining carrying value was reclassified to a definite-lived trade name as of November 30, 2025. Impairment charges recognized during fiscal 2026 on the Hydro Flask trade name prior to November 30, 2025 are discussed above in footnote 2 to this table. The remaining carrying value of the Curlsmith trade name as of February 28, 2026 was $1.9 million. The impairment charges recognized for the Drybar and Hydro Flask trade names reduced the carrying values of these assets to zero. The impairment charges were recognized in the Beauty & Wellness segment for Curlsmith and Drybar and in the Home & Outdoor segment for Hydro Flask. Balances as of February 28, 2025 reflect an impairment charge of $12.8 million to reduce the carrying value of the Drybar trade name to $7.0 million as of February 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;(5)Balances as of February 28, 2026 reflect total impairment charges of $29.2 million, which includes $10.7 million related to our Drybar customer relationship, $9.7 million related to our Curlsmith customer relationship and $8.8 million related to our Hydro Flask customer relationship. The impairment charges were recorded in the Beauty & Wellness segment for Curlsmith and Drybar and in the Home & Outdoor segment for Hydro Flask. The impairment charges reduced the carrying values of these assets to zero.

&nbsp;&nbsp;&nbsp;&nbsp;(6)Balances as of February 28, 2026 reflect total impairment charges of $3.6 million, which includes $2.8 million and $0.8 million recorded in the Beauty & Wellness and Home & Outdoor segments, respectively, related to Drybar and Hydro Flask other intangibles which reduced the carrying values of these assets to zero.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following tables summarize amortization expense related to our other intangible assets as follows:

---

| | |
|:---|:---|
| **Aggregate Amortization Expense *(in thousands)*** | |
| Fiscal 2026 | $**17059** |
| Fiscal 2025 | 18875 |
| Fiscal 2024 | 18326 |

---

---

| | |
|:---|:---|
| **Estimated Amortization Expense *(in thousands)*** | |
| Fiscal 2027 | $13102 |
| Fiscal 2028 | 10436 |
| Fiscal 2029 | 10408 |
| Fiscal 2030 | 10111 |
| Fiscal 2031 | 9281 |

---

**Note 8 - Share-Based Compensation Plans**

During the fiscal year, we had equity activity under two expired and two active share-based compensation plans. The expired plans consist of the 2008 Stock Incentive Plan (the "2008 Plan") and 2018 Stock Incentive Plan (the "2018 Plan"). The active plans consist of the 2025 Stock Incentive Plan (the "2025 Plan") and the 2018 Employee Stock Purchase Plan (the "2018 ESPP"). The plans are administered by the Compensation Committee of the Board of Directors, which consists of non-employee directors who are independent under the applicable listing standards for companies traded on the NASDAQ Stock Market LLC.

***2025 Plan***

On August 20, 2025, our shareholders approved the 2025 Plan which replaced the 2018 Plan. The 2025 Plan permits the granting of stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. As of February 28, 2026, the 2025 Plan had 1,102,944 shares available for future issuance, including shares which remained available for issuance under the 2018 Plan immediately prior to August 20, 2025.

***2018 Plan***

On August 20, 2025, our 2018 Plan was replaced by the 2025 Plan. As a result, the 2018 Plan terminated on August 20, 2025, but continues to apply to awards granted under the 2018 Plan before such date.

***2018 ESPP***

On August 22, 2018, our shareholders approved the 2018 ESPP. The aggregate number of shares of common stock that may be purchased under the 2018 ESPP will not exceed 750,000 shares. Under the terms of the plan, associates may authorize the withholding of up to 15% of their wages or salaries to purchase our shares of common stock, not to exceed $25,000 of the fair market value of such shares for any calendar year. The purchase price for shares acquired under the 2018 ESPP is equal to the lower of 85% of the share's fair market value on either the first day of each option period or the last day of each period. The plan will expire by its terms on September 1, 2028. Shares of common stock purchased under the 2018 ESPP vest immediately at the time of purchase. During fiscal 2026, there were 94,685 shares purchased under the plan.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Share-Based Compensation Expense***

We recorded share-based compensation expense in SG&A as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026 (1)** | **2025** | **2024** |
| Directors' stock compensation | $**784** | $785 | $787 |
| Service Condition Awards | **16983** | 11407 | 12345 |
| Performance Condition Awards | **(3634)** | 3611 | 5746 |
| Market Condition Awards | **1862** | 4529 | 13790 |
| Employee stock purchase plan | **890** | 1044 | 1204 |
| &nbsp;&nbsp;Share-based compensation expense | **16885** | 21376 | 33872 |
| Less: income tax benefits | **(1444)** | (1240) | (2110) |
| Share-based compensation expense, net of income tax benefits | $**15441** | $20136 | $31762 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Share-based compensation expense during fiscal 2026 includes a benefit for Performance Condition Awards, as a result of a change in estimate from target achievement to zero percent achievement for certain Performance Condition Awards granted during fiscal 2026, 2025 and 2024.

***Stock Options***

There have been no new grants of options since fiscal 2017 and all options outstanding at February 28, 2025 were exercisable. A summary of stock option activity under our 2008 plan was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in thousands, except contractual term and per share data)*** | **Options**  | **Weighted**<br>**Average**<br>**Exercise**<br>**Price**<br>**(per share)**  | **Weighted<br>Average<br>Remaining<br>Contractual<br>Term<br>(in years)** | **Intrinsic**<br>**Value**  |
| Outstanding at February 28, 2025 | **4** | $**87.61** | **0.2** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Expirations | **(4)** | **87.61** |  |  |
| Outstanding at February 28, 2026 | **—** | $**—** | **—** | $**—** |
| Exercisable at February 28, 2026 | **—** | $**—** | **—** | $**—** |

---

No options were exercised during fiscal 2026. The total intrinsic value of options exercised during fiscal 2025 and 2024, was $0.2 million and $0.3 million, respectively.

***Director Restricted Stock Awards***

During fiscal 2026, we issued under the 2018 Plan and 2025 Plan, 29,080 RSAs to non-employee members of the Board of Directors with a total grant date fair value of $0.8 million or $26.97 per share. The RSAs vested immediately, and accordingly, were expensed immediately. The total fair value of RSAs granted to our non-employee members of the Board of Directors that vested immediately on grant dates in both fiscal 2025 and 2024 was $0.8 million.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

***Service Condition Awards***

We grant RSAs and RSUs to associates, which primarily have specified graded vesting terms over two to four years, "Service Condition Awards." A summary of Service Condition Awards activity during fiscal 2026 follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands, except per share data)*** | **Number of <br>Service Condition Awards** | **Weighted Average<br>Grant Date Fair Value<br>(per share)** |
| Outstanding at February 28, 2025 | **268** | $**107.29** |
| &nbsp;&nbsp;Granted | **433** | **43.64** |
| &nbsp;&nbsp;Vested | **(148)** | **95.79** |
| &nbsp;&nbsp;Forfeited | **(101)** | **73.55** |
| Outstanding at February 28, 2026 | **452** | $**57.61** |

---

The total fair value of Service Condition Awards that vested in fiscal 2026, 2025 and 2024 was $5.5 million, $8.8 million and $6.2 million, respectively. The weighted average grant date fair value of Service Condition Awards granted during fiscal 2026, 2025 and 2024 was $43.64, $99.20 and $109.97, respectively.

***Performance Condition Awards***

We grant Performance Condition Awards to certain officers and associates, which cliff vest after three years. The vesting of these awards is contingent upon meeting one or more defined operational performance metrics over a three year performance period. The quantity of shares ultimately awarded can range from 0% to 200% of "Target", as defined in the award agreement as 100%, based on the level of achievement against the defined operational performance metrics. A summary of Performance Condition Awards activity during fiscal 2026 follows and reflects all PSAs granted and outstanding at maximum achievement of 200% of Target:

---

| | | |
|:---|:---|:---|
| ***(in thousands, except per share data)*** | **Number of Performance Condition Awards** | **Weighted Average<br>Grant Date Fair Value<br>(per share)** |
| Outstanding at February 28, 2025 | **421** | $**112.67** |
| &nbsp;&nbsp;Granted | **256** | **49.11** |
| &nbsp;&nbsp;Vested | **—** | **—** |
| &nbsp;&nbsp;Forfeited (1) | **(221)** | **112.58** |
| Outstanding at February 28, 2026 | **456** | $**77.02** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes fiscal 2023 Performance Condition Awards which had a performance achievement level of 0%.

No Performance Condition Awards vested in fiscal 2026 and 2025. The total fair value of Performance Condition Awards that vested in fiscal 2024 was $7.5 million. The weighted average grant date fair value of Performance Condition Awards granted during fiscal 2026, 2025 and 2024 was $49.11, $89.50 and $110.83, respectively.

***Market Condition Awards***

We grant Market Condition Awards to certain officers and associates, which cliff vest after three years. The vesting of these awards is primarily contingent upon meeting specified stock price return targets compared to a predetermined peer group over a three year period. The quantity of shares ultimately awarded typically can range from 0% to 200% of "Target", as defined in the award agreement as 100%, based on the level of achievement against the defined targets. A summary of Market Condition Awards

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

activity during fiscal 2026 follows and reflects all PSAs granted and outstanding at maximum achievement of 200% of Target:

---

| | | |
|:---|:---|:---|
| ***(in thousands, except per share data)*** | **Number of Market Condition Awards** | **Weighted Average<br>Grant Date Fair Value<br>(per share)** |
| Outstanding at February 28, 2025 | **241** | $**102.48** |
| &nbsp;&nbsp;Granted | **219** | **26.47** |
| &nbsp;&nbsp;Vested | **—** | **—** |
| &nbsp;&nbsp;Forfeited (1) | **(155)** | **98.28** |
| Outstanding at February 28, 2026 | **305** | $**50.32** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes fiscal 2023 Market Condition Awards which had a performance achievement level of 0%.

No Market Condition Awards vested in fiscal 2026, 2025 or 2024. The weighted average grant date fair value of Market Condition Awards granted during fiscal 2026, 2025 and 2024 was $26.47, $91.19 and $80.49, respectively.

The fair value of our Market Condition Awards are estimated using a Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved and is applied to the closing price of our common stock on the date of grant. The input variables utilized are included in the table below:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| | **2026** | **2025** | **2024** |
| Expected term in years | **3** | 3 | 3 |
| Risk free interest rate | **3.9%** | 4.3% | 4.6% |
| Expected volatility | **49.0%** | 41.0% | 46.0% |
| Expected dividend yield (1) | **— %** | —% | —% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)The Monte Carlo method assumes a reinvestment of dividends.

The expected term is consistent with the explicit service period and the risk free interest rate is based on U.S. Treasury securities with maturities equal to the expected term of the awards. Expected volatility is based equally on the historical volatility of our stock prices over the expected term of the awards and at-the-money call options traded on or near the grant date of the awards.

***Unrecognized Share-Based Compensation Expense***

As of February 28, 2026, our total unrecognized share-based compensation for all awards was $15.0 million, which will be recognized over a weighted average amortization period of 1.8 years. The total unrecognized share-based compensation reflects a weighted average estimate of 83% and 81% of Target achievement for Performance Condition Awards granted during fiscal 2026 and 2025, respectively, and an estimate of zero percent of Target achievement for Performance Condition Awards granted during fiscal 2024.

**Note 9 - Defined Contribution Plans**

We sponsor defined contribution savings plans in the U.S. and other countries where we have associates. Total company matching contributions made to these plans for fiscal 2026, 2025 and 2024 were $7.1 million, $6.7 million and $6.0 million, respectively.

**Note 10 - Repurchases of Common Stock**

In August 2024, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 20, 2024, for a period of three years, and

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

replaced our former repurchase authorization. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. As of February 28, 2026, our repurchase authorization allowed for the purchase of $498.0 million of common stock.

Our current equity-based compensation plans include provisions that allow for the "net exercise" of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as repurchases of shares.

The following table summarizes our share repurchase activity for the periods shown:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands, except share and per share data)*** | **2026** | **2025** | **2024** |
| Common stock repurchased on the open market: |  |  |  |
| &nbsp;&nbsp;&nbsp;Number of shares | **—** | 1011243 | 381200 |
| &nbsp;&nbsp;&nbsp;Aggregate value of shares | $**—** | $100019 | $50006 |
| &nbsp;&nbsp;&nbsp;Average price per share | $**—** | $98.91 | $131.18 |
| Common stock received in connection with share-based compensation: |  |  |  |
| &nbsp;&nbsp;&nbsp;Number of shares | **51025** | 27453 | 51332 |
| &nbsp;&nbsp;&nbsp;Aggregate value of shares | $**1915** | $3169 | $5216 |
| &nbsp;&nbsp;&nbsp;Average price per share | $**37.53** | $115.42 | $101.60 |

---

**Note 11 - Restructuring Plan**

During fiscal 2023, we initiated a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and effectiveness and reduce costs (referred to as "Project Pegasus"). As part of our Project Pegasus we incurred severance and employee related costs, professional fees, contract termination costs and other exit and disposal costs which were recorded as "Restructuring charges" in the consolidated statements of (loss) income. Severance and employee related costs consisted primarily of salary continuation benefits, prorated annual incentive compensation (based on eligibility), outplacement services and continuation of health benefits. Severance and employee related benefits were pursuant to our severance plan and accounted for in accordance with ASC 712, *Compensation - Nonretirement Postemployment Benefits*, based upon the characteristics of the termination benefits pursuant to our severance plan. Severance and employee related costs were recognized when the benefits were determined to be probable of being paid and reasonably estimable. Professional fees, contract termination costs and other exit and disposal costs were accounted for in accordance with ASC 420, *Exit or Disposal Cost Obligations* and recognized as incurred. Restructuring accruals are based upon management estimates at the time and subject to change depending upon changes in facts and circumstances subsequent to the date the original liability was recorded.

During the fourth quarter of fiscal 2025, we completed Project Pegasus, but still expect to realize the targeted savings through fiscal 2027. Project Pegasus included initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate and amplify cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending and improve our cash flow and working capital, as well as other activities. These initiatives have created operating efficiencies, as well as provided a platform to fund growth investments. During fiscal 2025 and 2024, we incurred pre-tax restructuring charges of $14.8 million and $18.7 million, respectively, in connection with Project Pegasus, primarily for professional fees and severance and employee related costs, which were recorded as "Restructuring charges" in the consolidated statements of (loss) income.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

During fiscal 2026, 2025 and 2024, we made total cash restructuring payments related to Project Pegasus of $7.7 million, $11.9 million and $18.7 million, respectively, primarily for professional fees and severance and employee related costs. Restructuring charges primarily represented cash expenditures and were paid by the end of fiscal 2026. For information regarding Project Pegasus savings, refer to Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "Project Pegasus" included within this Annual Report.

**Note 12 - Commitments and Contingencies**

**Indemnity Agreements**

Under agreements with customers, licensors and parties from whom we have acquired assets or entered into business combinations, we indemnify these parties against liability associated with our products. Additionally, we are party to a number of agreements under leases where we indemnify the lessor for liabilities attributable to our actions or conduct. The indemnity agreements to which we are a party do not, in general, increase our liability for claims related to our products or actions and have not materially affected our consolidated financial statements.

**Legal Matters**

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

**Water Filtration Patent Litigation**

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the U.S. District Court for the Western District of Texas (the "Patent Litigation"), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the U.S. International Trade Commission ("ITC") against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the "ITC Action"). The complaint in the ITC Action also alleged patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This action sought injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against the Company and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including the Company, filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company's favor. The ITC determined there was no violation by the Company and terminated the investigation. Brita LP subsequently appealed the ITC's decision to the Federal Circuit ("CAFC Appeal") and filed its Notice of Appeal on October 24, 2023. The Company intervened in the CAFC Appeal and oral argument occurred on August 5, 2025.

In connection with the CAFC Appeal, on October 15, 2025, the Federal Circuit issued a precedential opinion affirming the ITC's decision that Brita LP's claims were invalid. Following the ITC's determinations with respect to the ITC Action and the Federal Circuit's opinion in the CAFC Appeal, on

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

December 22, 2025, Brita filed a notice to dismiss the Patent Litigation in the District Court, ending the Patent Litigation in the Company's favor.

**EPA Regulatory Matter**

Our operations are subject to national, state, local, and provincial jurisdictions' environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the "EPA"), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission and the European Union.

During fiscal 2022 and 2023, we were in discussions with the EPA regarding the compliance of packaging and labeling claims on certain of our products in the air and water filtration and humidification categories within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging and labeling compliance discussions, we completed the repackaging and relabeling of impacted products during fiscal 2023. We continue to have ongoing settlement discussions with the EPA related to this matter. As of February 28, 2026, we accrued an estimated liability of $4.4 million, which represents our best estimate of probable settlement costs related to this matter.

For additional information refer to Item 1A., "Risk Factors," and to Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "EPA Compliance Costs" included within this Annual Report.

**Talcum Powder Litigation**

In fiscal 2022, we completed the sale of our North America personal care business to HRB Brands LLC ("HRB Brands"). After the sale, we were named as a defendant in multiple lawsuits related to the use of personal care products containing talcum powder, primarily Brut deodorant and Ammens powder sold by our wholly-owned subsidiary, Idelle Labs, Ltd. We tendered indemnification of these cases to HRB Brands, which assumed control of the defense of the claims. After many years, during the fourth quarter of fiscal 2026, we learned that HRB Brands asserted that it was contesting the indemnification of these cases and tendered the indemnification back to us. Consequently, in order to protect the Company and its rights and defenses, we began to defend these cases. The Company maintains its position that HRB Brands is obligated to defend and indemnify the Company against these claims and plans to vigorously contest HRB Brands' position. With respect to the talcum powder cases, we believe we have substantial defenses to the claims. The ultimate outcome of enforcing our indemnification claims against HRB Brands and the litigation relating to the talcum cases is inherently uncertain, and we cannot predict its resolution. As of February 28, 2026, we had accrued an estimated liability of $1.5 million for potential settlements of these cases. We cannot estimate the amount or range of amounts by which the liability may exceed the accrual established because of (i) the inherent difficulty in projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii) the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to individual defendants so that a defendant's share of liability may turn on the law of joint and several liability, which can vary by state, and (iii) the several possible developments that may occur that could affect the Company's estimate of the liability.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Commitments**

We sell certain of our products under trademarks licensed from third parties. Some of these trademark license agreements require us to pay minimum royalties. As of February 28, 2026, we estimate future minimum annual royalty payments over the noncancellable term of these arrangements to be approximately $6.2 million, $6.0 million, $5.8 million, $5.3 million, and $2.7 million per year, during the next five fiscal years, respectively.

**Note 13 - Long-Term Debt**

A summary of our long-term debt follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| Amended Credit Agreement: |  |  |
| &nbsp;&nbsp;Revolving loans | $**308200** | $678100 |
| &nbsp;&nbsp;Term loans | **477344** | 243750 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total borrowings under Amended Credit Agreement | **785544** | 921850 |
| Unamortized prepaid financing fees | **(4733)** | (4956) |
| &nbsp;&nbsp;Total long-term debt | **780811** | 916894 |
| Less: current maturities of long-term debt | **(25000)** | (9375) |
| Long-term debt, excluding current maturities | $**755811** | $907519 |

---

Aggregate annual maturities of our long-term debt as of February 28, 2026 were as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | |
| Fiscal 2027 | $25000 |
| Fiscal 2028 | 25000 |
| Fiscal 2029 | 735544 |
| Fiscal 2030 |  |
| Fiscal 2031 |  |
| Thereafter |  |
| Total | $785544 |

---

**Amended Credit Agreement**

On February 15, 2024, we entered into a credit agreement (the "Credit Agreement") with Bank of America, N.A., as administrative agent, and other lenders. The Credit Agreement replaced our prior credit agreement, which terminated on February 15, 2024. We utilized the proceeds from the refinancing to repay all principal, interest, and fees outstanding under the prior credit agreement without penalty. As a result, we recognized a loss on extinguishment of debt within "Interest expense" of $0.5 million during fiscal 2024, which consisted of a write-off of $0.4 million of unamortized prepaid financing fees related to the prior credit agreement and $0.1 million of lender fees related to debt under the Credit Agreement treated as an extinguishment. Additionally, we expensed $0.3 million of third-party fees in fiscal 2024 related to debt under the Credit Agreement treated as a modification, which was recognized within "Interest expense."

The Credit Agreement provides for aggregate commitments of $1.5 billion, which are available through (i) a $1.0 billion revolving credit facility, which includes a $50 million sublimit for the issuance of letters of credit, (ii) a $250 million term loan facility and (iii) a committed $250 million delayed draw term loan facility, which permitted multiple drawdowns until August 15, 2025. Proceeds can be used for working capital and other general corporate purposes, including funding permitted acquisitions. At the closing date, February 15, 2024, we borrowed $457.5 million under the revolving credit facility and $250.0 million under the term loan facility and utilized the proceeds to repay all debt outstanding under the prior credit agreement. During the first quarter of fiscal 2026, we borrowed $250.0 million under the delayed draw

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

term loan facility and utilized the proceeds to repay debt outstanding under the revolving credit facility. During the first quarter of fiscal 2026, we capitalized $0.4 million of lender fees and a de minimis amount of third-party fees incurred in connection with the delayed draw term loan facility borrowing, which were recorded as prepaid financing fees in long-term debt.

On November 25, 2025, we entered into an amendment to the Credit Agreement (the "Amendment", or as amended, the "Amended Credit Agreement"), which provides for the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reduces the commitment under the revolving credit facility from $1.0 billion to $750.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adds a maximum tier level pursuant to which, if the Net Leverage Ratio is greater than or equal to 4.00 to 1.00, then borrowings under the Amended Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin of 1.375% and 2.375% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings (as those terms are defined in the Amended Credit Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amends the minimum Interest Coverage Ratio financial covenant to replace the numerator with a Consolidated EBITDA measure instead of a Consolidated EBIT measure (as those terms are defined in the Amended Credit Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amends the maximum Leverage Ratio financial covenant so that it is not permitted to be greater than as set forth below as of the end of the fiscal quarter:

---

| | |
|:---|:---|
| **Fiscal Quarter Ending** | ***Maximum***<br>**Leverage Ratio** |
| November 30, 2025 | 4.50 to 1.00 |
| February 28, 2026 through August 31, 2026 | 4.50 to 1.00 |
| November 30, 2026 | 4.00 to 1.00 |
| February 28, 2027 through May 31, 2027 | 3.75 to 1.00 |
| August 31, 2027 and each fiscal quarter thereafter | 3.50 to 1.00 |

---

We may elect to use the Leverage Holiday in connection with the consummation of a Qualified Acquisition after August 31, 2027, if we are in compliance with the terms of the Amended Credit Agreement and meet the other terms and conditions relating to a Qualified Acquisition (as those terms are defined in the Amended Credit Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Until August 31, 2027, the following negative covenants are reduced, as described in the Amendment, a general investments basket, an unsecured indebtedness basket and the Permitted Receivables Financings (as defined in the Amended Credit Agreement) basket.

In connection with the Amendment, we recognized a $0.9 million charge within "Interest expense" to write-off unamortized prepaid financing fees related to the revolver due to the reduced commitment and capitalized $1.0 million of lender and third-party fees during the third quarter of fiscal 2026, which were recorded as prepaid financing fees in long-term debt.

The Amended Credit Agreement includes an accordion feature, which permits the Company to request to increase its borrowing capacity by an additional $300 million plus an unlimited amount when the Leverage Ratio, on a pro-forma basis, is less than 3.25 to 1.00. The Company's exercise of the accordion is subject to certain conditions being met, including lender approval. The Amended Credit Agreement matures on February 15, 2029. We are able to repay amounts borrowed at any time without penalty. Borrowings accrue interest under one of two alternative methods pursuant to the Amended Credit Agreement as described below. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment and letter of credit fees under the Amended Credit Agreement ranging from 0.1% to 0.45% per annum and 1.0% to 2.375% per annum, respectively, based on our Net Leverage Ratio. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% through February 28, 2025, 0.9375% through February 28, 2026, and 1.25% thereafter of the original principal balance of the term loans, which began in the first quarter of fiscal 2025 for the term loan facility and began in the second quarter of fiscal 2026

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

for the delayed draw term loan facility, with the remaining balance due at the maturity date. Borrowings under the Amended Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin based on the Net Leverage Ratio of 0% to 1.375% and 1.0% to 2.375% for Base Rate and Term SOFR borrowings, respectively.

The floating interest rates on our borrowings under the Amended Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $325 million and $550 million of the outstanding principal balance under the Amended Credit Agreement as of February 28, 2026 and February 28, 2025, respectively. See Notes 14, 15, and 16 for additional information regarding our interest rate swaps.

**Debt Covenants**

Our debt under our Amended Credit Agreement is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our Amended Credit Agreement requires the maintenance of certain key financial covenants defined in the accompanying Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Amended Credit Agreement. Our Amended Credit Agreement also contains other customary covenants, including, among other things, covenants restricting or limiting us, except under certain conditions set forth therein, from (1) incurring liens on our properties, (2) making certain types of investments, (3) incurring additional debt, and (4) assigning or transferring certain licenses. Our Amended Credit Agreement also contains customary events of default, including failure to pay principal or interest when due, among others. Upon an event of default under our Amended Credit Agreement, the lenders may, among other things, accelerate the maturity of any amounts outstanding. The commitments of the lenders to make loans to us under the Amended Credit Agreement are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender's commitments under the Amended Credit Agreement.

As of February 28, 2026, the balance of outstanding letters of credit was $9.5 million, the amount available for revolving loans under the Amended Credit Agreement was $432.3 million and the amount available per the maximum Leverage Ratio was $91.1 million. Covenants in the Amended Credit Agreement limit the amount of total indebtedness we can incur. As of February 28, 2026, these covenants effectively limited our ability to incur more than $91.1 million of additional debt from all sources, including the Amended Credit Agreement. As of February 28, 2026, we were in compliance with all covenants as defined under the terms of the Amended Credit Agreement.

**Interest and Capitalized Interest**

During fiscal 2026 and 2025, we incurred interest costs totaling $57.7 million and $51.9 million, respectively, none of which was capitalized. During fiscal 2024, we incurred interest costs totaling $53.9 million, of which we capitalized $0.9 million, as part of property and equipment in connection with the construction of a new distribution facility.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following table contains information about interest rates and the related weighted average borrowings outstanding under our Amended Credit Agreement, including under the prior credit agreement, for the periods presented below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2026** | **2025** | **2025** | **2024** | **2024** |
| Amended Credit Agreement: |  |  |  |  |  |  |
| &nbsp;&nbsp;Average borrowings outstanding (1) | **$** | **876070** | $| 761245 | $| 806415 |
| &nbsp;&nbsp;Average effective interest rate (2) | **6.3%** | **6.3%** | 6.6% | 6.6% | 6.4% | 6.4% |
| &nbsp;&nbsp;Interest rate range (3) | &nbsp;&nbsp;**5.9% - 8.5%** | &nbsp;&nbsp;**5.9% - 8.5%** | &nbsp;&nbsp;5.9% - 9.3% | &nbsp;&nbsp;5.9% - 9.3% | &nbsp;&nbsp;6.5% - 9.3% | &nbsp;&nbsp;6.5% - 9.3% |
| &nbsp;&nbsp;Weighted average interest rate on borrowings outstanding at year end (4) | **5.7%** | **5.7%** | 5.6% | 5.6% | 6.0% | 6.0% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Average borrowings outstanding is computed as the average of the current and four prior quarters ending balances outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;(2)The average effective interest rate during each year is computed by dividing the total interest expense associated with the borrowing for a fiscal year by the average borrowings outstanding for the same fiscal year. We included the impact of our interest rate swaps and commitment fees incurred under the Amended Credit Agreement and prior credit agreement in computing total interest expense.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Interest rate range reflects the interest rates on the borrowings under the Amended Credit Agreement and prior credit agreement, pursuant to the respective agreements, and excludes the impact of our interest rate swaps.

&nbsp;&nbsp;&nbsp;&nbsp;(4)The weighted average interest rate on borrowings outstanding at year end under the Amended Credit Agreement is computed inclusive of the impact of our interest rate swaps.

**Note 14 - Fair Value**

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity's own assumptions.

When circumstances dictate the transfer of an asset or liability to a different level, we report the transfer at the beginning of the reporting period in which the facts and circumstances resulting in the transfer occurred. There were no transfers between the fair value hierarchy levels during the periods presented.

**Recurring Fair Value Measurements**

All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills and our contingent consideration liability, are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. Our investments in U.S. Treasury Bills are classified as Level 1 because their value is based on quoted prices in active markets for identical assets. Our contingent consideration liability is classified as Level 3 because its valuation is primarily based on a

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

significant input unobservable in the market, specifically, projected adjusted EBITDA derived from internal forecasts. The following table presents the fair value of our financial assets and liabilities:

---

| | | |
|:---|:---|:---|
| | **Fair Value** | **Fair Value** |
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash equivalents (money market accounts) | $**4189** | $3852 |
| &nbsp;&nbsp;U.S. Treasury Bills | **11175** | 11268 |
| &nbsp;&nbsp;&nbsp;Interest rate swaps | **381** | 1065 |
| &nbsp;&nbsp;&nbsp;Foreign currency derivatives | **375** | 2163 |
| Total assets | $**16120** | $18348 |
| Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate swaps | $**196** | $221 |
| &nbsp;&nbsp;Contingent consideration | **5400** | 4100 |
| &nbsp;&nbsp;&nbsp;Foreign currency derivatives | **2954** | 119 |
| Total liabilities | $**8550** | $4440 |

---

All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills, are measured and recorded at fair value on a recurring basis. Our investments in U.S. Treasury Bills are recorded at amortized cost. As of February 28, 2026 and February 28, 2025, the current carrying amounts of our U.S. Treasury Bills were $2.6 million and $2.5 million, respectively, and were included within prepaid expenses and other current assets in our consolidated balance sheets. As of February 28, 2026 and February 28, 2025, the non-current carrying amounts of our U.S. Treasury Bills were $8.5 million and $8.7 million, respectively, and were included within other assets in our consolidated balance sheets.

The carrying amounts of cash and cash equivalents, accounts payable, accrued expenses and other current liabilities and income taxes receivable and payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

As of both February 28, 2026 and February 28, 2025, gross unrealized gains on our investments in U.S. Treasury Bills were $0.1 million and losses were not material. During fiscal 2026 and 2025, we recognized interest income on these investments of $0.5 million and $0.3 million, respectively, which is included in "Non-operating income, net" in our consolidated statements of (loss) income.

We use foreign currency forward contracts to manage our exposure to changes in foreign currency exchange rates. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 1, 15 and 16 for more information on our derivatives.

In connection with the acquisition of Olive & June in December 2024, we recognized contingent consideration, as a result of the total purchase consideration including contingent cash consideration of up to $15.0 million payable annually in three equal installments subject to Olive & June achieving certain adjusted EBITDA targets during calendar years 2025, 2026 and 2027. If the annual adjusted EBITDA target is not met, no payment is required. This contingent consideration liability is remeasured at fair value each reporting period until the contingency is resolved, with changes in fair value recognized in SG&A. The fair value of the contingent consideration liability was determined using a Monte Carlo simulation model, which utilizes projected adjusted EBITDA and corresponding volatility and discount rates to estimate the probability of the adjusted EBITDA targets being achieved. The projected adjusted EBITDA during the earn-out period was derived from internal forecasts and represents a Level 3 input, and was discounted using an estimated discount rate of 13% as of both February 28, 2026 and February 28, 2025. Adjusted EBITDA volatility was calculated based upon peer companies, and the third quartile

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

of 41% and 33% was selected as a key input into the Monte Carlo simulation model as of February 28, 2026 and February 28, 2025, respectively. In the simulated scenarios where a payment is earned, the projected contingent payments were discounted using an estimated credit risk discount rate of 6.6% and 6.5% as of February 28, 2026 and February 28, 2025, respectively. Changes in these inputs may result in a significant increase or decrease in the fair value of the contingent consideration liability with a corresponding impact to SG&A.

**Level 3 Fair Value Measurements**

The following table presents the changes in our Level 3 contingent consideration liability:

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** |
| Balance at beginning of period | $**4100** | $— |
| &nbsp;&nbsp;Acquisition (1) | **—** | 4100 |
| &nbsp;&nbsp;Changes in fair value (2) | **1300** |  |
| Balance at end of period (3) | $**5400** | $4100 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)As of the acquisition date, we recorded a liability for the estimated fair value of the contingent consideration of $4.1 million.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Reflects an increase in the estimated fair value of our contingent consideration liability, which was recognized in SG&A during fiscal 2026, all of which related to our contingent consideration liability outstanding as of February 28, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;(3)As of February 28, 2026 and February 28, 2025, the estimated fair value of the contingent consideration liability was $5.4 million and $4.1 million, respectively, of which $5.3 million and $1.8 million was included within accrued expenses and other current liabilities, respectively, and $0.1 million and $2.3 million was included within other liabilities, non-current, respectively, in our consolidated balance sheet.

**Non-Recurring Fair Value Measurements**

Assets remeasured to fair value on a non-recurring basis during fiscal 2025 and 2026 represent goodwill, indefinite-lived intangible assets and definite-lived intangible assets, which were impaired. We did not remeasure any assets to fair value on a non-recurring basis during fiscal 2024.

The following tables present the remaining carrying value of the assets that were remeasured to fair value on a non-recurring basis:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements** | **Fair Value Measurements** | **Fair Value Measurements** | **Fiscal 2026 Asset Impairment Charges** |
| ***(in thousands)*** | **February 28, 2026** | **Level 1** | **Level 2** | **Level 3** | **Fiscal 2026 Asset Impairment Charges** |
| Goodwill | $**472281** | $**—** | $**—** | $**472281** | $**706505** |
| Indefinite-lived intangible assets | **264600** | **—** | **—** | **264600** | **97000** |
| Definite-lived intangible assets | **108250** | **—** | **—** | **108250** | **82356** |
| Total | $**845131** | $**—** | $**—** | $**845131** | $**885861** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements** | **Fair Value Measurements** | **Fair Value Measurements** | **Fiscal 2025 Asset Impairment Charges** |
| ***(in thousands)*** | **February 28, 2025** | **Level 1** | **Level 2** | **Level 3** | **Fiscal 2025 Asset Impairment Charges** |
| Goodwill | $1182899 | $— | $— | $1182899 | $38670 |
| Definite-lived trade names | 75335 |  |  | 75335 | 12785 |
| Total | $1258234 | $— | $— | $1258234 | $51455 |

---

During fiscal 2026, our impairment testing resulted in impairment charges of $706.5 million, $97.0 million and $82.4 million to reduce the carrying values of our goodwill, indefinite-lived intangible assets and definite-lived intangible assets, respectively, to their estimated fair values of $472.3 million, $264.6 million and $108.3 million, respectively.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

During fiscal 2025, our impairment testing resulted in asset impairment charges of 38.7 million and $12.8 million to reduce the Drybar reporting unit goodwill and definite-lived trade name, respectively, to fair values of $134.3 million and $7.0 million, respectively. Refer to Note 7 for additional information on the assets impaired and their remaining carrying values as of February 28, 2026 and February 28, 2025.

We estimate the fair value of our reporting units using an income approach based upon a projected future DCF Model. Under the DCF Model, the fair value of each reporting unit is determined based on the present value of estimated future cash flows, discounted at a risk-adjusted rate of return. We use internal forecasts and strategic long-term plans to estimate future cash flows, including net sales revenue, gross profit margin, and earnings before interest and taxes margins. Other key estimates used in the DCF Model include, but are not limited to, discount rates, statutory tax rates, terminal growth rates, as well as working capital and capital expenditures needs. The discount rates are based on a weighted-average cost of capital utilizing industry market data of our peer group companies. Accordingly, this fair value measurement is classified as Level 3 since it is based primarily upon unobservable inputs that reflect management's assumptions.

We estimate the fair value of our trade names and trademark licenses using the relief from royalty method income approach which is based upon a DCF Model. The relief-from-royalty method estimates the fair value of a trade name or trademark license by discounting the hypothetical avoided royalty payments to their present value over the economic life of the asset. We estimate the fair value of our customer relationships and list using the distributor method income approach which is based upon a DCF model. The distributor method used financial margin information for distributors within the applicable industry and most representative of the Company to estimate a royalty rate. The determination of fair value using these methods entails a significant number of estimates and assumptions, which require management judgment, and include net sales revenue growth rates, discount rates, royalty rates, residual growth rates (as applicable) and customer attrition rates (as applicable). We use internal forecasts and strategic long-term plans to estimate net sales revenue growth rates and royalty rates. We utilize a constant growth model to determine the residual growth rates which are based upon long-term industry growth expectations and long-term expected inflation. Accordingly, this fair value measurement is classified as Level 3 since it is based primarily upon unobservable inputs that reflect management's assumptions. The most significant unobservable input (Level 3) used to estimate the fair value of our intangible assets was royalty rates that ranged from 0.6% to 5.5% as of February 28, 2026 and a royalty rate of 1.6% as of February 28, 2025.

For additional information regarding the testing and analysis performed, refer to Note 7 and Item 7., "Management's Discussion and Analysis of Financial Condition and Results of Operations," including "Critical Accounting Policies and Estimates" included within this Annual Report.

**Note 15 - Financial Instruments and Risk Management**

**Foreign Currency Risk**

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar ("foreign currencies"). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, accounts receivable and accounts payable are denominated in foreign currencies. Approximately 15% of our net sales revenue was denominated in foreign currencies during fiscal 2026 and approximately 14% during both fiscal 2025 and 2024. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

In our consolidated statements of (loss) income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign income tax receivables and payables and deferred income tax assets and liabilities are recognized in income tax expense (benefit), and all other foreign currency exchange rate gains and losses are recognized in SG&A. We recorded in income tax expense (benefit) a foreign currency exchange rate net gain of $0.4 million during fiscal 2026, a net loss of $0.7 million during fiscal 2025 and a net gain of $0.3 million during fiscal 2024. We recorded in SG&A a foreign currency exchange rate net gain of $3.2 million during fiscal 2026 and net losses of $1.5 million and $0.5 million during fiscal 2025 and 2024, respectively. We mitigate certain foreign currency exchange rate risk by using forward contracts to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges ("foreign currency contracts"). Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts. These undesignated derivatives are used to hedge monetary net asset and liability positions. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. For additional information on our accounting for derivatives see Note 1.

**Interest Rate Risk**

Interest on our outstanding debt as of February 28, 2026 and February 28, 2025 is based on variable floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Amended Credit Agreement, which totaled $785.5 million and $921.9 million as of February 28, 2026 and February 28, 2025, respectively. As of February 28, 2026 and February 28, 2025, $325 million and $550 million of the outstanding principal balance under the Amended Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges, and we evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. For additional information on our accounting for derivatives see Note 1.

The following tables summarize the fair values of our derivative instruments at the end of fiscal 2026 and 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2026** | **February 28, 2026** | **February 28, 2026** | **February 28, 2026** | **February 28, 2026** | **February 28, 2026** |
| <br>**Derivatives designated as hedging instruments** | **Hedge<br>Type** | **Final<br>Settlement<br>Date** | **Notional Amount** | **Prepaid<br>Expenses<br>and Other<br>Current<br>Assets** | **Other<br>Assets** | **Accrued<br>Expenses<br>and Other<br>Current<br>Liabilities** | **Other**<br>**Liabilities,**<br>**Non-Current** |
| Forward contracts - sell Euro | **Cash flow** | **11/2027** | **67000** | $**149** | $**137** | $**1239** | $**—** |
| Forward contracts - sell Canadian Dollars | **Cash flow** | **10/2027** | $**29600** | **23** | **8** | **330** | **—** |
| Forward contracts - sell Pounds | **Cash flow** | **12/2027** | £**32000** | **—** | **33** | **1174** | **42** |
| Forward contracts - sell Norwegian Kroner | **Cash flow** | **2/2027** | **30000** | **—** | **—** | **156** | **—** |
| Interest rate swaps (1) | **Cash flow** | **8/2027** | $**425000** | **381** | **—** | **130** | **66** |
| &nbsp;&nbsp;&nbsp;Subtotal |  |  |  | **553** | **178** | **3029** | **108** |
| **Derivatives not designated under hedge accounting** |  |  |  |  |  |  |  |
| Forward contracts - sell Euro | **(2)** | **3/2026** | **6764** | **25** | **—** | **—** | **—** |
| Forward contracts - buy Pounds | **(2)** | **3/2026** | £**787** | **—** | **—** | **13** | **—** |
| &nbsp;&nbsp;&nbsp;Subtotal |  |  |  | **25** | **—** | **13** | **—** |
| Total fair value |  |  |  | $**578** | $**178** | $**3042** | $**108** |

---

&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2025** | **February 28, 2025** | **February 28, 2025** | **February 28, 2025** | **February 28, 2025** | **February 28, 2025** | **February 28, 2025** |
| <br>**Derivatives designated as hedging instruments** | **Hedge<br>Type** | **Final<br>Settlement Date** | **Notional Amount** | **Prepaid<br>Expenses<br>and Other<br>Current<br>Assets** | **Other<br>Assets** | **Accrued<br>Expenses<br>and Other<br>Current<br>Liabilities** | **Other**<br>**Liabilities,**<br>**Non-Current** |
| Forward contracts - sell Euro | Cash flow | 2/2026 | 35000 | $1266 | $— | $— | $— |
| Forward contracts - sell Canadian Dollars | Cash flow | 2/2026 | $8000 | 38 |  |  |  |
| Forward contracts - sell Pounds | Cash flow | 2/2026 | £24950 | 788 |  | 99 |  |
| Forward contracts - sell Norwegian Kroner | Cash flow | 8/2025 | 10000 | 71 |  |  |  |
| Interest rate swaps | Cash flow | 8/2026 | $550000 | 763 | 302 | 221 |  |
| &nbsp;&nbsp;&nbsp;Subtotal |  |  |  | 2926 | 302 | 320 |  |
| **Derivatives not designated under hedge accounting** |  |  |  |  |  |  |  |
| Forward contracts - sell Euro | (2) | 3/2025 | 680 |  |  | 2 |  |
| Forward contracts - sell Pounds | (2) | 3/2025 | £1280 |  |  | 18 |  |
| &nbsp;&nbsp;&nbsp;Subtotal |  |  |  |  |  | 20 |  |
| Total fair value |  |  |  | $2926 | $302 | $340 | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes a forward-starting interest rate swap agreement effective March 1, 2026 with a notional amount of $100 million.

&nbsp;&nbsp;&nbsp;&nbsp;(2)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.

The pre-tax effects of derivative instruments designated as cash flow hedges for fiscal 2026 and 2025 were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| | **Gain (Loss)** <br>**Recognized in AOCI**  | **Gain (Loss)** <br>**Recognized in AOCI**  | **Gain (Loss) Reclassified<br>from AOCI into Income** | **Gain (Loss) Reclassified<br>from AOCI into Income** | **Gain (Loss) Reclassified<br>from AOCI into Income** |
| ***(in thousands)*** | **2026** | **2025** | **Location** | **2026** | **2025** |
| Foreign currency contracts - cash flow hedges | $**(11492)** | $3294 | Sales revenue, net | $**(6837)** | $1441 |
| Interest rate swaps - cash flow hedges | **2289** | 2401 | Interest expense | **2948** | 4061 |
| Total | $**(9203)** | $5695 |  | $**(3889)** | $5502 |

---

The pre-tax effects of derivative instruments not designated under hedge accounting for fiscal 2026 and 2025 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| | **Gain (Loss) <br>Recognized in Income** | **Gain (Loss) <br>Recognized in Income** | **Gain (Loss) <br>Recognized in Income** |
| ***(in thousands)*** | **Location** | **2026** | **2025** |
| Forward contracts | SG&A | $**(645)** | $76 |
| Total |  | $**(645)** | $76 |

---

We expect a net loss of $2.5 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 1, 14 and 16 for more information.

**Counterparty Credit Risk**

Financial instruments, including foreign currency contracts, forward contracts and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Note 16 - Accumulated Other Comprehensive Income (Loss)**

The changes in AOCI by component and related tax effects for fiscal 2026 and 2025 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| ***(in thousands)*** | **Interest<br>Rate Swaps** | **Foreign<br>Currency<br>Contracts** | **Total** |
| Balance at February 29, 2024 | $1917 | $182 | $2099 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income before reclassification | 2401 | 3294 | 5695 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified out of AOCI | (4061) | (1441) | (5502) |
| &nbsp;&nbsp;&nbsp;Tax effects | 389 | (403) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income | (1271) | 1450 | 179 |
| Balance at February 28, 2025 | $646 | $1632 | $2278 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassification | **2289** | **(11492)** | **(9203)** |
| &nbsp;&nbsp;&nbsp;Amounts reclassified out of AOCI | **(2948)** | **6837** | **3889** |
| &nbsp;&nbsp;&nbsp;Tax effects | **154** | **1005** | **1159** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss | **(505)** | **(3650)** | **(4155)** |
| Balance at February 28, 2026 | $**141** | $**(2018)** | $**(1877)** |

---

See Notes 1, 14 and 15 for additional information regarding our cash flow hedges.

**Note 17 - Segment and Geographic Information**

**Segment Information**

We operate through two strategic business divisions, each comprised of operating segments organized by our brands and product lines. Operating segments with similar economic and qualitative characteristics are aggregated into our two reportable segments, which align with our strategic business divisions. Our two reportable segments consist of Home & Outdoor and Beauty & Wellness. The Olive & June brand and products were added to the Beauty & Wellness segment upon the completion of the acquisition. For additional information on our segments refer to Note 1 and Item 1., "Business," included within this Annual Report.

Segment financial information is prepared in accordance with GAAP and our significant accounting policies described in Note 1. Resources are allocated and performance is assessed using segment operating income by our Chief Executive Officer, whom we have determined to be our Chief Operating Decision Maker ("CODM"). Our CODM utilizes segment operating income when making decisions about allocating capital and personnel to the segments, predominantly in the annual budget and quarterly forecasting processes. In addition, our CODM uses operating income, including comparison of actual results to budget and forecast, in assessing the performance of each segment and in evaluating product pricing, distribution strategies and marketing investments. Our CODM reviews balance sheet information at a consolidated level. We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, asset impairment charges and restructuring charges. The SG&A used to compute each segment's operating income is directly associated with the segment, plus shared services and corporate overhead expenses that are allocable to the segment. We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following tables summarize reportable segment information with a reconciliation to our consolidated results for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & <br>Wellness (1)** | **Total** |
| Sales revenue, net | $**832870** | $**953420** | $**1786290** |
| Less: (2) |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | **428182** | **542414** | **970596** |
| &nbsp;&nbsp;Operating expense (3) | **674432** | **923343** | **1597775** |
| Operating loss | $**(269744)** | $**(512337)** | $**(782081)** |
| &nbsp;&nbsp;Non-operating income, net |  |  | **982** |
| &nbsp;&nbsp;Interest expense |  |  | **57739** |
| Loss before income tax |  |  | $**(838838)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & <br>Wellness (1)** | **Total** |
| Sales revenue, net | $906331 | $1001334 | $1907665 |
| Less: (2) |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | 431924 | 561335 | 993259 |
| &nbsp;&nbsp;Operating expense (3) | 354806 | 416852 | 771658 |
| Operating income | $119601 | $23147 | $142748 |
| &nbsp;&nbsp;Non-operating income, net |  |  | 838 |
| &nbsp;&nbsp;Interest expense |  |  | 51922 |
| Income before income tax |  |  | $91664 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 29, 2024** | **Fiscal Year Ended February 29, 2024** | **Fiscal Year Ended February 29, 2024** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & Wellness** | **Total** |
| Sales revenue, net | $916381 | $1088669 | $2005050 |
| Less: (2) |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | 440737 | 615653 | 1056390 |
| &nbsp;&nbsp;Operating expense (3) | 332912 | 355159 | 688071 |
| Operating income | $142732 | $117857 | $260589 |
| &nbsp;&nbsp;Non-operating income, net |  |  | 1518 |
| &nbsp;&nbsp;Interest expense |  |  | 53065 |
| Income before income tax |  |  | $209042 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Fiscal 2026 includes a full year of operating results from Olive & June, acquired on December 16, 2024, compared to approximately eleven weeks of operating results in fiscal 2025. For additional information see Note 6.

&nbsp;&nbsp;&nbsp;&nbsp;(2)These significant expense categories and amounts align with the reportable segment information that is regularly provided to the CODM.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Operating expense for both reportable segments includes SG&A expense and restructuring charges. Fiscal 2026 operating expense also includes asset impairment charges of $885.9 million, of which $332.6 million and $553.3 million was recognized in our Home & Outdoor and Beauty & Wellness segments, respectively. Fiscal 2025 operating expense also includes asset impairment charges of $51.5 million in our Beauty & Wellness segment. See Note 7 for further information on the asset impairment charges.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

The following tables summarize reportable segment information for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & <br>Wellness (1)** | **Total** |
| Capital and intangible asset expenditures | $**18089** | $**21137** | $**39226** |
| Depreciation and amortization | **24597** | **28698** | **53295** |
| Non-cash share-based compensation | **6781** | **10104** | **16885** |
| Asset impairment charges | **332565** | **553296** | **885861** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** | **Fiscal Year Ended February 28, 2025** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & <br>Wellness (1)** | **Total** |
| Capital and intangible asset expenditures | $14275 | $15797 | $30072 |
| Depreciation and amortization | 26088 | 28960 | 55048 |
| Non-cash share-based compensation | 10402 | 10974 | 21376 |
| Asset impairment charges |  | 51455 | 51455 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Year Ended February 29, 2024** | **Fiscal Year Ended February 29, 2024** | **Fiscal Year Ended February 29, 2024** |
| ***(in thousands)*** | **Home & Outdoor** | **Beauty & Wellness** | **Total** |
| Capital and intangible asset expenditures | $28012 | $8632 | $36644 |
| Depreciation and amortization | 24595 | 26904 | 51499 |
| Non-cash share-based compensation | 16319 | 17553 | 33872 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Fiscal 2026 includes a full year of operating results from Olive & June, acquired on December 16, 2024, compared to approximately eleven weeks of operating results in fiscal 2025. For additional information see Note 6.

**Geographic Information**

The following table presents net sales revenue by geographic region, in U.S. Dollars. Net sales are attributed to countries based on the customer's location.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2026** | **2025** | **2025** | **2024** | **2024** |
| U.S. | $**1278045** | 71.5% | $1356750 | 71.1% | $1478134 | 73.7% |
| Canada | **74004** | 4.2% | 82501 | 4.3% | 82122 | 4.1% |
| EMEA | **293260** | 16.4% | 294954 | 15.5% | 284434 | 14.2% |
| Asia Pacific | **107112** | 6.0% | 125426 | 6.6% | 116157 | 5.8% |
| Latin America | **33869** | 1.9% | 48034 | 2.5% | 44203 | 2.2% |
| Total sales revenue, net | $**1786290** | 100.0% | $1907665 | 100.0% | $2005050 | 100.0% |

---

Worldwide sales to our largest customer, Amazon.com Inc., accounted for approximately 20%, 22% and 21% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively. Sales to our second largest customer, Walmart, Inc., including its worldwide affiliates, accounted for approximately 13%, 11% and 9% of our consolidated net sales revenue in fiscal 2026, 2025, and 2024, respectively. Sales to our third largest customer, Target Corporation, accounted for approximately 12%, 11% and 10% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively. Sales to these largest customers include sales across both of our business segments. No other customers accounted for 10% or more of consolidated net sales revenue during these fiscal years. Sales to our top five customers accounted for approximately 50%, 49% and 47% of our consolidated net sales revenue in fiscal 2026, 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Our U.S. and international long-lived assets were as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| U.S. | $**331517** | $342033 |
| International | **25875** | 23059 |
| Total | $**357392** | $365092 |

---

The table above classifies assets based upon the country where they are physically located. Long-lived assets included in the table above include property and equipment and operating lease assets.

**Note 18 - Income Taxes**

We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a significant portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intangible assets are primarily owned by foreign affiliates, resulting in proportionally higher earnings in jurisdictions with statutory tax rates lower than the U.S. Taxable income in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results as well as applicable transfer pricing and tax regulations.

In July 2025, a reconciliation bill, commonly referred to as the One Big Beautiful Bill Act, was signed into law. The legislation includes a broad range of U.S. tax reform provisions. There were no discrete effects upon enactment in the second quarter of fiscal 2026 or material impacts on our fiscal 2026 consolidated financial statements. This legislation is not expected to have a material impact on our consolidated financial statements in the foreseeable future.

The Organisation for Economic Co-operation and Development ("OECD") has introduced a framework to implement a global minimum corporate income tax of 15%, referred to as "Pillar Two." Certain countries in which we operate have enacted, or are in the process of enacting, domestic legislation aligned with OECD's Pillar Two "Model Rules." Pillar Two legislation in effect for our fiscal 2025 and 2026 has been incorporated into our consolidated financial statements. Differences in how Pillar Two rules are implemented and administered across jurisdictions may increase compliance complexity and could impact our future global effective tax rate.

In June 2025, the Group of Seven, comprised of Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S., announced an agreement under which U.S. multinational companies would be excluded from certain elements of the Pillar Two global minimum tax framework in exchange for the U.S. withdrawing planned retaliatory tax measures. In January 2026, the OECD released administrative guidance detailing a side-by-side ("SbS") package that reflects this agreement and establishes a framework permitting U.S. multinational enterprise groups to coexist with the Pillar Two rules. Under this guidance, U.S. parented groups may qualify for the Side by Side Safe Harbour and the Ultimate Parent Entity Safe Harbour, which can eliminate top-up taxes under the Income Inclusion Rule and the Undertaxed Profits Rule when elected, while leaving Qualified Domestic Minimum Top-up Taxes unaffected.

The SbS package also includes additional administrative guidance, such as a permanent simplified effective tax rate safe harbour, an extension of the transitional country by country reporting safe harbour and a new substance-based tax incentive safe harbour. We do not expect the SbS package to materially affect our Pillar Two related tax positions or liabilities going forward. We will continue to monitor the implications of the OECD guidance and domestic adoption as jurisdictions implement these rules.

In response to Pillar Two, on May 24, 2024, Barbados enacted a domestic corporate income tax rate of 9%, effective for our fiscal 2025 and a domestic minimum top-up tax ("DMTT") of 15% which was effective beginning with our fiscal 2026. During the first quarter of fiscal 2025, we incorporated the corporate income tax into our estimated annual effective tax rate and revalued our existing deferred tax

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

liabilities subject to the Barbados legislation, which resulted in a discrete tax charge of $6.0 million. However, as a result of the reorganization of our intangible assets in the fourth quarter of 2025 described below, the Barbados corporate income tax and DMTT did not have a material impact on our consolidated financial statements in fiscal 2026 and is not expected to in the foreseeable future.

Like Barbados, the government of Bermuda enacted a 15% corporate income tax that was effective for us beginning in fiscal 2026. The Bermuda corporate income tax allows for a beginning net operating loss balance related to the five years preceding the effective date. Accordingly, during fiscal 2024, we recorded a deferred tax asset of $9.3 million for the Bermuda net operating losses generated from fiscal 2021 through 2024 with an offsetting valuation allowance of $9.3 million. This Bermuda tax did not have a material impact on our consolidated financial statements in fiscal 2026 and is not expected to in the foreseeable future.

In the fourth quarter of fiscal 2025, we implemented a reorganization involving the transfer of intangible assets previously held by Helen of Troy Limited (Barbados) to our subsidiary in Switzerland. The reorganization resulted in the consolidation of the ownership of intangible assets, supporting streamlined internal licensing and centralized management of the intangible assets. Further, the reorganization resulted in a transitional income tax benefit of $64.6 million from the recognition of deferred tax assets of $74.0 million, partially offset by taxes associated with the transfer. As described below, a full valuation allowance was recorded on these deferred tax assets as of the end of the third quarter of fiscal 2026.

During fiscal 2026 and 2025, we recognized goodwill and other intangible asset impairment charges of $885.9 million and $51.5 million, respectively, which included $602.2 million and $22.5 million, respectively, that will not result in a tax benefit. Tax benefits, net of valuation allowances, of $19.8 million and $3.9 million on the impairment charges were recognized in fiscal 2026 and 2025, respectively.

The downward revisions to our internal forecasts utilized in our impairment testing during fiscal 2026 negatively impacted our assessment of the realizability of net deferred tax assets for our Switzerland subsidiary as of the beginning of the fiscal year and deferred tax assets generated by intangible asset impairments during fiscal 2026. Based on these revisions and in accordance with ASC 740, *Income Taxes*, we recorded discrete partial valuation allowances during the first and second quarters of fiscal 2026. As fiscal 2026 progressed, impairment-related losses resulted in a cumulative loss position over recent periods, which constituted significant objective negative evidence under ASC 740 and ultimately led to the recording of a full valuation allowance beginning in the third quarter of fiscal 2026. As a result, we recognized a cumulative valuation allowance of $106.6 million during fiscal 2026. We expect to maintain a full valuation allowance on these net deferred tax assets until we have objective factors that demonstrate the likelihood of realizing these deferred tax benefits.

The Company continues to elect to account for U.S. tax on global intangible low-taxed income ("GILTI") as a period cost and therefore has not recorded deferred taxes related to GILTI on its foreign subsidiaries.

We consider the undistributed earnings of our foreign subsidiaries to be indefinitely reinvested; accordingly, no taxes have been recognized on such earnings. We continue to evaluate our plans for reinvestment or repatriation of unremitted foreign earnings. If we determine that all or a portion of our foreign earnings are no longer indefinitely reinvested, we may be subject to additional foreign withholding taxes and U.S. income taxes. Due to the number of legal entities and jurisdictions involved, our legal entity structure, and the tax laws in the relevant jurisdictions, we believe it is not practicable to estimate the amount of additional taxes which may be payable upon distribution of these undistributed earnings.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Our components of (loss) income before income tax were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| U.S. | $**(341573)** | $19827 | $68957 |
| Non-U.S. | **(497265)** | 71837 | 140085 |
| Total | $**(838838)** | $91664 | $209042 |

---

Our components of income tax expense (benefit) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| Current: |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. federal | $**14263** | $9570 | $9259 |
| &nbsp;&nbsp;&nbsp;State | **3880** | 5046 | 2704 |
| &nbsp;&nbsp;&nbsp;Non-U.S. | **3992** | 29279 | 15275 |
|  | **22135** | 43895 | 27238 |
| Deferred: |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. federal | **(15584)** | (2287) | 9449 |
| &nbsp;&nbsp;&nbsp;State | **(3539)** | 614 | 3252 |
| &nbsp;&nbsp;&nbsp;Non-U.S. | **57132** | (74309) | 509 |
|  | **38009** | (75982) | 13210 |
| Total | $**60144** | $(32087) | $40448 |

---

Our total income tax expense (benefit) differs from the amounts computed by applying the U.S. statutory tax rate to income (loss) before income taxes. Although we are domiciled in Bermuda and now subject to a 15% corporate income tax rate, the parent entity generates losses and maintains a full valuation allowance against its deferred tax assets. As a result, we use the U.S. federal statutory rate of 21% as the starting point for our rate reconciliation, in accordance with ASC 740, *Income Taxes*, and the judgment framework outlined therein. This presentation is consistent with our historical practice and is intended to enhance comparability with other publicly traded multinational entities.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We have adopted ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, on a prospective basis. Our income tax rate reconciliation for fiscal 2026 was as follows:

---

| | | |
|:---|:---|:---|
| | **Fiscal Year Ended February 28, 2026** | **Fiscal Year Ended February 28, 2026** |
| | **(in thousands)** | **Percent** |
| Tax at U.S. federal statutory tax rate | $**(176156)** | **21.0%** |
| State and local income taxes, net of federal income tax effect (1) | **411** | **— %** |
| Foreign tax effects: |  |  |
| &nbsp;&nbsp;Switzerland |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Statutory tax rate difference | **47502** | **(5.7)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Cantonal and local taxes (2) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vaud changes in valuation allowances | **42030** | **(5.0)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vaud asset impairment | **10124** | **(1.2)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vaud taxes and other | **(28901)** | **3.4%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in valuation allowances | **64603** | **(7.7)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairment | **15561** | **(1.9)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | **(6892)** | **0.8%** |
| &nbsp;&nbsp;United Kingdom |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairment | **26984** | **(3.2)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | **(5639)** | **0.7%** |
| &nbsp;&nbsp;Other foreign jurisdictions | **2707** | **(0.3)%** |
| Effect of cross-border tax laws | **1437** | **(0.2)%** |
| Nontaxable or nondeductible items: |  |  |
| &nbsp;&nbsp;Asset impairment | **63732** | **(7.6)%** |
| &nbsp;&nbsp;Other | **4071** | **(0.5)%** |
| Changes in unrecognized tax benefits | **(2529)** | **0.3%** |
| Other items | **1099** | **(0.1)%** |
| Effective income tax rate | $**60144** | **(7.2)%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)State taxes in Mississippi and Texas made up the majority of the tax effect in this category.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Cantonal taxes in Vaud made up the majority of the tax effect in this category.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

Our income tax rate reconciliations for prior periods have not been adjusted and continue to reflect the presentation requirements in effect before the adoption of ASU 2023-09.

---

| | | |
|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| | **2025** | **2024** |
| Effective income tax rate at the U.S. statutory rate | 21.0% | 21.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of U.S. state income taxes | 5.6% | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of statutory tax rate in Macau | (3.5)% | (4.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of statutory tax rate in Barbados | (1.6)% | (2.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of statutory tax rate in Switzerland | (0.3)% | (1.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of income from other non-U.S. operations subject to varying rates | 2.4% | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of foreign exchange fluctuations | 3.2% | (0.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of stock compensation | 2.3% | 1.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of uncertain tax positions | (7.7)% | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of non-deductible executive compensation | 1.5% | 1.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of intangible asset reorganization | (70.5)% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of asset impairment | 2.2% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in valuation allowance | 2.5% | 3.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of base erosion and anti-abuse tax | 0.9% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in tax rates | 6.8% | (4.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other items | 0.2% | (0.7)% |
| Effective income tax rate | (35.0)% | 19.3% |

---

Each year there are significant transactions or events that are incidental to our core businesses and by a combination of their nature and jurisdiction, can have a disproportionate impact on our reported effective tax rates. Without these transactions or events, the trend in our effective tax rates would follow a more normalized pattern.

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities were as follows:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **February 28, 2026** | **February 28, 2025** |
| Deferred tax assets, gross: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating loss carryforwards and tax credits | $**46700** | $22436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **6650** | 5976 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **17264** | 18373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | **13913** | 10448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenditures | **3901** | 4911 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest limitation | **15904** | 13616 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other | **7403** | 5613 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | **55705** | 14033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total gross deferred tax assets | **167440** | 95406 |
| Valuation allowance | **(129240)** | (21374) |
| Deferred tax liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets | **(11446)** | (7844) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | **(25229)** | (27811) |
| Total deferred tax assets, net | $**1525** | $38377 |

---

In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. We consider the scheduled reversal of deferred tax liabilities, expected future taxable income and tax planning strategies in assessing the ultimate realization of deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not be recoverable. In fiscal 2026, the $107.9 million increase in our valuation allowance was principally due to deferred tax assets in Switzerland, most of which were generated as part of the intangible asset

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

reorganization in fiscal 2025 and intangible asset impairment charges recognized in fiscal 2026, that were determined to be non-realizable.

The composition of our operating loss carryforwards and tax credits at the end of fiscal 2026 was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | | **February 28, 2026** | **February 28, 2026** |
| ***(in thousands)*** |<br>**Tax Year<br> Expiration<br>Date Range** | **Deferred<br>Tax<br>Assets** | **Operating<br>Loss<br>Carryforward** |
| U.S. state operating loss carryforwards | **2036-2047** | $**2156** | $**43850** |
| Non-U.S. operating loss carryforwards with definite carryover periods | **2028-2046** | **24344** | **183569** |
| Non-U.S. operating loss carryforwards with indefinite carryover periods | **Indefinite** | **20200** | **115628** |
| &nbsp;&nbsp;Subtotal |  | **46700** | $**343047** |
| Less portion of valuation allowance established for operating loss carryforwards |  | **(43895)** |  |
| Total operating loss carryforwards, net of valuation allowance |  | $**2805** |  |

---

Any future amount of deferred tax asset considered realizable could be reduced in the near term if estimates of future taxable income during any carryforward periods are reduced.

During fiscal 2026, 2025 and 2024, changes in the total amount of unrecognized tax benefits (excluding interest and penalties) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| Total unrecognized tax benefits, beginning balance | $**605** | $6824 | $6018 |
| &nbsp;&nbsp;&nbsp;Tax positions taken during the current period | **—** | 894 | 806 |
| &nbsp;&nbsp;&nbsp;Tax positions taken during the prior period | **184** |  |  |
| &nbsp;&nbsp;&nbsp;Lapse in statute of limitations | **(605)** |  |  |
| &nbsp;&nbsp;&nbsp;Settlements | **—** | (7113) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total unrecognized tax benefits, ending balance | **184** | 605 | 6824 |
| &nbsp;&nbsp;&nbsp;Less current unrecognized tax benefits | **—** |  |  |
| Non-current unrecognized tax benefits | $**184** | $605 | $6824 |

---

During fiscal 2026, the amount of unrecognized tax benefits decreased by $0.4 million primarily due to lapses in statutes of limitations. If we are able to sustain our positions with the relevant taxing authorities, approximately $0.2 million (excluding interest and penalties) of uncertain tax position liabilities as of February 28, 2026 would favorably impact our effective tax rate in future periods.

We classify interest and penalties on uncertain tax positions as income tax expense. At the end of fiscal 2026 and 2025, the liability for tax-related interest and penalties associated with unrecognized tax benefits was $0.1 million and $2.2 million, respectively. Additionally, during fiscal 2026, 2025 and 2024, we recognized tax benefits of $2.1 million, $1.0 million and a de minimis amount of tax expense, respectively, from tax-related interest and penalties in the consolidated statements of (loss) income.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

We file income tax returns in the U.S. federal jurisdiction and in various states and foreign jurisdictions. As of February 28, 2026, tax years under examination or still subject to examination by material tax jurisdictions were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Jurisdiction** | **Tax Years Under Examination** | **Open Tax Years** | **Open Tax Years** |
| Barbados | **- None -** | **2021** | **2026** |
| China | **2009-2018** | **2009** | **2026** |
| Macao | **- None -** | **2021** | **2026** |
| Switzerland | **- None -** | **2021** | **2026** |
| United Kingdom | **- None -** | **2025** | **2026** |
| U.S. | **- None -** | **2022** | **2026** |

---

Following the adoption of ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, our cash income taxes paid, net of refunds, were as follows:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Fiscal Year Ended February 28, 2026** |
| &nbsp;&nbsp;U.S. Federal | $**14817** |
| &nbsp;&nbsp;Other | **2648** |
| Total U.S. | **17465** |
| &nbsp;&nbsp;Hong Kong | **(2962)** |
| &nbsp;&nbsp;Macao | **6152** |
| &nbsp;&nbsp;United Kingdom | **2707** |
| &nbsp;&nbsp;Other | **3163** |
| Total Non-U.S. | $**9060** |
| Total | $**26525** |

---

**Note 19 - Earnings Per Share**

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock-based awards (see Note 8). Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method.

The following table presents our weighted average basic and diluted shares outstanding for the periods shown:

---

| | | | |
|:---|:---|:---|:---|
| | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** | **Fiscal Years Ended Last Day of February,** |
| ***(in thousands)*** | **2026** | **2025** | **2024** |
| Weighted average shares outstanding, basic | **23002** | 23012 | 23865 |
| Incremental shares from share-based compensation arrangements | **—** | 53 | 105 |
| Weighted average shares outstanding, diluted (1) | **23002** | 23065 | 23970 |
| Anti-dilutive securities | **378** | 131 | 44 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Due to the net loss for fiscal 2026, 97 thousand incremental shares from share-based compensation arrangements were excluded from the computation of diluted weighted average shares outstanding because their effect would be anti-dilutive.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**HELEN OF TROY LIMITED AND SUBSIDIARIES**

**Schedule II - Valuation and Qualifying Accounts**

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in thousands)*** | **Beginning Balance** | **Additions (1)** | **Deductions (2)** | **Ending Balance** |
| Allowance for credit losses: |  |  |  |  |
| &nbsp;&nbsp;Year Ended February 28, 2026 | $**4294** | $**634** | $**5** | $**4923** |
| &nbsp;&nbsp;Year Ended February 28, 2025 | $7481 | $(143) | $3044 | $4294 |
| &nbsp;&nbsp;Year Ended February 29, 2024 | $1678 | $6103 | $300 | $7481 |
| Deferred tax asset valuation allowance: |  |  |  |  |
| &nbsp;&nbsp;Year Ended February 28, 2026 | $**21374** | $**107866** | $**—** | $**129240** |
| &nbsp;&nbsp;Year Ended February 28, 2025 | $19044 | $2330 | $— | $21374 |
| &nbsp;&nbsp;Year Ended February 29, 2024 | $10706 | $8338 | $— | $19044 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1)Additions to the allowance for credit losses represent periodic net charges to the allowance, inclusive of any recoveries of receivables previously written off. The addition to the allowance for credit losses in fiscal 2024, includes a charge for uncollectible receivables due to the bankruptcy of Bed, Bath & Beyond. In fiscal 2026, the addition to the deferred tax asset valuation allowance was primarily due to downward revisions to our internal forecasts utilized in our impairment testing during fiscal 2026 impacting the realizability of net deferred tax assets recorded in connection with the Company's intangible asset reorganization in fiscal 2025 and intangible asset impairment charges recognized in fiscal 2026. In fiscal 2025, the addition to the deferred tax asset valuation allowance was principally due to changes in the value of operating loss carryforwards not expected to be used in future years. In fiscal 2024, the addition to the deferred tax asset valuation allowance was primarily due to net operating loss carryforwards recorded in fiscal 2024 as a result of the Bermuda corporate income tax enactment that are not expected to be recoverable, partially offset by changes in estimates of the recoverability of deferred tax assets.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Deductions to the allowance for credit losses represent uncollectible balances written off. The deduction to the allowance for credit losses in fiscal 2025 was primarily due to the write-off of uncollectible Bed, Bath & Beyond balances.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure**

Not applicable.

**Item 9A. Controls and Procedures**

Based on their evaluation, as of the end of the period covered by this Annual Report on Form 10-K, our Company's Chief Executive Officer and Chief Financial Officer have concluded that our Company's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) are effective at the reasonable assurance level. During our fiscal quarter ended February 28, 2026, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Management's Report and Attestation Report on Internal Control Over Financial Reporting**

Management's report on internal control over financial reporting and the attestation report on internal control over financial reporting of the independent registered public accounting firm required by this item are set forth under Item 8., "Financial Statements and Supplementary Data" of this Annual Report and are incorporated herein by reference.

**Item 9B. Other Information**

**Rule 10b5-1 Trading Plans**

During the fiscal quarter ended February 28, 2026, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."

**Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections**

Not applicable.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**PART III**

**Item 10. Directors, Executive Officers and Corporate Governance**

Information in our definitive Proxy Statement for the 2026 Annual General Meeting of Shareholders (the "Proxy Statement") is incorporated by reference in response to this Item 10, as noted below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about our Directors who are standing for re-election is set forth under "Proposal 1: Election of Directors";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about our executive officers is set forth under "Executive Officers";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about our Audit Committee, including members of the committee, and our designated "audit committee financial experts" is set forth under "Board Committees and Meetings - Audit Committee";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about Section 16(a) beneficial ownership reporting compliance is set forth under "Delinquent Section 16(a) Reports" (if any to disclose);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about any material changes to procedures for recommending nominees to the board of directors is set forth under "Board Composition and Structure" and "Shareholder Proposals"; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• information about our insider trading policies and procedures is set forth under "Prohibition on Pledging and Hedging and Restrictions on Other Transactions Involving Common Stock."

We have adopted a Code of Ethics governing our Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, and finance department members. The full text of our Code of Ethics is published on our website, at www.helenoftroy.com, under the "Investor Relations-Governance" caption. The information on our website is not part of this Annual Report. We intend to disclose future amendments to, or waivers from, certain provisions of this Code of Ethics on our website or in a current report on Form 8-K.

**Item 11. Executive Compensation**

Information set forth under the captions "Director Compensation"; "Executive Compensation Tables"; "Equity Award Grant Practices"; "Compensation Discussion & Analysis"; "CEO Pay Ratio for Fiscal Year 2026"; "Compensation Committee Interlocks and Insider Participation"; and "Compensation Committee Report" in our Proxy Statement is incorporated by reference in response to this Item 11.

**Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**

Information set forth under the captions "Equity Compensation Plan Information" and "Security Ownership of Certain Beneficial Owners and Management" in our Proxy Statement is incorporated by reference in response to this Item 12.

**Item 13. Certain Relationships and Related Transactions, and Director Independence**

Information set forth under the captions "Certain Relationships - Related Person Transactions" and "Board Independence" in our Proxy Statement is incorporated by reference in response to this Item 13.

**Item 14. Principal Accountant Fees and Services**

Information set forth under the caption "Audit and Other Fees Paid to our Independent Registered Public Accounting Firm" and "Pre-Approval Policies and Procedures" in our Proxy Statement is incorporated by reference in response to this Item 14.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**PART IV**

**Item 15. Exhibits and Financial Statement Schedules**

---

| | |
|:---|:---|
| (a) | 1. Financial Statements: See "Index to Consolidated Financial Statements" under Item 8 in this Annual Report. |
| | 2. Financial Statement Schedule: See "Schedule II" in this Annual Report. |
| | 3. Exhibits |

---

The exhibit numbers succeeded by an asterisk (\*) indicate exhibits filed herewith. The exhibit numbers succeeded by two asterisks (\*\*) indicate exhibits furnished herewith that are not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability. All other exhibit numbers indicate exhibits filed by incorporation by reference. Exhibit numbers succeeded by a cross (†) are management contracts or compensatory plans or arrangements.

---

| | |
|:---|:---|
| 2.1 | <u>[Agreement and Plan of Merger dated as of December 8, 2010, among Helen of Troy Texas Corporation, KI Acquisition Corp., Kaz, Inc., the Company, and the Kaz, Inc. shareholders party thereto (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 9, 2010).](https://www.sec.gov/Archives/edgar/data/916789/000095012310112279/d78273exv2w1.htm)</u> |
| 3.1 | Memorandum of Association (incorporated by reference to Exhibit 3.1 to the Company's Registration Statement on Form S-4, File No. 33-73594, filed with the Securities and Exchange Commission on December 30, 1993). |
| 3.2 | <u>[Amended and Restated Bye-Laws (incorporated by reference to Appendix A to the Company](https://www.sec.gov/Archives/edgar/data/916789/000110465916129545/a16-10153_1def14a.htm#APPENDIXA_010354)['](https://www.sec.gov/Archives/edgar/data/916789/000110465916129545/a16-10153_1def14a.htm#APPENDIXA_010354)[s Definitive Proxy Statement on Schedule 14A, File No. 001-14669, filed with the Securities and Exchange Commission on June 27, 2016).](https://www.sec.gov/Archives/edgar/data/916789/000110465916129545/a16-10153_1def14a.htm#APPENDIXA_010354)</u> |
| 4.1 | <u>[Description of the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678920000024/fy20q410kexhibit41-1.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678920000024/fy20q410kexhibit41-1.htm)[s Securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934 (incorporated by reference to Exhibit 4.1 of the Company's Annual Report on Form 10-K for the fiscal year ended February 29, 2020, filed with the Securities and Exchange Commission on April 29, 2020).](https://www.sec.gov/Archives/edgar/data/916789/000091678920000024/fy20q410kexhibit41-1.htm)</u> |
| 10.1† | <u>[Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 of the Company](https://www.sec.gov/Archives/edgar/data/916789/000110465914031704/a14-4707_1ex10d1.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000110465914031704/a14-4707_1ex10d1.htm)[s Annual Report on Form 10-K for the fiscal year ended February 28, 2014, filed with the Securities and Exchange Commission on April 29, 2014).](https://www.sec.gov/Archives/edgar/data/916789/000110465914031704/a14-4707_1ex10d1.htm)</u> |
| 10.2† | <u>[Amended and Restated Helen of Troy Limited 2011 Annual Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company's Quarterly Report on 10-Q, filed with the Securities and Exchange Commission on October 11, 2016).](https://www.sec.gov/Archives/edgar/data/916789/000155837016008575/hele-20160831ex101784835.htm)</u> |
| 10.3† | <u>[Helen of Troy Limited 2018 Stock Incentive Plan (incorporated by reference to Annex B of the Company](https://www.sec.gov/Archives/edgar/data/916789/000104746918004800/a2236142zdef14a.htm#NA42)['](https://www.sec.gov/Archives/edgar/data/916789/000104746918004800/a2236142zdef14a.htm#NA42)[s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on June 28, 2018 (the "2018 Proxy")).](https://www.sec.gov/Archives/edgar/data/916789/000104746918004800/a2236142zdef14a.htm#NA42)</u> |
| 10.4† | <u>[Helen of Troy Limited 2018 Employee Stock Purchase Plan (incorporated by reference to Annex C of the 2018 Proxy).](https://www.sec.gov/Archives/edgar/data/916789/000104746918004800/a2236142zdef14a.htm#NA43)</u> |
| 10.5† | <u>[Amended and Restated](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)[Severance Agreement between Helen of Troy Nevada Corporation and Brian Grass, dated](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)[May 2, 2025](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)[(incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)[May 6, 2025](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)[).](https://www.sec.gov/Archives/edgar/data/916789/000091678925000015/exhibit101_briangrassame.htm)</u> |
| 10.6† | <u>[Amended and Restated Employment Agreement among Helen of Troy Nevada Corporation, Helen of Troy Limited, a Bermuda company, Helen of Troy Limited, a Barbados company, and Julien Mininberg, effective March 1, 2021 (incorporated by reference to Exhibit 10.1 to the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678920000085/a101amendedandrestatedem.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678920000085/a101amendedandrestatedem.htm)[s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 10, 2020](https://www.sec.gov/Archives/edgar/data/916789/000091678920000085/a101amendedandrestatedem.htm)[).](https://www.sec.gov/Archives/edgar/data/916789/000091678920000085/a101amendedandrestatedem.htm)</u> |
| 10.7† | <u>[Employment Agreement among Helen of Troy Nevada Corporation and Noel Geoffroy, dated April 25, 2023 (incorporated by reference to Exhibit 10.1 to the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678923000014/exhibit101noelgeoffroyem.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678923000014/exhibit101noelgeoffroyem.htm)[s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 26, 2023).](https://www.sec.gov/Archives/edgar/data/916789/000091678923000014/exhibit101noelgeoffroyem.htm)</u> |
| 10.8† | <u>[Employment Agreement between Helen of Troy Limited, Helen of Troy Nevada Corporation and Scott Uzzell, dated August 12, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2025).](https://www.sec.gov/Archives/edgar/data/916789/000091678925000051/exhibit101_scottuzzellem.htm)</u> |

---

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

---

| | |
|:---|:---|
| 10.9 | <u>[Credit Agreement dated February 15, 2024, by and among Helen of Troy Texas Corporation, Helen of Troy Limited, Bank of America, N.A., as administrative agent, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 20, 2024 (the "February 2024 8-K")).](https://www.sec.gov/Archives/edgar/data/916789/000091678924000007/exhibit101helenoftroybof.htm)</u> |
| 10.10 | <u>[Guaranty dated February 15, 2024, made by Helen of Troy Limited and certain of its subsidiaries in favor of Bank of America, N.A. and other lenders (incorporated by reference to Exhibit 10.2 of the Company's February 2024 8-K).](https://www.sec.gov/Archives/edgar/data/916789/000091678924000007/exhibit102helenoftroybof.htm)</u> |
| 10.11 | <u>[First Amendment to Credit Agreement dated November 25, 2025, by and among Helen of Troy Texas Corporation, Helen of Troy Limited, Bank of America, N.A., as administrative agent, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 25, 2025).](https://www.sec.gov/Archives/edgar/data/916789/000091678925000110/firstamendmenttohotcredi.htm)</u> |
| 10.12† | <u>[First Amendment to the Helen of Troy Limited 2018 Stock Incentive Plan dated February 28, 2024 (incorporated by reference to Exhibit 10.12 of the Company's 2024 10-K).](https://www.sec.gov/Archives/edgar/data/916789/000091678924000015/fy24_q4x10kxexhibit1012.htm)</u> |
| 10.13† | <u>[Helen of Tro](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)[y Limited 2025 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)[(incorporated by reference to Exhibit 10.1 of the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)[s C](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)[urrent Report on Form 8-K filed with the Securities and Exchange Commission on August 21, 2025).](https://www.sec.gov/Archives/edgar/data/916789/000091678925000054/exhibit101.htm)</u> |
| 19 | <u>[Policy on](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[Insider Trading](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[(incorporated by reference to Exhibit 19](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[to](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[s Annual Report o](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[n Form 10-K for the fiscal year ended February 28, 202](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[5, filed with the Securities and Exchange Commission on April 24, 2025](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[)](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)[.](https://www.sec.gov/Archives/edgar/data/916789/000091678925000012/fy25_q4x10kxexhibit19.htm)</u> |
| <u>[21\*](fy26_q4x10kxexhibit21.htm)</u> | <u>[Subsidiaries of the Registrant.](fy26_q4x10kxexhibit21.htm)</u> |
| <u>[23.1\*](fy26_q4x10kxexhibit231.htm)</u> | <u>[Consent of Independent Registered Public Accounting Firm, Grant Thornton LLP.](fy26_q4x10kxexhibit231.htm)</u> |
| <u>[31.1\*](fy26_q4x10kxexhibit311.htm)</u> | <u>[Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](fy26_q4x10kxexhibit311.htm)</u> |
| <u>[31.2\*](fy26_q4x10kxexhibit312.htm)</u> | <u>[Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](fy26_q4x10kxexhibit312.htm)</u> |
| <u>[32\*\*](fy26_q4x10kxexhibit32.htm)</u> | <u>[Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](fy26_q4x10kxexhibit32.htm)</u> |
| 97 | <u>[Policy Relating to Recovery of Erroneously Awarded Compensation (incorporated by reference to Exhibit 97 of the Company](https://www.sec.gov/Archives/edgar/data/916789/000091678924000015/fy24_q4x10kxexhibit97.htm)['](https://www.sec.gov/Archives/edgar/data/916789/000091678924000015/fy24_q4x10kxexhibit97.htm)[s 2024 10-K)](https://www.sec.gov/Archives/edgar/data/916789/000091678924000015/fy24_q4x10kxexhibit97.htm)</u>. |
| 101.INS\* | Inline XBRL Instance Document. |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema. |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase. |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase. |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase. |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase. |
| 104 | Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101. |

---

**Item 16. Form 10-K Summary**

None.

------

<u>[**Table of Contents**](#i936101cd7c9141b1bfa0ebe7f99e49a9_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| |
|:---|
| **HELEN OF TROY LIMITED** |
| <u>By: /s/ G. Scott Uzzell</u> |
| G. Scott Uzzell<br>Chief Executive Officer, Director and Principal Executive Officer<br>April 23, 2026 |

---

Pursuant to the requirements of the Exchange Act, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| <u>/s/ G. Scott Uzzell</u> | <u>/s/ Brian L. Grass</u> |
| G. Scott Uzzell<br>Chief Executive Officer, Director and Principal Executive Officer<br>April 23, 2026 | Brian L. Grass<br>Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer<br>April 23, 2026 |
| <u>/s/ Timothy F. Meeker</u> | <u>/s/ Tabata L. Gomez</u> |
| Timothy F. Meeker<br>Director, Chairman of the Board<br>April 23, 2026 | Tabata L. Gomez<br>Director<br>April 23, 2026 |
| <u>/s/ Beryl B. Raff</u> | <u>/s/ Krista L. Berry</u> |
| Beryl B. Raff<br>Director<br>April 23, 2026 | Krista L. Berry<br>Director<br>April 23, 2026 |
| <u>/s/ Darren G. Woody</u> | <u>/s/ Thurman K. Case</u> |
| Darren G. Woody<br>Director<br>April 23, 2026 | Thurman K. Case<br>Director<br>April 23, 2026 |
| <u>/s/ Vincent D. Carson</u> | <u>/s/ Elena B. Otero</u> |
| Vincent D. Carson <br>Director<br>April 23, 2026 | Elena B. Otero <br>Director<br>April 23, 2026 |

---

## Ex-21

**EXHIBIT 21**

**SUBSIDIARIES OF THE REGISTRANT**

The following subsidiaries of Helen of Troy Limited are as of February 28, 2026 and are all, directly or indirectly, wholly-owned by Helen of Troy Limited.

---

| | | |
|:---|:---|:---|
| Name | Incorporation | Doing Business as |
| B&W Enterprises Limited | British Virgin Islands | Same Name |
| Drybar Products LLC | Delaware | Same Name |
| Helen of Troy Canada, Inc. | Nevada | Same Name |
| Helen of Troy (Cayman) Limited | Cayman Islands | Same Name |
| Helen of Troy Chile S.A. | Chile | Same Name |
| Helen of Troy Consulting (Shenzhen) Company Limited | China | Same Name |
| Helen of Troy Consulting Vietnam | Vietnam | Same Name |
| Helen of Troy de Mexico S. de R.L. de C.V. | Mexico | Same Name |
| Helen of Troy Holding B.V. | Netherlands | Same Name |
| Helen of Troy Insurance Limited | Cayman Islands | Same Name |
| Helen of Troy Limited | Barbados | Same Name |
| Helen of Troy L.P. | Texas | Same Name |
| Helen of Troy Macao Limited | Macau | Same Name |
| Helen of Troy Middle East Services FZ – LLC | Dubai | Same Name |
| Helen of Troy Nevada Corporation | Nevada | Same Name |
| Helen of Troy Services Limited | Hong Kong | Same Name |
| Helen of Troy Texas Corporation | Texas | Same Name |
| H.O.T. Cayman Holding | Cayman Islands | Same Name |
| HOT (Jamaica) Limited | Jamaica | Same Name |
| HOT Latin America, LLC | Nevada | Same Name |
| HOT Nevada, Inc. | Nevada | Same Name |
| HOT Switzerland Services Sarl | Switzerland | Same Name |
| HOT (UK) Limited | England & Wales | Same Name |
| Idelle Labs, Ltd. | Texas | Same Name |
| Kaz Canada, Inc. | Massachusetts | Same Name |
| Kaz Europe Sarl | Switzerland | Same Name |
| Kaz (Far East) Limited | Hong Kong | Same Name |
| Kaz France SAS | France | Same Name |
| Kaz Hausgeraete GesmbH | Austria | Same Name |
| Kaz Hausgeraete GmbH | Germany | Same Name |
| Kaz, Inc. | New York | Same Name |
| Kaz USA, Inc. | Massachusetts | Same Name |
| Olive & June, LLC | Delaware | Same Name |
| OJCO, LLC | California | Same Name |
| OJIP, LLC | California | Same Name |
| OJP, LLC | California | Same Name |
| Osprey Child Safety Products, LLC | Colorado | Same Name |
| Osprey Europe B.V. | Netherlands | Same Name |
| Osprey Europe Limited | England and Wales | Same Name |

---

------

---

| | | |
|:---|:---|:---|
| Osprey Packs, Inc. | Colorado | Same Name |
| Osprey Packs Vietnam Company Limited | Vietnam | Same Name |
| Osprey Properties, LLC | Colorado | Same Name |
| Osprey Properties II, LLC | Colorado | Same Name |
| OXO International, Inc. | Nevada | Same Name |
| OXO International, Ltd. | Texas | Same Name |
| Pur Water Purification Products, Inc. | Nevada | Same Name |
| Recipe Products Ltd | England and Wales | Same Name and Curlsmith |
| Recipe Products Ltd USA | Delaware | Same Name and Curlsmith |
| Steel Technology, LLC | Oregon | Same Name and Hydro Flask |

---

## Exhibit 23.1

**EXHIBIT 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We have issued our reports dated April 23, 2026, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Helen of Troy Limited on Form 10-K for the year ended February 28, 2026. We consent to the incorporation by reference of said reports in the Registration Statements of Helen of Troy Limited on Forms S-8 (File No. 333-227074; File No. 333-227075; and File No. 333-289771).

/s/ GRANT THORNTON LLP

Dallas, Texas

April 23, 2026

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, G. Scott Uzzell, certify that:

1. I have reviewed this annual report on Form 10-K of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: <u>April 23, 2026</u>

<u>/s/ G. Scott Uzzell</u>

G. Scott Uzzell

Chief Executive Officer,

Director and Principal Executive Officer

## Exhibit 31.2

**EXHIBIT 31.2**

**<u>CERTIFICATION</u>**

I, Brian L. Grass, certify that:

1. I have reviewed this annual report on Form 10-K of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: <u>April 23, 2026</u>

<u>/s/ Brian L. Grass</u>

Brian L. Grass

Chief Financial Officer,

Principal Financial Officer and

Principal Accounting Officer

## Ex-32

**EXHIBIT 32**

**<u>CERTIFICATION</u>**

In connection with the Annual Report of Helen of Troy Limited (the "Company") on Form 10-K for the fiscal year ended February 28, 2026, as filed with the Securities and Exchange Commission (the "Report"), and pursuant to 18 U.S.C., Chapter 63, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, the Chief Executive Officer and Chief Financial Officer of the Company, hereby certifies that to the best of their knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: <u>April 23, 2026</u>

<u>/s/ G. Scott Uzzell</u>

G. Scott Uzzell

Chief Executive Officer,

Director and Principal Executive Officer

<u>/s/ Brian L. Grass</u>

Brian L. Grass

Chief Financial Officer,

Principal Financial Officer and

Principal Accounting Officer

This certification is not deemed to be "filed" for purposes of section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

<br>